Publications and communications of Bruyère, Olivier

BRUYERE, O., Reginster, J.-Y., & Beaudart, C. (July 2022). Lifestyle approaches to prevent and retard sarcopenia: A narrative review. Maturitas, 161, 44-48. doi:10.1016/j.maturitas.2022.02.004

SANFILIPPO, D., BEAUDART, C., Gaillard A, BORNHEIM, S., BRUYERE, O., & KAUX, J.-F. (26 March 2022). WHAT ARE THE MAIN RISK FACTORS FOR LOWER EXTREMITY RUNNING-RELATED INJURIES? A RETROSPECTIVE SURVEY BASED ON 3669 RESPONDENTS. Paper presented at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.

Brabant, C., Geerinck, A., BEAUDART, C., Tirelli, E., Geuzaine, C., & BRUYERE, O. (15 March 2022). Exposure to magnetic fields and childhood leukemia: a systematic review and meta-analysis of case-control and cohort studies. Reviews on Environmental Health, online first. doi:10.1515/reveh-2021-0112

Denoël, V., Bruyère, O., Louppe, G., Bureau, F., D'ORIO, V., Fontaine, S., Gillet, L., Guillaume, M., Haubruge, E., Lange, A.-C., Michel, F., Hulle, R. V., Arnst, M., Donneau, A.-F., & Saegerman, C. (04 March 2022). Decision-based interactive model to determine re-opening conditions of a large university campus in Belgium during the first COVID-19 wave. Archives of Public Health, 80 (1). doi:10.1186/s13690-022-00801-w

Pinto, D., Alshahrani, M., Chapurlat, R., Chevalley, T., Dennison, E., Camargos, B. M., Papaioannou, A., Silverman, S., Kaux, J.-F., Lane, N. E., Morales Torres, J., Paccou, J., Rizzoli, R., & Bruyère, O. (March 2022). The global approach to rehabilitation following an osteoporotic fragility fracture: A review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scientific advisors. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 33 (3), 527-540. doi:10.1007/s00198-021-06240-7

Ladang, A., Kovacs, S., Lengele, L., Locquet, M., Reginster, J.-Y., Bruyère, O., & Cavalier, E. (2022). Neurofilament light chain concentration in an aging population. Aging Clinical and Experimental Research, 34 (2), 331-339. doi:10.1007/s40520-021-02054-z

Lengele, L., Locquet, M., Moutschen, M., Beaudart, C., KAUX, J.-F., Gillain, S., Reginster, J.-Y., & Bruyère, O. (January 2022). Frailty but not sarcopenia nor malnutrition increases the risk of developing COVID-19 in older community-dwelling adults. Aging Clinical and Experimental Research, 34 (1), 223-234. doi:10.1007/s40520-021-01991-z

Locquet, M., Sanchez Rodriguez, M. D. C., Bruyère, O., Geerinck, A., Lengele, L., Reginster, J.-Y., & Beaudart, C. (2022). Intrinsic Capacity Defined Using Four Domains and Mortality Risk: A 5-Year Follow-Up of the SarcoPhAge Cohort. The journal of nutrition, health & aging, 26 (1), 23-29. doi:10.1007/s12603-021-1702-7

ROUSSEAU, A.-F., KELLENS, I., DELANAYE, P., Bruyère, O., Misset, B., & Croisier, J.-L. (January 2022). Experimental Approach of Quadriceps Strength Measurement: Implications for Assessments in Critically Ill Survivors. Diagnostics, 12 (1), 202. doi:10.3390/diagnostics12010202

Veronese, N., Honvo, G., Amuthavalli Thiyagarajan, J., Rizzoli, R., Cooper, C., BRUYERE, O., Mikton, C., Sumi, Y., Diaz, T., Reginster, J.-Y., Banerjee, A., & members of the WHO Collaborating Center Working Group on Locomotor Capacity. (2022). Attributes and definitions of locomotor capacity in older people: a World Health Organisation (WHO) locomotor capacity working group meeting report. Aging Clinical and Experimental Research, 34 (3), 481-483. doi:10.1007/s40520-022-02080-5

Willers, C., Norton, N., Harvey, N. C., Jacobson, T., Johansson, H., Lorentzon, M., McCloskey, E. V., Borgström, F., Kanis, J. A., Kaux, J.-F. (Other coll.), Reginster, J.-Y. (Other coll.), Bruyère, O. (Other coll.), Cavalier, E. (Other coll.), & LECART, M.-P. (Other coll.). (January 2022). Osteoporosis in Europe: a compendium of country-specific reports. Archives of Osteoporosis, 17 (1), 23. doi:10.1007/s11657-021-00969-8

Dellatte, J., Leclercq, V., Kaux, J.-F., Bruyère, O., & Martens, G. (November 2021). Self-medication in fitness centers. British Journal of Sports Medicine, 55 (S1), 135-136. doi:10.1136/bjsports-2021-IOC.325

SANFILIPPO, D., BEAUDART, C., Bruyère, O., Kaux, J.-F., & Martens, G. (November 2021). What are the main risk factors for lower-extremity running-related injuries? A retrospective survey-based on 3669 respondents. British Journal of Sports Medicine, 55 (S1), 127.

SANFILIPPO, D., BEAUDART, C., Gaillard, A., Bornheim, S., Bruyère, O., & Kaux, J.-F. (November 2021). What Are the Main Risk Factors for Lower Extremity Running-Related Injuries? A Retrospective Survey Based on 3669 Respondents. Orthopaedic Journal of Sports Medicine, 9 (11), 23259671211043444. doi:10.1177/23259671211043444

SANFILIPPO, D., BEAUDART, C., Gaillard, A., Bornheim, S., Bruyère, O., & Kaux, J.-F. (September 2021). What are the main risk factors for lower-extremity running-related injuries? A retrospective survey-based on 3669 respondents. Medicina dello Sport: Rivista di Fisiopatologia dello Sport, 74 (Suppl. 1 to n.3), 29.

Lengele, L., Bruyère, O., FADEUR, M., VERBRUGGE, A.-M., MARTIN, F., HANS, N., Misset, B., & ROUSSEAU, A.-F. (June 2021). Should We Worry About Nutrition Of Adults With Minor Burns? An Audit Of Their Intakes. Annals of Burns and Fire Disasters, 34 (2), 163-169.

Beaudart, C., Gillier, M., Bornheim, S., Van Beveren, J., Bruyère, O., & Kaux, J.-F. (February 2021). French Translation and Validation of the Victorian Institute of Sports Assessment for Gluteal Tendinopathy Questionnaire. PM and R, 13 (2), 137-143. doi:10.1002/pmrj.12391

Annweiler, C., BRUYERE, O., CAVALIER, E., young, J., & Souberbielle, C. (January 2021). Assurer un statut satisfaisant en vitamine D dans la population générale est particulièrement important dans le contexte de la Covid-19. Revue du Praticien, 71 (1), 7-11.

Arden, N. K., Perry, T. A., Bannuru, R. R., Bruyère, O., Cooper, C., Haugen, I. K., Hochberg, M. C., McAlindon, T. E., Mobasheri, A., & Reginster, J.-Y. (2021). Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines. Nature Reviews Rheumatology, 17, 59-66. doi:10.1038/s41584-020-00523-9

Beaudart, C., Bauer, J. M., Landi, F., Bruyère, O., Reginster, J.-Y., & Hiligsmann, M. (2021). Experts' preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS). Aging Clinical and Experimental Research, 33, 1079-1083. doi:10.1007/s40520-021-01794-2

Beaudart, C., Bonnefoy, M., Gilbert, T., Paillaud, E., Raynaud-Simon, A., Guérin, O., Jeandel, C., Le Sourd, B., Haine, M., Ferry, M., Rolland, Y., Berrut, G., Reginster, J.-Y., & Bruyère, O. (2021). Quelle qualité de vie pour le patient sarcopénique ? Gériatrie et Psychologie Neuropsychiatrie du Vieillissement, 19 (3), 245-252. doi:10.1684/pnv.2021.0948

Bruyère, O., Detilleux, J., & Reginster, J.-Y. (2021). Cost-Effectiveness Assessment of Different Glucosamines in Patients with Knee Osteoarthritis: A Simulation Model Adapted to Germany. Current Aging Science, 14 (3), 242-248. doi:10.2174/1874609814666210415092845

Cortet, B., Lombion, S., Naissant, B., Vidovic, E., & Bruyère, O. (2021). Non-Inferiority of a Single Injection of Sodium Hyaluronate Plus Sorbitol to Hylan G-F20: A 6-Month Randomized Controlled Trial. Advances in Therapy, 38 (5), 2271-2283. doi:10.1007/s12325-021-01648-3

Erdogan, T., Eris, S., Avci, S., Oren, M. M., Kucukdagli, P., Kilic, C., Beaudart, C., Bruyère, O., Karan, M. A., & Bahat, G. (2021). Sarcopenia quality‑of‑life questionnaire (SarQoL)®: translation, cross‑cultural adaptation and validation in Turkish. Aging Clinical and Experimental Research, in press. doi:10.1007/s40520-020-01780-0

Ferrer Soler, C., Cuvelier, C., Hars, M., Herrmann, F. R., Charpiot, A., Ducharne Wieczorkiewicz, C., Bruyère, O., Beaudart, C., Zekry, D., Gold, G., & Trombetti, A. (2021). Validation of the Perform-FES: a new fear of falling scale for hospitalized geriatric patients. Aging Clinical and Experimental Research, 33 (1), 67-76. doi:10.1007/s40520-020-01726-6

Geerinck, A., Beaudart, C., Reginster, J.-Y., Locquet, M., Monseur, C., GILLAIN, S., & Bruyère, O. (2021). Development and validation of a short version of the Sarcopenia Quality of Life questionnaire: the SF‑SarQoL. Quality of Life Research, in press. doi:10.1007/s11136-021-02823-3

Geerinck, A., Dawson-Hughes, B., Beaudart, C., Locquet, M., Reginster, J.-Y., & Bruyère, O. (2021). Assessment of the performance of the SarQoL questionnaire in screening for sarcopenia in older people. Aging Clinical and Experimental Research, 33, 2149-2155. doi:10.1007/s40520-021-01913-z

Geerinck, A., Locquet, M., Bruyère, O., Reginster, J.-Y., & Beaudart, C. (2021). Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL(®) questionnaire. Journal of Cachexia, Sarcopenia and Muscle, 12 (2), 319-330. doi:10.1002/jcsm.12687

Geerinck, A., Locquet, M., Hiligsmann, M., Reginster, J.-Y., Bruyère, O., & Beaudart, C. (2021). Patients' preferences for quality-of-life aspects in sarcopenia: a best-worst scaling study. European Geriatric Medicine, online first. doi:10.1007/s41999-021-00563-8

Geerinck, A., Locquet, M., Reginster, J.-Y., Bruyère, O., & Beaudart, C. (2021). Letter to the Editor: Discriminative Power of the Sarcopenia Quality of Life (SarQoL®) Questionnaire with the EWGSOP2 Criteria [letter to the editor]. The Journal of frailty & aging, 10 (2), 193-194. doi:10.14283/jfa.2020.47

Geerinck, A., Locquet, M., Reginster, J.-Y., Bruyère, O., & Beaudart, C. (2021). Discriminative power of the Sarcopenia Quality of Life (SarQoL) questionnaire with the EWGSOP2 criteria [letter to the editor]. Journal of Frailty and Aging, 10 (2), 193-194.

Gielen, E., Beckwée, D., Delaere, A., De Breucker, S., Vandewoude, M., Bautmans, I., Beaudart, C., Beyer, I., Bruyère, O., De Cock, A.-M., de Saint-Hubert, M., De Spiegeleer, A., & Perkisas, S. (2021). Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses. Nutrition Reviews, 79 (2), 121-147. doi:10.1093/nutrit/nuaa011

Lengele, L., Bruyère, O., Beaudart, C., Reginster, J.-Y., & Locquet, M. (2021). Malnutrition, assessed by the Global Leadership Initiative on Malnutrition (GLIM) criteria but not by the mini nutritional assessment (MNA), predicts the incidence of sarcopenia over a 5-year period in the SarcoPhAge cohort. Aging Clinical and Experimental Research, 33 (6), 1507-1517. doi:10.1007/s40520-021-01880-5

Lengele, L., Bruyère, O., Beaudart, C., Reginster, J.-Y., & Locquet, M. (2021). Impact of malnutrition status on muscle parameter changes over a 5-year follow-up of community-dwelling older adults from the SarcoPhage Cohort. Nutrients, 13 (2), 407. doi:10.3390/nu13020407

Lengele, L., Bruyère, O., Beaudart, C., Reginster, J.-Y., & Loquet, M. (2021). Correction to: Malnutrition, assessed by the Global Leadership Initiative on Malnutrition (GLIM) criteria but not by the mini nutritional assessment (MNA), predicts the incidence of sarcopenia over a 5‑year period in the SarcoPhAge cohort. Aging Clinical and Experimental Research. doi:10.1007/s40520-021-01901-3

Locquet, M., Benhotman, B., Bornheim, S., Van Beveren, J., D'Hooghe, P., Bruyère, O., & Kaux, J.-F. (January 2021). The "Ankle Instability Instrument": Cross-cultural adaptation and validation in French. Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons, 27 (1), 70-76. doi:10.1016/j.fas.2020.02.006

Locquet, M., Bonnard, F., Beaudart, C., COENDO, C., Gillain, S., Reginster, J.-Y., & Bruyère, O. (2021). An Assessment of the Toulouse Saint Louis University Mini Falls Assessment Tool to Predict Incident Falls among Older Adults Residing in Nursing Homes: A 6-Month Prospective Study. Journal of Nutrition, Health and Aging, 25 (7), 933-937. doi:10.1007/s12603-021-1651-1

Locquet, M., Bruyère, O., Lengele, L., Reginster, J.-Y., & Beaudart, C. (2021). Relationship between smoking and the incidence of sarcopenia: The SarcoPhAge cohort. Public Health, 193, 101-108. doi:10.1016/j.puhe.2021.01.017

Locquet, M., Diep, A. N., Beaudart, C., Dardenne, N., Brabant, C., Bruyère, O., & Donneau, A.-F. (2021). A systematic review of prediction models to diagnose COVID-19 in adults admitted to healthcare centers. Archives of Public Health, 79 (1), 105. doi:10.1186/s13690-021-00630-3

Meuris, C., Kremer, C., Geerinck, A., Locquet, M., Bruyère, O., Defêche, J., Meex, C., Hayette, M.-P., Duchene, L., Dellot, P., Azarzar, S., Maréchal, N., Sauvage, A.-S., Frippiat, F., Giot, J.-B., Léonard, P., Fombellida, K., Moutschen, M., Durkin, K., & Darcis, G. (2021). Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium. JAMA Network Open, 4 (10), 2128757. doi:10.1001/jamanetworkopen.2021.28757

Parsons, C. M., Judge, A., Meyer, R., Bruyère, O., Petit-Dop, F., Chapurlat, R., Reginster, J.-Y., Cooper, C., & Inskip, H. (January 2021). Determining individual trajectories of joint space loss: improved statistical methods for monitoring knee osteoarthritis disease progression. Osteoarthritis and Cartilage, 29 (1), 59-67. doi:10.1016/j.joca.2020.09.009

Reginster, J.-Y., Beaudart, C., Al-Daghri, N., Avouac, B., Bauer, J., Bere, N., Bruyère, O., Cerreta, F., Cesari, M., Rosa, M. M., Cooper, C., Cruz Jentoft, A. J., Dennison, E., Geerinck, A., Gielen, E., Landi, F., Laslop, A., Maggi, S., Prieto Yerro, M. C., & Fielding, R. A. (2021). Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults. Aging Clinical and Experimental Research, 33, 3-17. doi:10.1007/s40520-020-01663-4

Sanchez Rodriguez, M. D. C., Locquet, M., Bruyère, O., Lengele, L., CAVALIER, E., Reginster, J.-Y., & Beaudart, C. (2021). Prediction of 5-year mortality risk by malnutrition according to the GLIM format using seven pragmatic approaches to define the criterion of loss of muscle mass. Clinical Nutrition, 2188-2199. doi:10.1016/j.clnu.2020.09.047

Slomian, J., Reginster, J.-Y., Emonts, P., & Bruyère, O. (2021). Identifying maternal needs following childbirth: comparison between pregnant women and recent mothers. BMC Pregnancy and Childbirth, 21 (1), 405. doi:10.1186/s12884-021-03858-7

Zhang, Z., Huang, C., Cao, Y., Mu, R., Zhang, M. C., Xing, D., Fan, D., Ding, Y., Guo, J., Hou, Y., Jianhao, L., Veronese, N., Reginster, J.-Y., Bruyère, O., Cavalier, E., & Zhang, H. (2021). 2021 revised algorithm for the management of knee osteoarthritis-the Chinese viewpoint. Aging Clinical and Experimental Research, 33 (8), 2141-2147. doi:10.1007/s40520-021-01906-y

Beaudart, C., Lengele, L., Leclercq, V., Geerinck, A., Sanchez Rodriguez, M. D. C., Bruyère, O., & Reginster, J.-Y. (December 2020). Symptomatic Efficacy of Pharmacological Treatments for Knee Osteoarthritis: A Systematic Review and a Network Meta‑Analysis with a 6‑Month Time Horizon. Drugs, 80 (18), 1947-1959. doi:10.1007/s40265-020-01423-8

Geerinck, A., Reginster, J.-Y., Locquet, M., Monseur, C., Gillain, S., Bruyère, O., & Beaudart, C. (December 2020). Clinimetric properties of the newly developed short form sarcopenia quality of life (SF-SarQoL) questionnaire. Poster session presented at Society on Sarcopenia, Cachexia and Wasting Disorders conference.

Honvo, G., Lengele, L., Charles, A., Reginster, J.-Y., & Bruyère, O. (December 2020). Role of Collagen Derivatives in Osteoarthritis and Cartilage Repair: A Systematic Scoping Review With Evidence Mapping. Rheumatology and Therapy, 7 (4), 703-740. doi:10.1007/s40744-020-00240-5

SANFILIPPO, D., BEAUDART, C., Bornheim, S., Bruyère, O., & Kaux, J.-F. (December 2020). WHAT ARE THE MAIN RISK FACTORS FOR LOWER-EXTREMITY RUNNING-RELATED INJURIES? A RETROSPECTIVE SURVEY-BASED ON 3669 RESPONDENTS. Osteoporosis International, 31 (S1), 225.

Buckinx, F., Lecocq, G., Bornheim, S., Van Beveren, J., VALCU, C.-A., DANIEL, C., Bruyère, O., Reginster, J.-Y., D'Hooghe, P., & Kaux, J.-F. (August 2020). French translation and validation of the Achilles Tendon Total Rupture Score "ATRS". Foot and Ankle Surgery, 26 (6), 662-668. doi:10.1016/j.fas.2019.08.010

Geerinck, A., Beaudart, C., Locquet, M., Reginster, J.-Y., & Bruyère, O. (August 2020). Association between SARC-F and quality of life measured with the SarQoL questionnaire in older, community-dwelling subjects from the SarcoPhAge cohort. Poster session presented at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.

Locquet, M., Willems, T., Specque, C., Beaudart, C., Bruyère, O., Van Beveren, J., Dardenne, N., Reginster, J.-Y., & Kaux, J.-F. (July 2020). Cross-cultural adaptation, translation, and validation of the functional assessment scale for acute hamstring injuries (FASH) questionnaire for French-speaking patients. Disability and Rehabilitation, 42 (14), 2076-2082. doi:10.1080/09638288.2018.1544669

Bruyère, O., Kaux, J.-F., & Locquet, M. (2020). Traduction et validation d'un questionnaire. Kinésithérapie du Sport Information, (2), 18-19.

Geerinck, A., Beaudart, C., Salvan, Q., Van Beveren, J., D'Hooghe, P., Bruyère, O., & Kaux, J.-F. (June 2020). French translation and validation of the Cumberland Ankle Instability Tool, an instrument for measuring functional ankle instability. Foot and Ankle Surgery, 26 (4), 391-397. doi:10.1016/j.fas.2019.05.002

Fuggle, N. R., Cooper, C., Oreffo, R. O. C., Price, A. J., Kaux, J.-F., Maheu, E., Cutolo, M., Honvo, G., Conaghan, P. G., Berenbaum, F., Branco, J., Brandi, M. L., Cortet, B., Veronese, N., Kurth, A. A., Matijevic, R., Roth, R., Pelletier, J. P., Martel-Pelletier, J., & Reginster, J.-Y. (April 2020). Alternative and complementary therapies in osteoarthritis and cartilage repair. Aging Clinical and Experimental Research, 32 (4), 547-560. doi:10.1007/s40520-020-01515-1

Beaudart, C., Hagelstein, T., Van Beveren, J., GODON, B., Bruyère, O., & Kaux, J.-F. (March 2020). French translation and validation of the exercise-induced leg pain Questionnaire. Disability and Rehabilitation, 42 (6), 857-862. doi:10.1080/09638288.2018.1508512

Geerinck, A., Beaudart, C., Locquet, M., Reginster, J.-Y., & Bruyère, O. (March 2020). Association between frailty and quality of life measured with the SarQoL®, SF-36 and EQ-5D questionnaires in older people from the SarcoPhAge cohort. Poster session presented at International Conference on Frailty and Sarcopenia Research, Toulouse, France.

Kaux, J.-F., & Bruyère, O. (2020). Traduction de questionnaires algofonctionnels en français. Kinésithérapie du Sport Information, (1), 17.

Locquet, M., Bornheim, S., Colas, L., Van Beveren, J., Bruyère, O., Reginster, J.-Y., & Kaux, J.-F. (March 2020). Erratum à « Traduction en langue française, adaptation transculturelle et validation du questionnaire “Victorian Institute of Sport Assessment Scale for Proximal Hamstring Tendinopathy” (VISA-H) [J. Traumatol. Sport 36 (2019) 217–221](S0762915X19300385)(10.1016/j.jts.2019.04.001). Journal de Traumatologie du Sport, 37 (1), 62. doi:10.1016/j.jts.2020.01.001

Neuprez, A., Neuprez, A., KAUX, J.-F., KURTH, W., DANIEL, C., THIRION, T., Hustin, J.-P., Gillet, P., Bruyère, O., & Reginster, J.-Y. (March 2020). Total joint replacement improves pain, functional quality of life, and health utilities in patients with late-stage knee and hip osteoarthritis for up to 5 years. Clinical Rheumatology, 39 (3), 861-871. doi:10.1007/s10067-019-04811-y

Mouton, A., Gillet, N., Mouton, F., Van Kann, D., Bruyère, O., Cloes, M., & Buckinx, F. (26 February 2020). Effets d’un tapis de jeu géant d’activité physique sur le niveau d’activité physique ambulatoire, des personnes âgées résidant en maison de repos. Paper presented at 11ème Biennale de l'Association pour la Recherche sur l'Intervention en Sport : ‘Former des citoyens physiquement éduqués : Un défi pour les intervenants en milieux scolaire, sportif et des loisirs’, Liège, Belgium.

Leclercq, V., Hiligsmann, M., Parisi, G., Beaudart, C., Tirelli, E., & Bruyère, O. (February 2020). Prioritization of items of the AMSTAR 2 tool to critically appraise systematic reviews and meta-analyses: A best-worst scaling approach. Paper presented at REWARD EQUATOR Conference 2020.

ALLEPAERTS, S., Buckinx, F., Bruyère, O., Reginster, J.-Y., PAQUOT, N., & GILLAIN, S. (2020). Clinical impact of nutritional status and energy balance in elderly hospitalized patients. Journal of Nutrition, Health and Aging, 24 (10), 1073-79. doi:10.1007/s12603-020-1527-9

Beaudart, C., Bauer, J., Landi, F., Bruyère, O., Reginster, J.-Y., & Hiligsmann, M. (2020). A discrete-choice experiment to assess experts’ preferences for sarcopenia outcomes. Osteoporosis International, 31 (S1), 320.

Beaudart, C., Bruyère, O., Cruz-Jentoft, A. J., Vaquero-Pinto, M. N., Locquet, M., Bauer, J., Cooper, C., Rolland, Y., Dupuy, C., Landi, F., Reginster, J.-Y., Maggi, S., Rizzoli, R., & Hiligsmann, M. (2020). Patient’s engagement in the identification of critical outcomes in sarcopenia. Journal of the American Directors Associations, 21 (2), 284-286. doi:10.1016/j.jamda.2019.09.004

Beaudart, C., Bruyère, O., Geerinck, A., Hajaoui, M., Scafoglieri, A., Perkisas, S., Bautmans, I., Gielen, E., Reginster, J.-Y., & Buckinx, F. (2020). Equation models developed with bioelectric impedance analysis tools to assess muscle mass: A systematic review. Clinical Nutrition ESPEN, 35, 47-62. doi:10.1016/j.clnesp.2019.09.012

Beaudart, C., Lengele, L., Geerinck, A., Leclercq, V., Sanchez Rodriguez, M. D. C., Bruyère, O., & Reginster, J.-Y. (2020). Efficacy of symptomatic treatments for knee OA: a systematic review and network meta-analysis with a 6-month time-horizon. Osteoporosis International, 31 (S1), 56.

Beaudart, C., Locquet, M., Lengele, L., Reginster, J.-Y., & Bruyère, O. (2020). The different diagnosis criteria of the EWGSOP2 definition and long-term clinical outcomes. Osteoporosis International, 31 (S1), 58.

Beaudart, C., Locquet, M., Lengele, L., Reginster, J.-Y., & Bruyère, O. (2020). Performance of the “Yubi-wakka (finger-ring) test as self-screening method for sarcopenia using the SarcoPhAge, Belgian cohort study. Osteoporosis International, 31 (S1), 85 and 302.

Berete, F., Demarest, S., Charafeddine, R., Bruyère, O., & Van der Heyden, J. (2020). Correction to: Comparing health insurance data and health interview survey data for ascertaining chronic disease prevalence in Belgium. Archives of Public Health, 78, 136. doi:10.1186/s13690-020-00521-z

Berete, F., Demarest, S., Charafeddine, R., Bruyère, O., & Van der Heyden, J. (2020). Comparing health insurance data and health interview survey data for ascertaining chronic disease prevalence in Belgium. Archives of Public Health, 78 (1), 120. doi:10.1186/s13690-020-00500-4

Berete, F., Van der Heyden, J., Demarest, S., Charafeddine, R., Tafforeau, J., Van Oyen, H., Bruyère, O., & Renard, F. (2020). Validity of self-reported mammography uptake in the Belgian health interview survey: selection and reporting bias. European Journal of Public Health, 31 (1), 214-220. doi:10.1093/eurpub/ckaa217

Bruyère, O., Dardenne, N., Donneau, A.-F., & Reginster, J.-Y. (2020). Responder Profile to Pharmaceutical-Grade Chondroitin Sulfate: An Analysis of the CONCEPT Trial. Advances in Therapy, 37 (11), 4641-4648. doi:10.1007/s12325-020-01484-x

Buckinx, F., Bruyère, O., Lengele, L., Reginster, J.-Y., Marchal, Q., Hurtrez, P., & Mouton, A. (2020). The effects of GAMotion (a giant exercising board game) on physical capacity, motivation and quality of life among nursing home residents: A pilot interventional study. Experimental Gerontology, 138, 110983. doi:10.1016/j.exger.2020.110983

Buckinx, F., Marchal, Q., Hurtrez, P., Bruyère, O., Reginster, J.-Y., & Mouton, A. (2020). The effects of GAMotion (a giant exercising board game) on physical capacity, motivation and quality of life among nursing home residents: a randomized controlled trial. Osteoporosis International, 31 (S1), 261.

Cavalier, E., & Bruyère, O. (2020). Vitamin D for the older patient: From hype to hope? Current Opinion in Clinical Nutrition and Metabolic Care, 23 (1), 4-7. doi:10.1097/MCO.0000000000000616

Cavalier, E., LUKAS, P., Bottani, M., Aarsand, A. K., Ceriotti, F., Coşkun, A., Díaz-Garzón, J., Fernàndez-Calle, P., Guerra, E., Locatelli, M., Sandberg, S., Carobene, A., Åkesson, K., Bhattoa, H. P., Bruyère, O., Cooper, C., Eastell, R., Garnero, P., Heijboer, A., & on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation and IOF-IFCC Committee on Bone Metabolism. (2020). European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein—a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism. Osteoporosis International, 31 (8), 1461-1470. doi:10.1007/s00198-020-05362-8

Charles, A., Buckinx, F., Locquet, M., Reginster, J.-Y., Petermans, J., Gruslin, B., & Bruyère, O. (2020). Prediction of adverse outcomes in nursing home residents according to intrinsic capacity proposed by the World Health Organization. Journal of Gerontology: Series A, Biological Sciences and Medical Sciences, 75 (8), 1594-1599. doi:10.1093/gerona/glz218

Charles, A., Buckinx, F., Mouton, A., Reginster, J.-Y., & Bruyère, O. (2020). Motivational climate of group exercise sessions in nursing homes. Archives of Public Health, 78 (1), 43. doi:10.1186/s13690-020-00425-y

Charles, A., Buckinx, F., Reginster, J.-Y., Mouton, A., & Bruyère, O. (2020). Motivational climate of group exercise sessions in nursing homes. Osteoporosis International, 31 (S1), 217-218.

Charles, A., Detilleux, J., Buckinx, F., Reginster, J.-Y., Gruslin, B., & Bruyère, O. (2020). Physical performance trajectories and mortality among nursing-home residents: the results of the SENIOR Cohort. Osteoporosis International, 31 (S1), 57.

Charles, A., Detilleux, J., Buckinx, F., Reginster, J.-Y., Gruslin, B., & Bruyère, O. (2020). Physical performance trajectories and mortality among nursing home residents: results of the SENIOR cohort. Age and Ageing, 49 (5), 800-806. doi:10.1093/ageing/afaa034

Charles, A., Girard, A., Buckinx, F., Mouton, A., Reginster, J.-Y., & Bruyère, O. (2020). Senior physical activity contests in nursing homes: a feasibility study. Aging Clinical and Experimental Research, 32 (5), 869-876. doi:10.1007/s40520-020-01529-9

Charles, A., Girard, A., Buckinx, F., Mouton, A., Reginster, J.-Y., & Bruyère, O. (2020). Senior physical activity contests in nursing homes: a feasibility study. Osteoporosis International, 31 (S1), 217.

Dzhus, M., Dzhus, M., Masnyi, M., Kulyk, M., Mostbauer, H., Ivashkivsky, O., Boyko, Y., Cherchenko, K., Geerinck, A., Reginster, J.-Y., Bruyère, O., & Beaudart, C. (2020). Cross-sectional evaluation of the sarcopenia quality of life (Sarqol) questionnaire: Translation and validation of its psychometric properties. Annals of Geriatric Medicine and Research, 24 (2), 139-147. doi:10.4235/AGMR.20.0020

Fuggle, N. R., Cooper, C., Harvey, N. C., Al-Daghri, N., Brandi, M.-L., Bruyère, O., Cano, A., Dennison, E. M., Diez-Perez, A., Kaufman, J.-M., Palacios, S., Prieto-Alhambra, D., Rozenberg, S., Thomas, T., Tremollieres, F., Rizzoli, R., Kanis, J. A., & Reginster, J.-Y. (2020). Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs. Drugs, 80 (15), 1537-52. doi:10.1007/s40265-020-01364-2

Geerinck, A., Beaudart, C., Locquet, M., Reginster, J.-Y., & Bruyère, O. (2020). Association between SARC-F and quality of life measured by SARQOL® questionnaire in older, community-dwelling subjects friom the SarcoPhAge cohort. Osteoporosis International, 31 (S1), 451.

Geerinck, A., Bruyère, O., Locquet, M., Gillain, S., Monseur, C., Reginster, J.-Y., & Beaudart, C. (2020). Development of a short version of the sarcopenia quality of life (SARQOL®) questionnaire. Osteoporosis International, 31 (S1), 450-451.

Geerinck, A., Locquet, M., Bruyère, O., Reginster, J.-Y., & Beaudart, C. (2020). Evaluating quality of life in frailty: applicability and psychometric properties of the SARQOL® questionnaire. Osteoporosis International, 31 (S1), 450.

Hiligsmann, M., Beaudart, C., Bruyère, O., Biver, E., Bauer, J., Cruz-Jentoft, A. J., Gesmundo, A., Goissier, S., Landi, F., Locquet, M., Maggi, S., Rizzoli, R., Rolland, Y., Vaquero, N., Cooper, C., & Reginster, J.-Y. (2020). Outcome priorities for older persons with sarcopenia. Journal of the American Directors Associations, 21 (2), 267-271.e2. doi:10.1016/j.jamda.2019.08.026

Hiligsmann, M., Dennison, E., Beaudart, C., Herrero-Beaumont, G., Branco, J., Bruyère, O., Conaghan, P. G., Cooper, C., Al-Daghri, N., Jiwa, F., Lems, W., Pinto, D., Rizzoli, R., Thomas, T., Uebelhart, D., Veronese, N., & Reginster, J.-Y. (2020). A discrete-choice experiment to assess patients’preferences for osteoarthritis treatment: an ESCEO working group. Seminars in Arthritis and Rheumatism, 50 (5), 859-866. doi:10.1016/j.semarthrit.2020.08.005

Kanis, J. A., Harvey, N. C., McCloskey, E., Bruyère, O., Veronese, N., Lorentzon, M., Cooper, C., Rizzoli, R., Adib, G., Al-Daghri, N., Campusano, C., Chandran, M., Dawson-Hughes, B., Javaid, K., Jiwa, F., Johansson, H., Lee, J. K., Liu, E., Messina, D., & Reginster, J.-Y. (2020). Correction to: Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 31 (4), 797-798. doi:10.1007/s00198-020-05297-0

Kanis, J. A., Harvey, N. C., McCloskey, E., Bruyère, O., Veronese, N., Lorentzon, M., Cooper, C., Rizzoli, R., Adib, G., Al-Daghri, N., Campusano, C., Chandran, M., Dawson-Hughes, B., Javaid, K., Jiwa, F., Johansson, H., Lee, J. K., Liu, E., Messina, D., & Reginster, J.-Y. (2020). Algorithm for the management of patients at low, high and vey high risk of osteoporotic fractures. Osteoporosis International, 31 (1), 1-12. doi:10.1007/s00198-019-05176-3

Kanis, J. A., Harvey, N. C., McCloskey, E. V., Bruyère, O., Veronese, N., Lorentzon, M., Cooper, C., Rizzoli, R., Adib, G., Al-Daghri, N., Campusano, C., Chandran, M., Dawson-Hughes, B., Javaid, M. K., Jiwa, F., Johansson, H., Lee, J. K., Liu, E., Messina, O., & Reginster, J.-Y. (2020). ESCEO-IOF algorithm for the management of low/high/very high risk of fracture. Osteoporosis International, 31 (S1), 33.

LADANG, A., Beaudart, C., Locquet, M., Reginster, J.-Y., & Bruyère, O. (2020). Evaluation of a panel of microRNAs that predicts fragility fracture risk: a pilot study. Calcified Tissue International, 106 (3), 239-247. doi:10.1007/s00223-019-00628-8

Leclercq, V., Beaudart, C., Ajamieh, S., Tirelli, E., & Bruyère, O. (2020). The methodological quality of meta-analyses indexed in PsycINFO: leads for enhancements – a meta-epidemiological study. BMJ Open, 10, 036349. doi:10.1136/bmjopen-2019-036349

Leclercq, V., Beaudart, C., Tirelli, E., & Bruyère, O. (2020). Psychometric measurements of AMSTAR 2 in a sample of meta-analyses indexed in PsycINFO. Journal of Clinical Epidemiology, 119, 144-145. doi:10.1016/j.jclinepi.2019.10.005

Leclercq, V., Hiligsmann, M., Parisi, G., Beaudart, C., Tirelli, E., & Bruyère, O. (2020). Best-worst scaling identified adequate statistical methods and literature search as the most important items of AMSTAR2 (A measurement tool to assess systematic reviews). Journal of Clinical Epidemiology, 128, 74-82. doi:10.1016/j.jclinepi.2020.08.011

Lengele, L., Beaudart, C., Locquet, M., Reginster, J.-Y., & Bruyère, O. (2020). 5-year adverse outcomes of sarcopenia diagnosed according to six different definitions. Osteoporosis International, 31 (S1), 47-48.

Lengele, L., Moehlinger, P., Bruyère, O., Locquet, M., Reginster, J.-Y., & Beaudart, C. (2020). Association between Changes in Nutrient Intake and Changes in Muscle Strength and Physical Performance in the SarcoPhAge Cohort. Nutrients, 12 (11), 3485, 1-16. doi:10.3390/nu12113485

Locquet, M., Beaudart, C., Reginster, J.-Y., Bruyère, O., & Croisier, J.-L. (2020). Muscle strengthevaluated using the hand-held dynamometer MicroFET2 in older adults: a reliability study. Osteoporosis International, 31 (S1), 301-302.

Lorentzon, M., Branco, J., Brandi, M. L., Bruyère, O., Chapurlat, R., Cooper, C., Cortet, B., Diez-Perez, A., Ferrari, S., Gasparik, A., Herrman, M., Jorgensen, N. R., Kanis, J. A., Kaufman, J. M., Laslop, A., Locquet, M., Matijevic, R., McCloskey, E. V., Minisola, S., & CAVALIER, E. (2020). Clinical application of bone turnover markers in postmenopausal osteoporosis. Osteoporosis International, 31 (S1), 65-66.

Matijević, R., Hrnjaković, O., Đurđević, A., Geerinck, A., Beaudart, C., Bruyère, O., Dulić, O., Harhaji, V., & Rašović, P. (2020). Translation and psychometric performance of the Serbian version of the Sarcopenia Quality of Life (SarQoL®) questionnaire. Srpski Arhiv za Celokupno Lekarstvo, 148 (11-12), 742-748. doi:10.2298/SARH200924114M

Mavungu Landu, D. J., Marini Djang'Eing'A, R., Hubert, P., Frederich, M., Michel, B., Gretry, L., Messina Ndzomo, J. P., Bruyère, O., Reginster, J.-Y., & Manzambi Kuwekita, J. (2020). Les déterminants de l’accès à des médicaments antipaludiques de qualité en territoires périurbains africains : résultats d’une enquête menée à Kinshasa (Congo). Journal d’Épidémiologie et de Santé Publique, 21, 85-100.

Parsons, C. M., Judge, A., Meyer, R., Bruyère, O., Petir-Dop, F., Chapurlat, R., Reginster, J.-Y., Inskip, H., & Cooper, C. (2020). Improved statistical methods for monitoring knee osteoarthritis disease progression. Osteoporosis International, 31 (S1), 524.

ROUSSEAU, A.-F., Lengele, L., FADEUR, M., MARTIN, F., HANS, N., Bruyère, O., & Misset, B. (2020). Quantification of nutritional intakes in burn outpatients. Journal of Burn Care and Research, 41 (Suppl 1), 153.

Rozenberg, S., Bruyère, O., Bergmann, P., Cavalier, E., Gielen, E., Goemaere, S., Kaufman, J. M., Lapauw, B., Laurent, M. R., De Schepper, J., & Body, J. J. (2020). How to manage osteoporosis before the age of 50. Maturitas, 138, 14-25. doi:10.1016/j.maturitas.2020.05.004

Sanchez Rodriguez, M. D. C., Bergmann, P., Body, J. J., Cavalier, E., Gielen, E., Goemaere, S., Lapauw, B., Laurent, M. R., Rozenberg, S., Honvo, G., Beaudart, C., & Bruyère, O. (2020). The Belgian Bone Club 2020 guidelines for the management of osteoporosis in postmenopausal women. Maturitas, 139, 69 - 89. doi:10.1016/j.maturitas.2020.05.006

Sanchez Rodriguez, M. D. C., Locquet, M., Reginster, J.-Y., Cavalier, E., Bruyère, O., & Beaudart, C. (2020). Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study. Journal of Cachexia, Sarcopenia and Muscle, 11 (5), 1200-1211. doi:10.1002/jcsm.12574

Sanchez Rodriguez, M. D. C., Locquet, M., Reginster, J.-Y., CAVALIER, E., Bruyère, O., & Beaudart, C. (2020). Diagnosis of malnutrition using GLIM criteria : validity of 7 pragmatic approaches which do not require the measurement of muscle mass. Osteoporosis International, 31 (S1), 618.

Tooth, C., Gofflot, A., Schwartz, C., Croisier, J.-L., Beaudart, C., Bruyère, O., & Forthomme, B. (2020). Risk Factors of Overuse Shoulder Injuries in Overhead Athletes: A Systematic Review. Sports Health, 12 (5), 478-87. doi:10.1177/1941738120931764

Tsekoura, M., Billis, E., Gliatis, J., Tsepis, E., Matzaroglou, C., Sakkas, G. K., Beaudart, C., Bruyère, O., Tyllianakis, M., & Panagiotopoulos, E. (2020). Cross cultural adaptation of the Greek sarcopenia quality of life (SarQoL) questionnaire. Disability and Rehabilitation, 42 (7), 1006-1012. doi:10.1080/09638288.2018.1514076

Tsekoura, M., Billis, E., Tsepis, E., Lampropoulou, S., Beaudart, C., Bruyère, O., Yilmaz, O., Bahat, G., & Gliatis, J. (2020). Cross-cultural adaptation and validation of the Greek Version of the SARC-F for evaluating sarcopenia in Greek older adults. Journal of musculoskeletal & neuronal interactions, 20 (4), 505-12.

Veronese, N., Demurtas, J., Smith, L., Reginster, J.-Y., Bruyère, O., Beaudart, C., Honvo, G., & Maggi, S. (2020). Glucosamine sulphate: an umbrella review of health outcomes. Therapeutic Advances in Musculoskeletal Disease, 12, 1-12. doi:10.1177/1759720X20975927

Veronese, N., Demurtas, J., Soysal, P., Smith, O., Bruyère, O., Reginster, J.-Y., Beaudart, C., Cooper, C., Mirko, M., & Maggi, S. (2020). Sarcopenia and health-related outcomes: an umbrella review of observational studies. Osteoporosis International, 31 (S1), 198-199.

Demoulin, C., Bruyère, O., Vandeput, D., & van Assche, D. (December 2019). Prise en charge non-pharmacologique de la coxarthrose et de la gonarthrose : résumé des recommandations. Axxon Magazine pour et par les kinésithérapeutes, 44, 22-25.

Geerinck, A., Beaudart, C., Dardenne, N., Reginster, J.-Y., & Bruyère, O. (December 2019). An exploration of the structural validity of the Sarcopenia Quality of Life (SarQoL) questionnaire with exploratory and confirmatory factor analysis. Paper presented at Journée des doctorants en Santé Publique.

Locquet, M., Bornheim, S., Colas, L., Van Beveren, J., Bruyère, O., Reginster, J.-Y., & Kaux, J.-F. (December 2019). Traduction en langue française, adaptation transculturelle et validation du questionnaire « Victorian Institute of Sport Assessment Scale for Proximal Hamstring Tendinopathy » (VISA-H). Journal de Traumatologie du Sport, 36 (4), 217-221. doi:10.1016/j.jts.2019.04.001

Gillain, S., Boutaayamou, M., Schwartz, C., BRUYERE, O., Bruls, O., CROISIER, J.-L., SALMON, E., Reginster, J.-Y., GARRAUX, G., & PETERMANS, J. (October 2019). Using supervised learning machine algorithm to identify future fallers based on gait patterns: a two-year longitudinal study. Poster session presented at XXIIèmes Journées d'Automne de la SBGG, LIEGE, Belgium.

Gillain, S., Boutaayamou, M., Schwartz, C., Dardenne, N., BRUYERE, O., Bruls, O., Croisier, J.-L., SALMON, E., Reginster, J.-Y., GARRAUX, G., & Petermans, J. (October 2019). Identify future fallers based on gait symmetry dual task changes: a two-year longitudinal study. Poster session presented at 22èmes Journées d'Automne de la SBGG, LIEGE, Belgium.

Bauer, J. M., Cruz-Jentoft, A. J., Fielding, R. A., Kanis, J. A., Reginster, J.-Y., Bruyère, O., Cesari, M., Chapurlat, R., Al-Daghri, N., Dennison, E., Kaufman, J.-M., Landi, F., Laslop, A., Locquet, M., Maggi, S., McCloskey, E., Perna, S., Rizzoli, R., Rolland, Y., & FMedSci, C. C. (August 2019). Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review. Calcified Tissue International, 105 (2), 109-24. doi:10.1007/s00223-019-00561-w

Veronese, N., Cooper, C., Reginster, J.-Y., Hochberg, M., Branco, J., Bruyère, O., Chapurlat, R., Al-Daghri, N., Dennison, E., Herrero-Beaumont, G., Kaux, J.-F., Maheu, E., Rizzoli, R., Roth, R., Rovati, L. C., Uebelhart, D., Vlaskovska, M., & Scheen, A. (August 2019). Type 2 diabetes mellitus and osteoarthritis. Seminars in Arthritis and Rheumatism, 49 (1), 9-19. doi:10.1016/j.semarthrit.2019.01.005

Beaudart, C., Bruyère, O., Reginster, J.-Y., Bauer, J., Cooper, C., Cruz-Jentoft, A. J., Dupuy, C., Landi, F., Locquet, M., Maggi, S., Rizzoli, R., Rolland, Y., Vaquero, N., & Hiligsmann, M. (July 2019). Identification and prioritization of important oucomes for patients in sarcopenia. Osteoporosis International, 30 (S2), 189-S190.

Beaudart, C., Rolland, Y., Cruz-Jentoft, A. J., Bauer, J. M., Sieber, C., Cooper, C., Al-Daghri, N., Araujo de Carvalho, I., Bautmans, I., Bernabei, R., Bruyère, O., Cesari, M., Cherubini, A., Dawson-Hughes, B., Kanis, J. A., Kaufman, J. M., Landi, F., Maggi, S., McCloskey, J., & Fielding, R. A. (July 2019). Assessment of muscle function and physical performance in daily clinical practice: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Calcified Tissue International, 105 (1), 1-14. doi:10.1007/s00223-019-00545-w

Bruyère, O., Detilleux, J., & Reginster, J.-Y. (July 2019). Cost-effectiveness assessment of different glucosamines in patients with knee osteoarthritis: A simulation model adapted to Germany. Osteoporosis International, 30 (S2), 181-S182.

Buckinx, F., Beaudart, C., Reginster, J.-Y., Rolland, Y., Cesari, M., Rizzoli, R., PETERMANS, J., & Bruyère, O. (July 2019). Development of a frailty specific patient reported outcome (PRO): the FRAILQOL. Osteoporosis International, 30 (S2), 465-S466.

Charles, A., Buckinx, F., Mouton, A., Reginster, J.-Y., Gruslin, B., & Bruyère, O. (July 2019). Energy expenditure of nursing home residents and participation in exercise classes: an analysis of the SENIOR cohort. Osteoporosis International, 30 (S2), 430. doi:10.1016/j.jamda.2019.04.007

Fuggle, N. R., Curtis, E. M., Shaw, S., Spooner, L., Bruyère, O., Ntanil, G., Parsons, C., Conaghan, P. G., Corp, N., Honvo, G., Maggi, S., Uebelhart, D., Baird, J., Dennison, E. M., Reginster, J.-Y., & Cooper, C. (July 2019). Safety of analgesics, non-steroidal anti-inflammatory drugs and opioids. Osteoporosis International, 30 (S2), 186-S187.

Hajaoui, M., Locquet, M., Beaudart, C., Reginster, J.-Y., PETERMANS, J., & Bruyère, O. (July 2019). Sarcopenia : performance of the SARC-F questionnaire according to the european consensus criteria, EWGSOP1 vs. EWGSOP2. Osteoporosis International, 30 (S2), 539-S540.

Hiligsmann, M., Beaudart, C., Bruyère, O., Biver, E., Bauer, J., Cruz-Jentoft, A. J., Gesmundo, A., Goisser, S., Lansi, F., Locquet, M., Maggi, S., Rizzoli, R., Rolland, Y., Vaquero, N., & Reginster, J.-Y. (July 2019). A cross-european discrete choice experiment to assess patients’ preferences for sarcopenia outcomes. Osteoporosis International, 30 (S2), 190.

Honvo, G., Bannuru, R. R., Bruyère, O., Rannou, F., Herrero-Beaumont, G., Uebelhaert, D., Cooper, C., Arden, N., Conaghan, P. G., Reginster, J.-Y., Thomas, T., & McAlindon, T. (July 2019). Recommendations for the reporting of harms in manuscripts on studies assessing osteoarthritis drugs: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Osteoporosis International, 30 (S2), 569-S570.

Honvo, G., Bruyère, O., Geerinck, A., Veronese, N., & Reginster, J.-Y. (July 2019). Effect of oral chondroitin sulfate on functional status in patients with knee osteoarthritis: outcomes of a comprehensive meta-analysis exploring inconsistencies in randomized, placebo-controlled trials. Osteoporosis International, 30 (S2), 452-S453.

Honvo, G., Bruyère, O., Geerinck, A., Veronese, N., & Reginster, J.-Y. (July 2019). Effect of oral chondroitin on pain in patients with knee osteoarthritis: outcomes of a comprehensive meta-analysis exploring inconsistencies in randomised, placebo-controlled trials. Osteoporosis International, 30 (S2), 175.

Honvo, G., Reginster, J.-Y., Rannou, F., Rygaert, X., Geerinck, A., Rabenda, V., McAlindon, T., Charles, A., Fuggle, N. R., Cooper, C., Curtis, E. M., Arden, N., Avouac, B., & Bruyère, O. (July 2019). Safety of an intra-articular hyaluronic acid injections in osteoarthritis: outcomes of a systematic review and meta-analysis. Osteoporosis International, 30 (S2), 290.

Kaux, J.-F., Bornheim, S., Remy, G., Van Beveren, J., Reginster, J.-Y., Bruyère, O., Dardenne, N., & Buckinx, F. (2019). Cross-cultural adaptation, translation in French and validation of the Anterior Knee Pain Scale (AKPS). In V. Bunc & E. Tsolakidis, Book of abstracts - 24th Annual Congress of the European College of Sport Science (pp. 400).

LADANG, A., Beaudart, C., Locquet, M., Reginster, J.-Y., Bruyère, O., & Cavalier, E. (July 2019). Fragility fracture risk prediction in elderly people based on a micro RNA panel. Osteoporosis International, 30 (S2), 299-S300.

Leclercq, V., Beaudart, C., Ajamieh, S., Rabenda, V., Tirelli, E., & Bruyère, O. (July 2019). Meta-analyses indexed in PsycINFO had a better completeness of reporting when they mention PRISMA. Journal of Clinical Epidemiology, 115, 46-54. doi:10.1016/j.jclinepi.2019.06.014

Leclercq, V., Beaudart, C., Ajamieh, S., Tirelli, E., & Bruyère, O. (July 2019). The methodological quality of meta-analyses in behavioral and social sciences: leads for enhancements according to AMSTAR2. Paper presented at European Congress of Psychology, Moscow, Russia.

Locquet, M., Beaudart, C., Croisier, J.-L., Reginster, J.-Y., & Bruyère, O. (July 2019). Determinants and health consequences of a rapid muscle health decline in older adults from the SacoPhAge study. Osteoporosis International, 30 (S2), 211 and S275.

Locquet, M., Beaudart, C., Durieux, N., Reginster, J.-Y., & Bruyère, O. (July 2019). Relationship between the changes over time of bone and muscle health in children and adults : a systematic review and meta-analysis. Osteoporosis International, 30 (S2), 176-S177.

Parsons, C. M., Meyer, R., Judge, A., Bruyère, O., Petit-Dop, F., Chapurlat, R., Reginster, J.-Y., Inskip, H., & Cooper, C. (July 2019). Determining individual trajectories of joint space loss: a Bayesian approach for assessing osteoarthritis progression. Osteoporosis International, 30 (S2), 537-S538.

Reginster, J.-Y., Honvo, G., Geerinck, A., & Bruyère, O. (July 2019). Efficacy and tolerance of pharmaceutical-grade chondroitin sulfate: what does evidence-based medicine say? Osteoporosis International, 30 (S2), 779.

Bonnefoy, M., Gilbert, T., Bruyère, O., Paillaud, E., Raynaud-Simon, A., Guérin, O., Jeandel, C., Le Sourd, B., Haine, M., Ferry, M., Rolland, Y., & Berrut, G. (June 2019). Quels bénéfices attendre de la supplémentation en protéines pour limiter la perte de masse et de fonction musculaire chez le sujet âgé fragile ? Gériatrie et Psychologie Neuropsychiatrie du Vieillissement, 17 (2), 137-43. doi:10.1684/pnv.2019.0804

Honvo, G., Bruyère, O., & Reginster, J.-Y. (June 2019). Update on the role of pharmaceutical‑grade chondroitin sulfate in the symptomatic management of knee osteoarthritis. Aging Clinical and Experimental Research, 31 (8), 1163-1167. doi:10.1007/s40520-019-01253-z

Leclercq, V., Beaudart, C., Ajamieh, S., Rabenda, V., Tirelli, E., & Bruyère, O. (14 May 2019). The methodological quality of meta-analyses in behavioral and social sciences: leads for enhancements according to AMSTAR 2. Poster session presented at Annual Meeting of the Belgian Association for Psychological Sciences, Liège, Belgium.

Leclercq, V., Beaudart, C., Ajamieh, S., Rabenda, V., Tirelli, E., & Bruyère, O. (14 May 2019). The explicit use of PRISMA and its effect on the reporting completeness of meta-analyses in the field of behavioral and social sciences. Poster session presented at Annual Meeting of the Belgian Association for Psychological Sciences.

Buckinx, F., Bornheim, S., Remy, G., Van Beveren, J., Reginster, J.-Y., Bruyère, O., Dardenne, N., & Kaux, J.-F. (May 2019). French translation and validation of the “Anterior Knee Pain Scale” (AKPS). Disability and Rehabilitation, 41 (9), 1089-1094. doi:10.1080/09638288.2017.1419288

Geerinck, A., Alekna, V., Beaudart, C., Bautmans, I., Cooper, C., De Souza Orlandi, F., Konstantynowicz, J., Monterro-Errasquin, B., Topinkova, E., Tsekoura, M., Reginster, J.-Y., & Bruyère, O. (29 April 2019). Standard error of measurement and smallest detectable change of the Sarcopenia Quality of Life (SarQoL) questionnaire: An analysis of subjects from 9 validation studies. PLoS ONE, 14 (4). doi:10.1371/journal.pone.0216065

Honvo, G., Bruyère, O., Geerinck, A., & Reginster, J.-Y. (April 2019). Symptomatic efficacy of oral chondroitin sulfate in knee osteoarthritis: A systematic review and meta-analysis of randomized, placebo-controlled trials. Osteoarthritis and Cartilage, 27 (Suppl 1), 498–S499. doi:10.1016/j.joca.2019.02.558

Honvo, G., Reginster, J.-Y., Geerinck, A., & Bruyère, O. (April 2019). Safety of oral chondroitin sulfate in the management of knee osteoarthritis: results of a new meta-analysis of randomized. Placebo-controlled trials. Osteoarthritis and Cartilage, 27 (Suppl 1), 499. doi:10.1016/j.joca.2019.02.559

LADANG, A., Beaudart, C., Locquet, M., Reginster, J.-Y., Bruyère, O., & CAVALIER, E. (April 2019). Risk-fracture prediction in elderly people based on a microRNA panel. Poster session presented at IOF-WHO osteoporosis congress.

DELANAYE, P., Bataille, S., Quinonez, K., Buckinx, F., Warling, X., KRZESINSKI, J.-M., Pottel, H., Burtey, S., Bruyère, O., & CAVALIER, E. (25 January 2019). Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis. Journal of Renal Nutrition, 29 (6), 511-520. doi:10.1053/j.jrn.2018.11.010

Alekna, V., Kilaite, J., Tamulaitiene, M., Geerinck, A., Mastaviciute, A., Bruyère, O., Reginster, J.-Y., & Beaudart, C. (2019). Validation of the Lithuanian version of sarcopenia‑specific quality of life questionnaire (SarQoL®). European Geriatric Medicine, 10, 761-767. doi:10.1007/s41999-019-00208-x

Bauer, J. M., Cruz-Jentoft, A. J., Fielding, R. A., Kanis, J. A., Reginster, J.-Y., Bruyère, O., Cesari, M., Chapurlat, R., Al-Daghri, N., Dennison, E., Kaufman, J.-M., Landi, F., Laslop, A., Locquet, M., Maggi, S., McCloskey, E., Perna, S., Rizzoli, R., Rolland, Y., & Cooper, C. (2019). Correction to: Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (Calcified Tissue International, (2019), 105, 2, (109-124), 10.1007/s00223-019-00561-w). Calcified Tissue International, 105 (2), 125-126. doi:10.1007/s00223-019-00587-0

Beaudart, C., Locquet, M., Touvier, M., Reginster, J.-Y., & Bruyère, O. (2019). Association between dietary nutrient intake and sarcopenia in the SarcoPhAge study. Aging Clinical and Experimental Research, 31, 815-824. doi:10.1007/s40520-019-01186-7

Beaudart, C., Sanchez Rodriguez, M. D. C., Locquet, M., Reginster, J.-Y., Lengele, L., & Bruyère, O. (2019). Malnutrition as a strong predictor of the onset of sarcopenia. Nutrients, 11 (12), 2883. doi:10.3390/nu11122883

Beckwée, D., Delaere, A., Aelbrecht, S., Baert, V., Beaudart, C., Bruyère, O., de Saint-Hubert, M., Bautmans, I., & Sarcopenia Guidelines Development Group of the Belgian Society of Gerontology and Geriatrics (BSGG). (2019). Exercise Interventions for the Prevention and Treatment of Sarcopenia. A Systematic Umbrella Review. Journal of Nutrition, Health and Aging, 23, 494-502. doi:10.1007/s12603-019-1196-8

Bruyère, O. (2019). The 2014–2016 ESCEO algorithm for the management of knee osteoarthritis. Osteoporosis International, 30 (S2), 187-188.

Bruyère, O. (2019). Physical performance in older people: actual evidence. Osteoporosis International, 30 (S2), 221-222.

Bruyère, O. (2019). Is there a responder profile to pharmaceutical-grade chondroitin sulfate? An analysis of the CONCEPT study. Osteoporosis International, 30 (S2), 780.

Bruyère, O., Beaudart, C., & Aubertin-Leheudre, M. (2019). Muscle strength/power assessment and outcomes. Osteoporosis International, 30 (S2), 209.

Bruyère, O., Beaudart, C., Ethgen, O., Reginster, J.-Y., & Locquet, M. (2019). The health economics burden of sarcopenia: a systematic review. Maturitas, 119, 61-9. doi:10.1016/j.maturitas.2018.11.003

Bruyère, O., Honvo, G., Veronese, N., Arden, N. K., Branco, J., Curtis, E. M., Al-Daghri, N. M., Herrero-Beaumont, G., Martel-Pelletier, J., Pelletier, J.-P., Rannou, F., Rizzoli, R., Roth, R., Uebelhart, D., Cooper, C., & Reginster, J.-Y. (2019). An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Seminars in Arthritis and Rheumatism, 49 (3), 337-350. doi:10.1016/j.semarthrit.2019.04.008

Bruyère, O., Reginster, J.-Y., Honvo, G., & Detilleux, J. (2019). Cost-effectiveness evaluation of glucosamine for osteoarthritis based on simulation of individual patient data obtained from aggregated data in published studies. Aging Clinical and Experimental Research, 31 (6), 881-887. doi:10.1007/s40520-019-01138-1

Buckinx, F., Charles, A., Quabron, A., Van Hees, T., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2019). Impact of frailty status on the cost of drugs and dietary supplements prescribed to nursing home residents: the SENIOR cohort. Aging Clinical and Experimental Research, 31, 875-880. doi:10.1007/s40520-019-01162-1

Buckinx, F., Charles, A., Reginster, J.-Y., PETERMANS, J., & Bruyère, O. (2019). Apports de la cohorte liégeoise SENIOR dans l’étude de la fragilité en maison de repos. Revue Médicale de Liège, 74 (4), 212-217.

Buckinx, F., Croisier, J.-L., Charles, A., Petermans, J., Reginster, J.-Y., Rygaert, X., & Bruyère, O. (2019). Normative data for isometric strength of 8 different muscle groups and their usefulness as a predictor of loss of autonomy among physically active nursing home residents: The senior cohort. Journal of Musculoskeletal Neuronal Interactions, 19 (3), 258-265.

Buckinx, F., Paquot, N., FADEUR, M., BACUS, L., Reginster, J.-Y., Allepaerts, S., Petermans, J., Biquet, S., & Bruyère, O. (2019). Assessment of the energy expenditure of Belgian nursing home residents using indirect calorimetry. Nutrition, 57, 12-16. doi:10.1016/j.nut.2018.05.010

Charles, A., Buckinx, F., Cataldo, D., Rygaert, X., Gruslin, B., Reginster, J.-Y., & Bruyère, O. (2019). Relationship between peak expiratory flow and incidence of frailty, deaths and falls among nursing home residents: Results of the SENIOR cohort. Archives of Gerontology and Geriatrics, 85. doi:10.1016/j.archger.2019.103913

Charles, A., Buckinx, F., Locquet, M., Reginster, J.-Y., PETERMANS, J., Gruslin, B., & Bruyère, O. (2019). Intrinsic capacity and its association with mortality over 3 years in nursing homes: Results of the SENIOR cohort. Osteoporosis International, 30 (S2), 177-178.

Charles, A., Buckinx, F., Mouton, A., Reginster, J.-Y., Petermans, J., Gruslin, B., & Bruyère, O. (2019). Energy expenditure of nursing home residents and participation in exercise classes: an analysis of the SENIOR cohort [letter to the editor]. Journal of the American Medical Directors Association, 20 (9), 1183-1184. doi:10.1016/j.jamda.2019.04.007

Cooper, C., Chapurlat, R., Al-Daghri, N., Herrero-Beaumont, G., Bruyère, O., Rannou, F., Roth, R., Uebelhart, D., & Reginster, J.-Y. (2019). Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: what does the literature say ? Drugs and Aging, 36 (suppl 1), 15-24. doi:10.1007/s40266-019-00660-1

CRUZ-JENTOFT, J., BAHAT, G., BAUER, J., BOIRIE, Y., Bruyère, O., CEDERHOLM, T., Cooper, C., LANDI, F., ROLLAND, Y., SAYER, A. A., SCHNEIDER, M., SIEBER, C. C., TOPINKOVA, E., VANDEWOUDE, M., VISSER, M., ZAMBONI, M., BAUTMANS, I., BAEYENS, J. P., CESARI, M., & SCHOLS, J. (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing, 48, 16-31. doi:10.1093/ageing/afy169

Curtis, E., Fuggle, N., Shaw, S., Spooner, S., Ntani, G., Parsons, C., Corp, N., Honvo, G., Baird, J., Maggi, S., Dennison, E., Bruyère, O., Reginster, J.-Y., & Cooper, C. (2019). Safety of cyclooxygenase-2 inhibitors in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs and Aging, 36 (suppl 1), 25-44. doi:10.1007/s40266-019-00664-x

de Wit, M., Cooper, C., Reginster, J.-Y., Tugwell, P., Bere, N., Conaghan, P., Roberts, C., Aujoulat, I., Al-Daghri, N., Araujo de Carvalho, I., Barker, M., Bedlington, N., Brandi, M. L., Bruyère, O., Burlet, N., Halbout, P., Hiligsmann, M., Jiwa, F., Kanis, J. A., & Vlaskovska, M. (2019). Practical guidance for patient-centred health research. Lancet, 393, 1095-1096. doi:10.1016/S0140-6736(19)30034-0

de Wit, M., Cooper, C., Tugwell, P., Bere, N., Kirwan, J., Conaghan, P. G., Roberts, C., Aujoulat, I., Al-Daghri, N., Araujo de Carvalho, I., Barker, M., Bedlington, N., Brandi, M. L., Bruyère, O., Burlet, N., Halbout, P., Hiligsmann, M., Jiwa, F., Kanis, J. A., & Reginster, J.-Y. (2019). Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clinical and Experimental Research, 31 (7), 905-915. doi:10.1007/s40520-019-01193-8

Delanaye, P., Bataille, P., Quinonez, K., Buckinx, F., Warling, X., KRZESINSKI, J.-M., Pottel, H., Burtey, S., Bruyère, O., & CAVALIER, E. (2019). Myostatin and insulin growth factor 1 are biomarkers of muscle strength, muscle mass, and mortality in hemodialysis patients. Osteoporosis International, 30 (S2), 270.

Demoulin, C., Bruyère, O., Vandeput, D., & Van Assche, D. (2019). Prise en charge non pharmacologique de la coxarthrose et de la gonarthrose. Ortho-Rhumato, 17 (4).

Dennison, E. M., Cooper, C., Kanis, J. A., Bruyère, O., Silverman, S., McCloskey, E., Abrahamsen, B., Prieto-Alhambra, D., Ferrari, S., & On behalf of the IOF Epidemiology/Quality of Life Working Group. (2019). Fracture risk following intermission of osteoporosis therapy. Osteoporosis International, 30 (9), 1733-1743. doi:10.1007/s00198-019-05002-w

Diez-Perez, A., Brandi, M. L., AL-Daghri, N., Branco J.C., Bruyère, O., Cavalli, L., Cooper, C., Cortet, B., Dawson-Hughes, B., Dimai, H. P., Gonnelli, S., Hadji, P., Halbout, P., Kaufman, J. M., Kurth, A., Locquet, M., Maggi, S., Matijevic, R., Reginster, J.-Y., & Thierry, T. (2019). Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art—outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clinical and Experimental Research, 31 (10), 1375-1389. doi:10.1007/s40520-019-01294-4

Eymard, F., Parsons, C., Edwards, M. H., Petit-Dop, F., Reginster, J.-Y., Bruyère, O., Chevalier, X., Cooper, C., & Richette, P. (2019). Impact du traitement par statines dans la progression radiologique de la gonarthrose: résultats issus de l'analyse post-hoc de l'essai SEKOIA. Revue du Rhumatisme, 86, 81-86. doi:10.1016/j.rhum.2018.09.002

FUGGLE, N., Curtis, E., Shaw, S., Spooner, L., Bruyère, O., Ntani, G., Parsons, C., Conaghan, P. G., Corp, N., Honvo, G., Uebelhart, D., Baird, J., Dennison, E., Reginster, J.-Y., & Cooper, C. (2019). Safety of opioids in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs and Aging, 36 (suppl 1), 129-143. doi:10.1007/s40266-019-00666-9

Geerinck, A., Beaudart, C., Dardenne, N., Reginster, J.-Y., & Bruyère, O. (2019). An exploration of the structural validity of the sarcopenia quality of life (SARQOL®) questionnaire with exploratory and confirmatory factor analysis. Osteoporosis International, 30 (S2), 537.

Geerinck, A., Beaudart, C., Reginster, J.-Y., & Bruyère, O. (2019). Comparison of the psychometric properties of the SarQoL® questionnaire with the EWGSOP and EWGSOP2 criteria for sarcopenia. Osteoporosis International, 30 (S2), 179.

Gillain, S., Boutaayamou, M., Schwartz, C., Bruls, O., Bruyère, O., Croisier, J.-L., Salmon, E., Reginster, J.-Y., Garraux, G., & Petermans, J. (2019). Using supervised learning machine algorithm to identify future fallers based on gait patterns: A two-year longitudinal study. Experimental Gerontology, 127 (first online). doi:10.1016/j.exger.2019.110730

GILLAIN, S., Boutaayamou, M., Schwartz, C., Dardenne, N., Bruyère, O., Bruls, O., Croisier, J.-L., SALMON, E., Reginster, J.-Y., GARRAUX, G., & PETERMANS, J. (2019). Gait symmetry in the dual task condition as a predictor of future falls among independent older adults: a 2-year longitudinal study. Aging Clinical and Experimental Research, 31 (8), 1057-1067. doi:10.1007/s40520-019-01210-w

Hajaoui, M., Locquet, M., Beaudart, C., Reginster, J.-Y., Petermans, J., & Bruyère, O. (2019). Sarcopenia: Performance of the SARC-F Questionnaire According to the European Consensus Criteria, EWGSOP1 and EWGSOP2 [letter to the editor]. Journal of the American Medical Directors Association, 20 (9), 1182-1183. doi:10.1016/j.jamda.2019.05.021

Hiligsmann, M., Cornelissen, D., Vrijens, B., Abrahamsen, B., Al-Daghri, N., Biver, E., Brandi, M. L., Bruyère, O., Burlet, N., Cooper, C., Cortet, B., Dennison, E., Diez-Perez, A., Gasparik, A., Grosso, A., Hadji, P., Halbout, P., Kanis, J. A., Kaufman, J. M., & Reginster, J.-Y. (2019). Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF). Osteoporosis International, 30 (11), 2155-2165. doi:10.1007/s00198-019-05104-5

Hiligsmann, M., Pinto, D., Dennison, E., Al-Daghri, N., Beaudart, C., Branco, J., Bruyère, O., Conaghan, P. G., Cooper, C., Herrero-Beaumont, G., Jiwa, F., Lems, W., Rizzoli, R., Thomas, T., Veronese, N., & Reginster, J.-Y. (January 2019). Patients’ preferences for osteoarthritis treatment: the value of stated-preference studies. Aging Clinical and Experimental Research, 31 (1), 1-3. doi:10.1007/s40520-018-1098-3

Hiligsmann, M., Reginster, J.-Y., Tosteson, A. N. A., Bukata, S. V., Saag, K. G., Gold, D. T., Halbout, P., Jiwa, F., Lewiecki, E. M., Pinto, D., Adachi, J. D., Al-Daghri, N., Bruyère, O., Chandran, M., Cooper, C., Harvey, N. C., Einhorn, T. A., Kanis, J. A., Kendler, D. L., & Silverman, S. (January 2019). Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation. Osteoporosis International, 30 (1), 45-57. doi:10.1007/s00198-018-4744-x

Honvo, G., Bannuru, R. R., Bruyère, O., Rannou, F., Herrero-Beaumont, G., Uebelhart, D., Cooper, C., Arden, N., Conaghan, P. G., Reginster, J.-Y., Thomas, T., & McAlindon, T. (2019). Recommendations for the reporting harms in manuscripts on clinical trials assessing osteoarthritis drugs: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Drugs and Aging, 36 (suppl 1), 145-159. doi:10.1007/s40266-019-00667-8

Honvo, G., Bruyère, O., Geerinck, A., Veronese, N., & Reginster, J.-Y. (2019). Efficacy of chondroitin sulfate in patients with knee osteoarthritis: a comprehensive meta-analysis exploring inconsistencies in randomized, placebo-controlled trials. Advances in Therapy, 36 (5), 1085-99. doi:10.1007/s12325-019-00921-w

Honvo, G., Leclercq, V., Geerinck, A., Thomas, T., Veronese, N., Charles, A., Rabenda, V., Beaudart, C., Cooper, C., Reginster, J.-Y., & Bruyère, O. (2019). Safety of topical non-steroidal anti-inflammatory drugs in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs and Aging, 36 (suppl 1), 45-64. doi:10.1007/s40266-019-00661-0

Honvo, G., Reginster, J.-Y., Rabenda, V., Geerinck, A., Mkinsi, O., Charles, A., Rizzoli, R., Cooper, C., Avouac, B., & Bruyère, O. (2019). Safety of symptomatic slow-acting drugs for osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs and Aging, 36 (suppl 1), 65-99. doi:10.1007/s40266-019-00662-z

Honvo, G., Reginster, J.-Y., Rannou, F., Rygaert, X., Geerinck, A., Rabenda, V., McAlindon, T., Charles, A., Fuggle, N., Cooper, C., Curtis, E., Arden, N., Avouac, B., & Bruyère, O. (2019). Safety of intra-articular hyaluronic acid injections in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs and Aging, 36 (suppl 1), 101-127. doi:10.1007/s40266-019-00657-w

Kucharz, E. J., Szántó, S., Ivanova Goycheva, M., Petronijević, M., Šimnovec, K., Domżalski, M., Gallelli, L., Kamenov, Z., Konstantynowicz, J., Radunović, G., Šteňo, B., Stoilov, R., Stok, R., Vrana, R., Bruyère, O., Cooper, C., & Reginster, J.-Y. (2019). Endorsement by Central European experts of the revised ESCEO algorithm for the management of knee osteoarthritis. Rheumatology International, 39, 1117-1123. doi:10.1007/s00296-019-04332-6

Kucharz, E. J., Szántó, S., Ivanova Goycheva, M., Petronijević, M., Šimnovec, K., Domżalski, M., Gallelli, L., Kamenov, Z., Konstantynowicz, J., Radunović, G., Šteňo, B., Stoilov, R., Stok, R., Vrana, R., Bruyère, O., Cooper, C., & Reginster, J.-Y. (2019). Correction to: Endorsement by Central European experts of the revised ESCEO algorithm for the management of knee osteoarthritis (Rheumatology International, (2019), 39, 7, (1117-1123), 10.1007/s00296-019-04332-6). Rheumatology International, 39 (9), 1661-1662. doi:10.1007/s00296-019-04347-z

Locquet, M., Beaudart, C., Durieux, N., Reginster, J.-Y., & Bruyère, O. (2019). Relationship between the changes over time of bone mass and muscle health in children and adults: A systematic review and meta-analysis. BMC Musculoskeletal Disorders, 20, 429. doi:10.1186/s12891-019-2752-4

Locquet, M., Beaudart, C., Hajaoui, M., PETERMANS, J., Reginster, J.-Y., & Bruyère, O. (2019). Three-Year Adverse Health Consequences of Sarcopenia in Community-Dwelling Older Adults According to 5 Diagnosis Definitions. Journal of the American Medical Directors Association, 20, 43-46. doi:10.1016/j.jamda.2018.06.004

Locquet, M., Beaudart, C., Petermans, J., & Bruyère, O. (2019). EWGSOP 2 vs. EWGSOP 1: impact on the prevalence of sarcopenia and its outcomes. Osteoporosis International, 30 (S2), 275-S276.

Locquet, M., Beaudart, C., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2019). EWGSOP2 versus EWGSOP1: impact of the prevalence of sarcopenia and its major health consequences. Journal of the American Medical Directors Association, 20 (3), 384-385. doi:10.1016/j.jamda.2018.11.027

Locquet, M., Beaudart, C., Reginster, J.-Y., & Bruyère, O. (2019). Association between the decline in muscle health and the decline in bone health in older individuals from the SarcoPhAge Cohort. Calcified Tissue International, 104, 273-284. doi:10.1007/s00223-018-0503-4

Locquet, M., & Bruyère, O. (2019). Les analyses ROC en épidémiologie: comment savoir si mon test diagnostique est performant? Vaisseaux, Coeur, Poumons, 24 (7), 1-3.

Lorentzon, M., Branco, J. C., Brandi, M. L., Bruyère, O., Chapurlat, R. D., Cooper, C., Cortet, B., Diez-Perez, A. D., Ferrari, S. L., Gasparik, A. I., Herrmann, M., Jorgensen, N. R., Kanis, J. A., Kaufman, J.-M., Laslop, A., Locquet, M., Matijevic, R., McCloskey, E. V., Minisola, S., & Cavalier, E. (2019). Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis. Advances in Therapy, 36 (10), 2811-2824. doi:10.1007/s12325-019-01063-9

Parsons, C., Judge, A., Leyland, K., Bruyère, O., Petit Dop, F., Chapurlat, R., Reginster, J.-Y., Edwards, M., Dennison, E., Cooper, C., Inskip, H., & SEKOIA Study Group. (2019). Novel approach to estimate osteoarthritis progression: use of the reliable change index in the evaluation of joint space loss. Arthritis Care and Research, 71 (2), 300-7. doi:10.1002/acr.23596

Reginster, J.-Y., Bruyère, O., Conaghan, P. G., McAlindon, T., & Cooper, C. (2019). Importance of safety in the management of osteoarthritis and the need for updated meta-analyses and recommendations for reporting harms. Drugs and Aging, 36 (Suppl 1), 3-6. doi:10.1007/s40266-019-00659-8

Saengnipanthkul, S., Waikakul, S., Rojanasthien, S., Totemchokchyakarn, K., Srinkapaibulaya, A., Cheh Chin, T., Mai Hong, N., Bruyère, O., Cooper, C., Reginster, J.-Y., & Lwin, M. (2019). Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment. International Journal of Rheumatic Diseases, 22 (3), 376-385. doi:10.1111/1756-185X.13068

Slomian, J., Honvo, G., EMONTS, P., Reginster, J.-Y., & Bruyère, O. (2019). Consequences of maternal postpartum depression: a systematic review of maternal and infant outcomes. Women's Health, 15, 1-55. doi:10.1177/1745506519844044

Thiyagarajan, J. A., Araujo de Carvalho, I., Peña-Rosas, J. P., Chadha, S., Mariotti, S. P., Dua, T., Albanese, E., Bruyère, O., Cesari, M., Dangour, A., Dias, A., Guerra, M., Keeffe, J., Kerse, N., Khan, Q. U. A., Liu, C.-J., Murthy, G. V. S., Ndegwa, S. N., Reginster, J.-Y., & Beard, J. R. (2019). Redesigning care for older people to preserve physical and mental capacity: WHO guidelines on community-level interventions in integrated care. PLoS Medicine, 16 (10). doi:10.1371/journal.pmed.1002948

Veronese, N., Demurtas, J., Soysal, P., Smith, L., Torbahn, G., Schoene, D., Schwingshackl, L., Sieber, C., Bauer, J., Cesari, M., Bruyère, O., Reginster, J.-Y., Beaudart, C., Cruz-Jentoft, A. J., Cooper, C., Petrovic, M., Maggi, S., & the Special Interest Groups in Systematic Reviews and Meta-analyses for healthy ageing Sarcopenia and Frailty and resilience in older persons of the European Geriatric Medicine Society (EuGMS). (2019). Sarcopenia and health-related outcomes: an umbrella review of observational studies. European Geriatric Medicine, 10 (6), 853-862. doi:10.1007/s41999-019-00233-w

MILANTS, C., Bruyère, O., & Kaux, J.-F. (2018). Responders to Platelet-Rich Plasma in Osteoarthritis: A Technical Analysis. In Back to rehab, rehab for back (pp. 51).

Geerinck, A., Scheppers, A., Beaudart, C., Bruyère, O., Vandenbussche, W., Bautmans, R., Delye, S., & Bautmans, I. (December 2018). Translation and validation of the Dutch SarQoL, a quality of life questionnaire specific to sarcopenia. Journal of Musculoskeletal and Neuronal Interactions, 18(4), 463-472.

Geerinck, A., Beaudart, C., Bautmans, I., Cooper, C., De Souza Orlandi, F., Konstantynowicz, J., Monterro-Errasquin, B., Topinkova, E., Tsekoura, M., Reginster, J.-Y., & Bruyère, O. (13 November 2018). Standard error of measurement and smallest detectable change of the SarQoL questionnaire: an analysis of subjects from 8 validation studies. Poster session presented at European congress of the International society for Pharmaeconomics and Outcomes Research (ISPOR), Barcelona, Spain.

Geerinck, A., Bruyère, O., Locquet, M., Reginster, J.-Y., & Beaudart, C. (November 2018). Evaluation of the responsiveness of the SarQoL® questionnaire, a patient-reported outcome measure specific to sarcopenia. Advances in Therapy, 35, 1842-1858. doi:10.1007/s12325-018-0820-z

Leclercq, V., Beaudart, C., Ajamieh, S., Rabenda, V., Tirelli, E., & Bruyère, O. (November 2018). Poor quality reporting of the meta-analyses in psychology as assessed using the PRISMA Statement. European Journal of Public Health, 28 (4), 509. doi:10.1093/eurpub/cky218.292

Geerinck, A., Beaudart, C., Bautmans, I., Cooper, C., De Souza Orlandi, F., Konstantynowicz, J., Monterro-Errasquin, B., Topinkova, E., Tsekoura, M., Reginster, J.-Y., & Bruyère, O. (11 October 2018). Standard error of measurement and smallest detectable change of the SarQoL questionnaire: an analysis of subjects from 8 validation studies. Paper presented at 14th International Congress of the European Geriatric Medicine Society, Berlin, Germany.

LECLERC, A.-F., Slomian, J., JERUSALEM, G., COUCKE, P., BURY, T., Deflandre, D., DEVOS, M., Bruyère, O., Foidart-Dessalle, M., KAUX, J.-F., Crielaard, J.-M., & Maquet, D. (October 2018). Exercise and Education Program After Breast Cancer: Benefits on Quality of Life and Symptoms at 3, 6, 12, and 24 Months' Follow-up. Clinical Breast Cancer, 18 (5), 1189-e1204. doi:10.1016/j.clbc.2018.05.004

Leclercq, V., Beaudart, C., Ajamieh, S., Rabenda, V., Tirelli, E., & Bruyère, O. (October 2018). The use of PRISMA statement improves the reporting quality of meta-analyses published in the field of psychology. Value in Health Regional Issues, 21, 401. doi:10.1016/j.jval.2018.09.2380

MILANTS, C., Bruyère, O., & Kaux, J.-F. (2018). Response to: Comment on “Responders to Platelet-Rich Plasma in Osteoarthritis: A Technical Analysis”. BioMed Research International, 2718156. doi:10.1155/2018/2718156

Martin, P.* , Bladier, C.* , Meek, B.* , Bruyère, O.* , Feinblatt, E.* , Touvier, M.* , Watier, L.* , & Makowski, D.*. (July 2018). Weight of Evidence for Hazard Identification: A Critical Review of the Literature. Environmental Health Perspectives, 126 (7). doi:10.1289/EHP3067

MILANTS, C., Bruyère, O., & Kaux, J.-F. (2018). KNEE OSTEOARTHRITIS AND PLATELET-RICH PLASMA TREATMENT : HOW TO IMPROVE THE EFFICIENCY ? In 12th International Society of Physical and Rehabilitation Medicine World Congress.

Reginster, J.-Y., Bruyère, O., & Cooper, C. (July 2018). Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms. Annals of the Rheumatic Diseases, 77 (7), 1-2. doi:10.1136/annrheumdis-2017-212251

GILLAIN, S., Boutaayamou, M., Schwartz, C., WOJTASIK, V., CHRISTELBACH, S., Dardenne, N., Bruls, O., Bruyère, O., Reginster, J.-Y., CROISIER, J.-L., GARRAUX, G., & PETERMANS, J. (June 2018). Dépister les sujets à risque de chute parmi nos aînés robutes: intérêt de la marche rapide. Poster session presented at Congrès de la CIFGG, Montreux, Switzerland.

Beaudart, C., Hagelstein, T., Van Beveren, J., GODON, B., Bruyère, O., & Kaux, J.-F. (2018). French translation and validation of the Exercise-Induced Leg Pain Questionnaire. In Abstract Book - 21st European Congress of Physical and Rehabilitation Medicine (pp. 400).

Buckinx, F., Bornheim, S., Remy, G., Van Beveren, J., Reginster, J.-Y., Bruyère, O., Dardenne, N., & Kaux, J.-F. (2018). French cross-cultural adaptation and measurement properties of the “ANTERIOR KNEE PAIN SCALE”. In Abstract Book - 21st European Congress of Physical and Rehabilitation Medicine (pp. 399).

Dale, L. P., Suggs, L. S., Dey, A., Izquierdo, M., Rizzoli, R., Dias, A., Khan, Q. U. A., Keeffe, J., Forbes, D. A., Chirenda, J., Hustavenes, M., Bruyère, O., & Woo, J. (2018). Be He@lthy - Be Mobile (A handbook on how to implement mAgeing). Geneva, Switzerland: International Telecommunication Union.

Locquet, M., Willems, T., Specque, C., Van Beveren, J., Bruyère, O., & Kaux, J.-F. (2018). Cross-cultural adaptation in French and validation of Functional Assessment Scale for acute Hamstring injuries (FASH). In Abstract Book - 21st European Congress of Physical and Rehabilitation Medicine (pp. 401).

MILANTS, C., Bruyère, O., & Kaux, J.-F. (2018). Responders to Platelet-Rich Plasma in Osteoarthritis: A Technical Analysis. In abstract Book - 21st European Congress of Physical and Rehabilitation Medicine (pp. 402).

Charles, A., Buckinx, F., Cataldo, D., Rygaert, X., Reginster, J.-Y., & Bruyère, O. (22 April 2018). Relationship between peak expiratory flow, physical capacity and incidence of frailty among nursing home residents. Poster session presented at WCO IOF - ESCEO, Cracovie, Poland.

GEERINCK, A., Bruyère, O., Locquet, M., Reginster, J.-Y., & Beaudart, C. (21 April 2018). Evaluation of the responsiveness of a patient-reported outcome measure specific to sarcopenia: the SarQoL questionnaire. Poster session presented at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Krakow, Poland.

Buckinx, F., Charles, A., Quabron, A., Van Hees, T., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2018). Impact du statut de fragilité des résidents de maisons de repos sur le coût lié à la consommation de produits pharmaceutiques : résultats de la cohorte SENIOR. Cahiers de l'Année Gérontologique, 15.

Buckinx, F., Adam, S., Charles, A., Rygaert, X., Reginster, J.-Y., & Bruyère, O. (2018). Agisme en maison de repos : résultats de la cohorte SENIOR. Cahiers de l'Année Gérontologique, 28.

Buckinx, F., Charles, A., Quabron, A., VAN HEES, T., Petermans, J., Reginster, J.-Y., & Bruyère, O. (05 April 2018). Impact of the frailty status on the cost of drugs consumed in nursing homes: results froim the Senior cohort. Osteoporosis International, 29 S1, 356.

Buckinx, F., Croisier, J.-L., Charles, A., Petermans, J., Reginster, J.-Y., Rygaert, X., & Bruyère, O. (2018). Valeurs normatives de la force isométrique pour 8 groupes musculaires différents et leur valeur predictive de la perte d’autonomie chez les personnes âgées résidant en maison de repos: l’étude SENIOR. Cahiers de l'Année Gérontologique, 28.

Charles, A., Buckinx, F., Cataldo, D., Reginster, J.-Y., Rygaert, X., & Bruyère, O. (05 April 2018). Relation entre le débit expiratoire de pointe, les capacités physiques et l’incidence de la fragilité chez les personnes âgées résidant en maison de repos : résultats de la cohorte SENIOR. Paper presented at 6ème Congrès Fragilité du Sujet Âgé Le Vieillissement en Santé Prévention de la Perte d'Autonomie, Paris, France.

Beaudart, C., Bruyère, O., Reginster, J.-Y., Bauer, J., Cooper, C., Cruz-Jentoft, A., Landi, F., Locquet, M., Maggi, S., Rizzoli, R., Rolland, Y., Vaquero, N., & Hiligsmann, M. (April 2018). Patient’s engagement in the identification of critical outcomes in sarcopenia. Osteoporosis International, 29 S1, 299.

Beaudart, C., Locquet, M., Touvier, M., Reginster, J.-Y., & Bruyère, O. (April 2018). Association between dietary nutrient intake and sarcopenia: the SarcoPhAge cohort study. Osteoporosis International, 29 S1, 57.

Bruyère, O. (April 2018). Vitamin D and muscle function. Osteoporosis International, 29 (Suppl1), 124.

Bruyère, O. (April 2018). Cost-effectiveness evaluation of glucosamine in osteoarthritis based on simulation of data coming from published studies. Osteoporosis International, 29 (Suppl1), 554-5.

Bruyère, O., & Beaudart, C. (April 2018). Muscle Function assessment in daily practice. Osteoporosis International, 29 (Suppl1), 87.

Bruyère, O., Curtis, E., Honvo, G., Fuggle, N., Reginster, J.-Y., & Cooper, C. (April 2018). Reassessment of the safety of anti-osteoarthritis medications. Osteoporosis International, 29 S1, 324-325.

Buckinx, F., Baudry, S., Bautmans, I., Beaudart, C., Croisier, J.-L., Gielen, E., KAUX, J.-F., Perkisas, S., Scafoglieri, A., Bruyère, O., & On behalf of the Belgian Ageing Muscle Society. (April 2018). L'évaluation de la masse et de la force musculaires en pratique clinique. Ortho-Rhumato, 16 (2), 14-20.

Buckinx, F., Charles, A., Rygaert, X., Reginster, J.-Y., Adam, S., & Bruyère, O. (April 2018). Own attitude regarding aging among nursing home residents: results of the Senior cohort. Osteoporosis International, 29 S1, 357.

Buckinx, F., Charles, A., Rygaert, X., Reginster, J.-Y., Petermans, J., & Bruyère, O. (April 2018). Dynamic approach of the frailty status in nursing homes: 2-year prospective follow-up of the Senior cohort. Osteoporosis International, 29 S1, 59.

Charles, A., Buckinx, F., Cataldo, D., Reginster, J.-Y., Rygaert, X., & Bruyère, O. (April 2018). Relationship between peak expiratory flow, physical capacity and incidence of frailty among nursing home residents. Osteoporosis International, 29 S1, 548.

GEERINCK, A., Bruyère, O., Locquet, M., Reginster, J.-Y., & Beaudart, C. (April 2018). Evaluation of the responsiveness of the SARQOL® questionnaire: results from the SarcoPhAge study. Osteoporosis International, 29 S1, 300.

Honvo, G., Leclercq, V., GEERINCK, A., Rabenda, V., Beaudart, C., Cooper, C., Reginster, J.-Y., & Bruyère, O. (April 2018). Adverse events associated with topical non-steroidal anti-inflammatory drugs (NSAIDS) in osteoarthritis: a systematic review and meta-analysis of randomized, placebo-controlled trials. Osteoporosis International, 29 S1, 550.

Honvo, G., Rabenda, V., GEERINCK, A., Cooper, C., Reginster, J.-Y., & Bruyère, O. (April 2018). Adverse events associated with symptomatic slow-acting drugs in osteoarthritis (SYSADOAS): a systematic review and stratified meta-analysis of randomized, placebo-controlled trials. Osteoporosis International, 29 S1, 549-550.

Konstantynowicz, J., Abramowicz, P., Glinkowski, W., Taranta, E., Marcinowicz, L., Reginster, J.-Y., Bruyère, O., & Beaudart, C. (April 2018). The polish validation of the Sarquol®, a quality of life questionnaire specific for sarcopenia: the evidence of a good utility. Osteoporosis International, 29 S1, 541-542.

Locquet, M., Beaudart, C., Reginster, J.-Y., & Bruyère, O. (April 2018). Determinants of rapid muscle function declines over 1 year in community-dwelling older adults: the SarcoPhAge study. Osteoporosis International, 29 S1, 339-340.

Locquet, M., Beaudart, C., Reginster, J.-Y., & Bruyère, O. (April 2018). Consequences of relevant muscle function decline over 1 year in older individuals living in the community: results from the SarcoPhAge study. Osteoporosis International, 29 S1, 339.

Locquet, M., Beaudart, C., Reginster, J.-Y., Hajaoui, M., & Bruyère, O. (April 2018). Association between decline in muscle health and bone health in older individuals fom the SarcoPhAge cohort. Osteoporosis International, 29 S1, 212.

Locquet, M., Beaudart, C., Reginster, J.-Y., Petermans, J., & Bruyère, O. (April 2018). Three-year adverse health consequences of sarcopenia in community-dwelling older adults: Results from the SarcoPhAge cohort study. Osteoporosis International, 29 S1, 60-61.

MILANTS, C., Bruyère, O., & Kaux, J.-F. (April 2018). KNEE OSTEOARTHRITIS AND PLATELET-RICH PLASMA TREATMENT: HOW TO IMPROVE THE EFFICIENCY? Osteoporosis International, 29 (Supplement 1), 380.

Neuprez, A., Neuprez, A., KAUX, J.-F., KURTH, W., DANIEL, C., THIRION, T., HUSKIN, J.-P., Gillet, P., Bruyère, O., & Reginster, J.-Y. (April 2018). Early Clinically Relevant Improvement in Quality of Life and Clinical Outcomes 1 Year Postsurgery in Patients with Knee and Hip Joint Arthroplasties. Cartilage, 9 (2), 127-139. doi:10.1177/1947603517743000

Neuprez, A., Neuprez, A., Maheu, E., Bruyère, O., Kaux, J.-F., & Reginster, J.-Y. (April 2018). Determinants of clinical and radiological progression of hand osteoarthritis over 2 years. Osteoporosis International, 29 S1, 438.

Rabenda, V., Leclercq, V., Reginster, J.-Y., & Bruyère, O. (April 2018). Review of terminology of measurement properties for patient-reported outcomes measures. Osteoporosis International, 29 S1, 482.

Rabenda, V., Leclercq, V., Reginster, J.-Y., & Bruyère, O. (April 2018). Critical appraisal of psychometric methods used in validation of patient-reported outcomes measures. Osteoporosis International, 29 S1, 480-481.

Reginster, J.-Y., Arden, N. K., Haugen, I., Rannou, F., Cavalier, E., Bruyère, O., Branco, J., Chapurlat, R., Basset, S., Al-Daghri, N., Dennison, E., Herrero-Beaumont, G., Laslop, A., Leeb, B., Maggi, S., Mkinsi, O., Povzun, A., Prieto-Alhambra, D., Thomas, T., & Cooper, C. (April 2018). Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: consensus of a working group of the ESCEO. Osteoporosis International, 29 (Suppl1), 71-2.

Sornay-Rendu, E., Beaudart, C., Bruyère, O., & Chapurlat, R. (April 2018). The discriminative ability of SARQOL according to the definition of sarcopenia: The OFELY study. Osteoporosis International, 29 (Suppl1), 61.

Tsekoura, M., Billis, E., Gliatis, J., Tsepis, E., Matzaroglou, C., Sakkas, G., Beaudart, C., Bruyère, O., & Panagiotopoulos, E. (April 2018). Sarcopenia and quality of life questionnaire (SARQOL): Greek cross cultural adaptation. Osteoporosis International, 29 (Suppl1), 93.

Kaux, J.-F., Buckinx, F., Bornheim, S., Van Beveren, J., Dardenne, N., & Bruyère, O. (March 2018). Adaptation interculturelle du questionnaire Kujala Anterior Knee Pain Scale pour les patients francophones. Journal de Traumatologie du Sport, 35 (1), 62.

Kaux, J.-F., Hagelstein, T., Van Beveren, J., Bruyère, O., & Beaudart, C. (March 2018). Traduction et validation du Exercise-Induced Leg Pain, questionnaire pour les patients francophones. Journal de Traumatologie du Sport, 35 (1), 62-63.

Bruyère, O. (February 2018). Pharmaceutical-grade chondroitin sulfate in the management of knee osteoarthritis. Expert Opinion on Pharmacotherapy, 19 (4), 409-412. doi:10.1080/14656566.2018.1442438

GEERINCK, A., Scheppers, A., Beaudart, C., Bruyère, O., Vandenbussche, W., Bautmans, R., Delye, S., & Bautmans, I. (February 2018). Translation and validation of the psychometric properties of the Dutch version of the SarQoL®, a quality of life questionnaire specific to sarcopenia. Paper presented at Winter Meeting, Ostende, Belgium.

Bahat, G., Yilmaz, O., Merve Oren, M., Akif Karan, M., Reginster, J.-Y., Bruyère, O., & Beaudart, C. (2018). Cross-cultural adaptation and validation of the SARC-F to assess sarcopenia: methodological report from European Union Geriatric Medicine Society Sarcopenia Special Interest Group. European Geriatric Medicine, 9, 23-28. doi:10.1007/s41999-017-0003-5

Bataille, S., QUINONEZ, K., Buckinx, F., Warling, X., KRZESINSKI, J.-M., Pottel, H., Burtey, S., Bruyère, O., CAVALIER, E., & DELANAYE, P. (2018). La myostatine et l’IGF1 sont de bons biomarqueurs de la force musculaire chez les patients hémodialysés chroniques. Néphrologie et Thérapeutique, 14 (5), 4.

Beaudart, C., Biver, E., Bruyère, O., Cooper, C., Al-Daghri, N., Reginster, J.-Y., & Rizzoli, R. (2018). Quality of life assessment in musculo-skeletal health. Aging Clinical and Experimental Research, 30 (5), 413-418. doi:10.1007/s40520-017-0794-8

Beaudart, C., Locquet, M., Bornheim, S., Reginster, J.-Y., & Bruyère, O. (2018). French translation and validation of the sarcopenia screening tool SARC-F. European Geriatric Medicine, 9, 29-37. doi:10.1007/s41999-017-0007-1

Beaudart, C., Locquet, M., Reginster, J.-Y., Delandsheere, L., Petermans, J., & Bruyère, O. (2018). Quality of life in sarcopenia measured with the SarQoL®: impact of the use of different diagnosis definitions. Aging Clinical and Experimental Research, 30, 307-313. doi:10.1007/s40520-017-0866-9

Beaudart, C., Rabenda, V., Simmons, M., Geerinck, A., Araujo De Carvalho, I., Reginster, J.-Y., Amuthavalli Thiyagarajan, J., & Bruyère, O. (2018). Effects of protein, essential amino acids, B-Hydroxy B-Methylbutyrate, creatine, Dehydroepiandrosterone and fatty acid supplementation on muscle mass, muscle strength and physical performance in older people aged 60 years and over. A systematic review of the litterature. Journal of Nutrition, Health and Aging, 22 (1), 117-130. doi:10.1007/s12603-017-0934-z

Bruyère, O., Cooper, C., Al-Daghri, N., Dennison, E. M., Rizzoli, R., & Reginster, J.-Y. (2018). Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clinical and Experimental Research, 30, 111-117. doi:10.1007/s40520-017-0861-1

Buckinx, F., Bruyère, O., Reginster, J.-Y., Charles, A., DELANAYE, P., & CAVALIER, E. (2018). Plasma Klotho and Mortality Risk Among Nursing Home Residents: Results From the SENIOR Cohort [letter to the editor]. Journal of the American Medical Directors Association, 19 (12), 1139-1140. doi:10.1016/j.jamda.2018.08.010

Buckinx, F., Charles, A., Rygaert, X., Reginster, J.-Y., Adam, S.* , & Bruyère, O.*. (2018). Own attitude toward aging among nursing home residents: results of the SENIOR cohort. Aging Clinical and Experimental Research, 10, 1151-1159. doi:10.1007/s40520-018-1013-y

Buckinx, F., Croisier, J.-L., Reginster, J.-Y., Lenaerts, C., Brunois, T., Rygaert, X., PETERMANS, J., & Bruyère, O. (2018). Prediction of the Incidence of Falls and Deaths Among Elderly Nursing Home Residents: The SENIOR Study. Journal of the American Medical Directors Association, 19 (1), 18-24. doi:10.1016/j.jamda.2017.06.014

Buckinx, F., Landi, F., Cesari, F., Fielding, R. A., Visser, M., Engelke, K., Maggi, S., Dennison, E., Al-daghri, N. M., ALLEPAERTS, S., Bauer, J., Bautmans, I., Brandi, M. L., Bruyère, O., Cederholm, T., Cerrata, F., Cherubini, A., Cooper, C., Cruz-Jentoft, A., & Kanis, J. A. (2018). Pitfalls in the measurement of muscle mass; a need for a reference standard. Journal of Cachexia, Sarcopenia and Muscle, 9, 269-278. doi:10.1002/jcsm.12268

Buckinx, F., Landi, F., Cesari, M., Fielding, R., Visser, M., Engelke, K., Maggi, S., Dennison, E., Al-Daghri, N., ALLEPAERTS, S., Bauer, J., Bautmans, I., Brandi, M.-L., Bruyère, O., Cederholm, T., Cerreta, F., Cherubini, A., Cooper, C., Cruz-Jentoft, A., & Kanis, J. (2018). The authors reply: Letter on: "Pitfalls in the measurement of muscle mass: a need for a reference standard" by Clark et al. Journal of Cachexia, Sarcopenia and Muscle, 9 (7), 1272-1274. doi:10.1002/jcsm.12387

Buckinx, F., Landi, F., Cesari, M., Fielding, R. A., Visser, M., Engelke, K., Maggi, S., Dennison, E., Al-Daghri, N. M., ALLEPAERTS, S., Bauer, J., Bautmans, I., Brandi, M. L., Bruyère, O., Cederholm, T., Cerreta, F., Cherubini, A., Cooper, C., Cruz-Jentoft, A., & Kanis, J. A. (2018). The authors reply: Dual energy X-ray absorptiometry: gold standard for muscle mass ? by Scafoglieri et al. Journal of Cachexia, Sarcopenia and Muscle, 9, 788-790. doi:10.1002/jcsm.12329

De Spiegeleer, A., Beckwée, D., Bautmans, I., Petrovic, M., Beaudart, C., Beyer, I., Bruyère, O., De Breucker, S., De Cock, A.-M., Delaere, A., de Saint-Hubert, M., Gielen, E., Perkisas, S., Vandewoude, M., & the Sarcopenia Guidelines Development group of the Belgian Society of Gerontology and Geriatrics (BSGG). (2018). Pharmacological Interventions to Improve Muscle Mass, Muscle Strength and Physical Performance in Older People: An Umbrella Review of Systematic Reviews and Meta-analyses. Drugs and Aging, 35 (8), 719-34. doi:10.1007/s40266-018-0566-y

DELANAYE, P., QUINONEZ, K., Buckinx, F., KRZESINSKI, J.-M., & Bruyère, O. (2018). Hand grip strength measurement in haemodialysis patients: before or after the session? Clinical Kidney Journal, 11 (4), 555-558. doi:10.1093/ckj/sfx139

Dierks, R. M. L., Bruyère, O., & Reginster, J.-Y. (2018). Critical analysis of valuation and strategical orientation of merger and acquisition deals in the pharmaceutical industry. Expert Review of Pharmacoeconomics and Outcomes Research, 18 (2), 147-60. doi:10.1080/14737167.2018.1417040

Eymard, F., Parsons, C., Edwards, M. H., Petit-Dop, F., Reginster, J.-Y., Bruyère, O., Chevalier, X., Cooper, C., & Richette, P. (2018). Statin use and knee osteoarthritis progression: Results from a post-hoc analysis of the SEKOIA trial. Joint Bone Spine, 85 (5), 609-614. doi:10.1016/j.jbspin.2017.09.014

Gasparik, A. I., Mihai, G., Beaudart, C., Bruyère, O., Pop, R.-M., Reginster, J.-Y., & Pascanu, I. M. (2018). Correction to: Psychometric performance of the Romanian version of the SarQoL®, a health-related quality of life questionnaire for sarcopenia (Archives of Osteoporosis, (2017), 12, 1, (103), 10.1007/s11657-017-0397-1). Archives of Osteoporosis, 13 (1), 98. doi:10.1007/s11657-018-0516-7

GILLAIN, S., Boutaayamou, M., Beaudart, C., DEMONCEAU, M., Bruyère, O., Reginster, J.-Y., Garraux, G., & PETERMANS, J. (2018). Assessing gait parameters with accelerometer-based methods to identify older adults at risk of falls: a systematic review. European Geriatric Medicine, 9, 435-448. doi:10.1007/s41999-018-0061-3

Kaux, J.-F., Buckinx, F., Croisier, J.-L., & Bruyère, O. (January 2018). Cross-cultural adaptation and validation of the Kujala Anterior Knee Pain Scale (AKPS) questionnaire for French-speaking patients. Journal of Rehabilitation Medicine, 50 (1), 121-122.

Kaux, J.-F., Croisier, J.-L., & Bruyère, O. (January 2018). Validity and reliability of the French translation of the VISA-A questionnaire. Journal of Rehabilitation Medicine, 50 (1), 121.

Kaux, J.-F., CROISIER, J.-L., & Bruyère, O. (January 2018). Translation and Validation of the VISA-P Questionnaire for French-Speaking Patients. Journal of Rehabilitation Medicine, 50 (1), 110.

Kaux, J.-F., Croisier, J.-L., & Bruyère, O. (January 2018). Cross-cultural adaptation and validation of the Patient-Rated Tennis Elbow Evaluation Questionnaire on lateral elbow tendinopathy for French-speaking patients. Journal of Rehabilitation Medicine, 50 (1), 122.

Konstantynowicz, J., Abramowicz, P., Glinkowski, W., Taranta, E., Marcinowicz, L., Dymitrowicz, M., Reginster, J.-Y., Bruyère, O., & Beaudart, C. (2018). Polish Validation of the SarQoL®, a Quality of Life Questionnaire Specific to Sarcopenia. Journal of Clinical Medicine, 7, 323-332. doi:10.3390/jcm7100323

Locquet, M., Beaudart, C., Bruyère, O., Kanis, J. A., Delandsheere, L., & Reginster, J.-Y. (2018). Bone health assessment in older people with or without muscle health impairment. Osteoporosis International, 29, 1057-1067. doi:10.1007/s00198-018-4384-1

Locquet, M., Beaudart, C., Delandsheere, L., Reginster, J.-Y., & Bruyère, O. (2018). Subjective sleep quality among sarcopenic and non-sarcopenic older adults - results from the SarcoPhAge Cohort. Journal of Frailty and Aging, 7, 176-181. doi:10.14283/jfa.2018.13

Locquet, M., Beaudart, C., Reginster, J.-Y., PETERMANS, J., & Bruyère, O. (2018). Comparison of the performance of five screening methods for sarcopenia. Clinical Epidemiology, 10, 71-82. doi:10.2147/CLEP.S148638

Malafarina, V., Reginster, J.-Y., Cabrerizo, S., Bruyère, O., Kanis, J. A., Martinez, J. A., & Zulet, M. A. (2018). Nutritional status and nutritional treatment are related to outcomes and mortality in older adults with hip fracture. Nutrients, 10, 555. doi:10.3390/nu10050555

Marquet, M., Boutaayamou, M., Schwartz, C., Locquet, M., Bruyère, O., Croisier, J.-L., & Adam, S. (2018). Does negative information about aging influence older adults’ physical performance and subjective age? Archives of Gerontology and Geriatrics, 78, 181-189. doi:10.1016/j.archger.2018.06.013

Neuprez, A., Neuprez, A., KURTH, W., Gillet, P., Bruyère, O., & Reginster, J.-Y. (2018). Profile of osteoarthritic patients undergoing hip or knee arthroplasty, a step toward a definition of the “need for surgery”. Aging Clinical and Experimental Research, 30, 315-321. doi:10.1007/s40520-017-0780-1

Reginster, J.-Y., Arden, N. K., Haugen, I. K., Rannou, F., Cavalier, E., Bruyère, O., Branco, J., Chapurlat, R., Collaud Basset, S., Al-Daghri, N. M., Dennison, E. M., Herrero-Beaumont, G., Laslop, A., Leeb, B. F., Maggi, S., Mkinsi, O., Povzun, A. S., Prieto-Alhambra, D., Thomas, T., & Cooper, C. (2018). Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Seminars in Arthritis and Rheumatism, 48, 1-8. doi:10.1016/j.semarthrit.2017.12.003

Robinson, S. M., Reginster, J.-Y., Rizzoli, R., Shaw, S. C., Kanis, J. A., Bautmans, I., Bischoff-Ferrari, H., Bruyère, O., Cesari, M., Dawson-Hughes, B., Fielding, R. A., Kaufman, J. M., Landi, F., Malafarina, V., Rolland, Y., Van Loon, L. J., Vellas, B., Visser, M., & Cooper, C. (2018). Does nutrition play a role in the prevention and management of sarcopenia? Clinical Nutrition, 37, 1121-1132. doi:10.1016/j.clnu.2017.08.016

ROUSSEAU, A.-F., KELLENS, I., Freycenon, G., Dardenne, N., Bruyère, O., DAMAS, P., & Croisier, J.-L. (2018). Highly standardized quadriceps dynamometry of critically ill adults at bedside: a step towards individualized rehabilitation. Acta Anaesthesiologica Belgica, 69, 159-164.

Sanchez Rodriguez, M. D. C., & Bruyère, O. (2018). The International Registry of patients with sarcopenia: applying research in sarcopenia to clinical practice. European Geriatric Medicine, 9, 735-738. doi:10.1007/s41999-018-0108-5

Slomian, J., Vigneron, L., EMONTS, P., Reginster, J.-Y., & Bruyère, O. (2018). The "Happy Mums" website dedicated to the perinatal period: evaluation of its acceptability by parents and professionals. Midwifery, 66, 17-24. doi:10.1016/j.midw.2018.07.009

Slomian, J., Vigneron, L., EMONTS, P., Reginster, J.-Y., & Bruyère, O. (2018). Evaluation du site internet Happy-Mums.be conçu en vue de tenter d’aider les mères à combler leurs besoins en période postnatale. Poster session presented at 46ème Assises Nationales des Sages-Femmes, Marseille, France.

Veronese, N., Soysal, P., Stubbs, B., Marengoni, A., Demurtas, J., Maggi, S., Petrovic, M., Verdejo-Bravo, C., Aharony, L., De Cock, J., Nuotio, M. S., Pedone, C., Rifel, J., Vandewalle, N., Velghe, A., Vella, A., Solmi, M., Koyanagi, A., Thompson, T., & The Special Interest Group of Systematic Reviews and Meta-Analysis for Healthy Aging, E. G. M. S. E. (2018). Association between urinary incontinence and frailty: a systematic review and meta-analysis. European Geriatric Medicine, 9 (5), 571-578. doi:10.1007/s41999-018-0102-y

VRANKEN, L., EMONTS, P., Bruyère, O., & CAVALIER, E. (January 2018). Prévalence de l’hypovitaminose D chez la femme enceinte : quelle est la situation en région liégeoise ? Revue Médicale de Liège, 73 (1), 10-16.

Buckinx, F., Remy, G., Bornheim, S., Van Beveren, J., Dardenne, N., Bruyère, O., & Kaux, J.-F. (10 December 2017). French translation and validation of the AKPS questionnaire. Paper presented at 5th Congress of E.C.O.S.E.P, Dubai, United Arab Emirates.

Kaux, J.-F., Hagelstein, T., Van Beveren, J., Bruyère, O., & Beaudart, C. (09 December 2017). French Translation and validation of the Exercise-Induced Leg Pain. Paper presented at 5th Congress of E.C.O.S.E.P, Dubai, United Arab Emirates.

Demoulin, C., Halleux, V., Darlow, B., MARTIN, E., Roussel, N., Humblet, F., Bornheim, S., Flynn, D., SALAMUN, I., Renders, P., Kaux, J.-F., & Bruyère, O. (December 2017). Traduction en langue française de la version longue du « Back Pain Attitudes Questionnaire » et étude de ses qualités psychométriques. Mains Libres, 4, 19-27.

Leclerc, A.-F., Foidart-Dessalle, M., Tomasella, M., Coucke, P., DEVOS, M., Bruyère, O., Bury, T., Deflandre, D., Jerusalem, G., LIFRANGE, E., KAUX, J.-F., Crielaard, J.-M., & Maquet, D. (October 2017). Multidisciplinary rehabilitation program after breast cancer: benefits on physical function, anthropometry and quality of life. European Journal of Physical and Rehabilitation Medicine, 53 (5), 633-642. doi:10.23736/S1973-9087.17.04551-8

Bruyère, O., Croisier, J.-L., & Kaux, J.-F. (September 2017). Cross-cultural adaptation and validation of the Patient-Rated Tennis Elbow Evaluation Questionnaire on lateral elbow tendinopathy for French-speaking patients. European Journal of Sports Medicine, 5 (Supplement 1), 66-67.

Bruyère, O., Kaux, J.-F., & Croisier, J.-L. (September 2017). Validity and reliability of the French translation of the VISA-A questionnaire. European Journal of Sports Medicine, 5 (Supplement 1), 64.

Buckinx, F., Bruyère, O., & Kaux, J.-F. (September 2017). Cross-cultural adaptation and validation of the Kujala Anterior Knee Pain Scale (AKPS) questionnaire for French-speaking patients. European Journal of Sports Medicine, 5 (Supplement 1), 65.

Kaux, J.-F., Croisier, J.-L., & Bruyère, O. (September 2017). Translation and validation of the VISA-P questionnaire for French-speaking patients. European Journal of Sports Medicine, 5 (supplement 1), 63.

ROUSSEAU, A.-F., Freycenon, G., KELLENS, I., Dardenne, N., Bruyère, O., DAMAS, P., & Croisier, J.-L. (September 2017). Reliability of a standardized protocol for bedside quadriceps strength measurement in critically ill patients. Intensive Care Medicine Experimental, 5 (S2), 327.

MILANTS, C., Bruyère, O., & Kaux, J.-F. (2017). Responders to platelet-rich plasma (PRP) in osteoarthritis: A technical analysis. BioMed Research International, 7538604. doi:10.1155/2017/7538604

Mouton, A., Gillet, N., Mouton, F., Van Kann, D., Bruyère, O., Cloes, M., & Buckinx, F. (08 July 2017). Effects of a giant exercising board game intervention on ambulatory physical activity among nursing home residents: a preliminary study. Paper presented at ECSS MetropolisRuhr 2017, Essen, Germany.

Buckinx, F., Reginster, J.-Y., Morelle, A., Paquot, N., Labeye, N., Locquet, M., Adam, S.* , & Bruyère, O.*. (04 July 2017). Influence of environmental factors on food intake among nursing home residents: a survey combined with a video approach. Clinical Interventions in Aging, 12, 1055-1064. doi:10.2147/CIA.S135937

Slomian, J., Bruyère, O., Reginster, J.-Y., & Emonts, P. (May 2017). The internet as a source of information used by women after childbirth to meet their need for information: A web-based survey. Midwifery, 48, 46-52. doi:10.1016/j.midw.2017.03.005

Cianferotti, L., Bertoldo, F., Bischoff-Ferrari, H., Bruyère, O., Cooper, C., Cutolo, M., Kanis, J. A., Kaufman, J.-M., Reginster, J.-Y., Rizzoli, R., & Brandi, M. L. (April 2017). Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO). Endocrine, 56 (2), 245-61. doi:10.1007/s12020-017-1290-9

Demoulin, C., HALLEUX, V., DARLOW, B., MARTIN, E., ROUSSEL, N., Humblet, F., Bornheim, S., FLYNN, D., SALAMUN, I., Renders, P., Crielaard, J.-M., & Bruyère, O. (April 2017). Traduction en français du "back pain attitudes questionnaire" et étude de ses qualités métrologiques. Kinesitherapie, La Revue, 184, 22-23.

QUINONEZ, K., Buckinx, F., KRZESINSKI, J.-M., DELANAYE, P., & Bruyère, O. (18 March 2017). Mesure de la force de préhension chez le patient hémodialysé : quand l’effectuer ? Paper presented at V congrès francophone Fragilité du sujet âgé & Prévention de la perte d’autonomie. Rencontres scientifiques sur la sarcopénie, Paris, France.

Beaudart, C., Dawson, A., Shaw, S. C., Harvey, N. C., Kanis, J. A., Binkley, N., Reginster, J.-Y., Chapurlat, R., Chan, D. C., Bruyère, O., Rizzoli, R., Cooper, C., & Dennison, E. M. (March 2017). Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporosis International, 28 (6), 1817-33. doi:10.1007/s00198-017-3980-9

Beaudart, C., Edwards, M., Moss, C., Reginster, J.-Y., Moon, R., Parsons, C., DEMOULIN, C., Rizzoli, R., Biver, E., Dennison, E., Bruyère, O., & Cooper, C. (March 2017). English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia. Age and Ageing, 46 (2), 271-7. doi:10.1093/ageing/afw192

Beaudart, C., Locquet, M., Reginster, J.-Y., PETERMANS, J., & Bruyère, O. (March 2017). The SarcoPhAge study: evolution of sarcopenic subjects after 2 years of follow-up. Osteoporosis International, 28 Suppl 1, 208.

Buckinx, F., Lenaerts, C., Brunois, T., Rygaert, X., Reginster, J.-Y., PETERMANS, J., & Bruyère, O. (March 2017). Interest of 10 current definitions of frailty to predict the incidence of falls and deaths among elderly nursing home residents. Osteoporosis International, 28 Suppl 1, 69.

Buckinx, F., Reginster, J.-Y., Beaudart, C., Brunois, T., Lenaerts, C., Croisier, J.-L., PETERMANS, J., & Bruyère, O. (March 2017). Sarcopenia in nursing home residents: the senior cohort. Osteoporosis International, 28 Suppl 1, 123-124.

Buckinx, F., Reginster, J.-Y., Beaudart, C., Brunois, T., Lenaerts, C., Croisier, J.-L., PETERMANS, J., & Bruyère, O. (March 2017). Prevalence of sarcopenia according to 10 different operational definitions of frailty. Osteoporosis International, 28 (Supp 1), 317-318.

Ethgen, O., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J.-Y. (March 2017). The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action. Calcified Tissue International, 100 (3), 229-234. doi:10.1007/s00223-016-0220-9

Ethgen, O., & Bruyère, O. (2017). Epidemiological product assessment. In G. Emilien, R. Weitkunat, & F. Lüdicke (Eds.), Consumer Perception of Product Risks and Benefits (pp. 85-104). Springer International Publishing. doi:10.1007/978-3-319-50530-5_5

Locquet, M., Beaudart, C., Delandsheere, L., Reginster, J.-Y., & Bruyère, O. (March 2017). Subjective sleep quality in sarcopenic vs non-sarcopenic older adults from the sarcophage cohort. Osteoporosis International, 28 Suppl 1, 173-174.

Locquet, M., Beaudart, C., Delandsheere, L., Reginster, J.-Y., & Bruyère, O. (March 2017). Sensitivity and specificity of the sarc-F questionnaire according to different definitions of sarcopenia: results from the SarchoPhAge study. Osteoporosis International, 28 Suppl 1, 201.

Locquet, M., Beaudart, C., Delandsheere, L., Reginster, J.-Y., Kanis, J. A., & Bruyère, O. (March 2017). Bone quality assessment among sarcopenic and non sarcopenic elderly subjects from the SarcoPhAge Study. Osteoporosis International, 28 Suppl 1, 206-207.

Neuprez, A., KURTH, W., GILLET, P., Bruyère, O., & Reginster, J.-Y. (March 2017). Profile of osteoarthritic patients undergoing total hip and knee arthroplasty. Osteoporosis International, 28 Suppl 1, 252.

Buckinx, F., Mouton, A., Reginster, J.-Y., Croisier, J.-L., Dardenne, N., Beaudart, C., Nelis, J., Lambert, E., Appelboom, G., & Bruyère, O. (February 2017). Relationship between ambulatory physical activity assessed by activity trackers and physical frailty among nursing home residents. Gait and Posture, 54, 56-61. doi:10.1016/j.gaitpost.2017.02.010

Herrero-Beaumont, G., Roman-Blas, J. A., Bruyère, O., Cooper, C., Kanis, J., Maggi, S., Rizzoli, R., & Reginster, J.-Y. (February 2017). Clinical settings in knee osteoarthritis: Pathophysiology guides treatment. Maturitas, 96, 54-57. doi:10.1016/j.maturitas.2016.11.013

Rabenda, V., Beaudart, C., & Bruyère, O. (February 2017). Il n'est jamais trop tard pour apprendre à (bien) lire ... La Méta-Analyse. Ortho-Rhumato, 15 (1), 27-32.

ALLEPAERTS, S., DOUPAGNE, G., WEBER, J., Buckinx, F., Bruyère, O., PAQUOT, N., & PETERMANS, J. (2017). Besoins et apports énergétiques en fonction de l'indice de masse corporelle des patients hospitalisés dans le service de gériatrie du CHU Liège. Poster session presented at XXèmes Journées d'Automne, Liège, Belgium.

Beaudart, C., Biver, E., Reginster, J.-Y., Rizzoli, R., Bolland, Y., PETERMANS, J., GILLAIN, S., Buckinx, F., Dardenne, N., & Bruyère, O. (2017). Validation of the SarQoL, a specific health-related quality of life questionnaire for Sarcopenia. Journal of Cachexia, Sarcopenia and Muscle, 8 (2), 238-44. doi:10.1002/jcsm.12149

Beaudart, C., Locquet, M., Reginster, J.-Y., PETERMANS, J., & Bruyère, O. (2017). Results of the SarcoPhAge study after 2 years of follow-up. Journal of Frailty and Aging, 6 Suppl 1, 111-112.

Beaudart, C., Locquet, M., Reginster, J.-Y., PETERMANS, J., & Bruyère, O. (2017). L'étude SarcoPhAge: devenir des sujets sarcopéniques après 2 ans de suivi. L'Année Gérontologique, 31 (1), 42.

Beaudart, C., Reginster, J.-Y., Geerinck, A., Locquet, M., & Bruyère, O. (2017). Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia. Expert Review of Pharmacoeconomics and Outcomes Research, 17 (4), 335-341. doi:10.1080/14737167.2017.1360768

Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J.-Y., & Bruyère, O. (2017). Health outcomes of sarcopenia: a systematic review and metaanalysis. Osteoporosis International, 28 Suppl 1, 67.

Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J.-Y., & Bruyère, O. (January 2017). Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS ONE, 12 (1), 0169548. doi:10.1371/journal.pone.0169548

Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J.-Y., & Bruyère, O. (2017). Analyse des conséquences cliniques de la sarcopénie: une revue systématique et méta-analyse. L'Année Gérontologique, 31 (1), 18.

Bruyère, O. (2017). Survey of ESCEO algorithm: methodology and results. Osteoporosis International, 28 (S1), 635.

Bruyère, O. (2017). Role of nutrition and physical exercise in maintaining intrinsic capacity. Osteoporosis International, 28 (S1), 84.

Bruyère, O. (2017). Connected devices in musculo-skeletal health. Osteoporosis International, 28 (S1), 88.

Bruyère, O., Bergmann, P., CAVALIER, E., Gielen, E., Goemaere, S., Kaufman, J.-M., Rozenberg, S., & Body, J.-J. (2017). Skeletal health in breast cancer survivors. Maturitas, 105, 78-82. doi:10.1016/j.maturitas.2017.08.008

Bruyère, O., Buckinx, F., Beaudart, C., Reginster, J.-Y., Bauer, J., Cederholm, T., Cherubini, A., Cooper, C., Cruz-Jentoft, A. J., Landi, F., Maggi, S., Rizzoli, R., Sayer, A. A., Sieber, C., Vellas, B., & Cesari, M. (2017). How clinical practitioners assess frailty in their daily practice: an international survey. Aging Clinical and Experimental Research, 29, 905-12. doi:10.1007/s40520-017-0806-8

Bruyère, O., Cavalier, E., Buckinx, F., & Reginster, J.-Y. (January 2017). Relevance of vitamin D in the pathogenesis and therapy of frailty. Current Opinion in Clinical Nutrition and Metabolic Care, 20 (1), 26-29. doi:10.1097/MCO.0000000000000334

Bruyère, O., CAVALIER, E., & Reginster, J.-Y. (2017). Vitamin D and osteosarcopenia: an update from epidemiological studies. Current Opinion in Clinical Nutrition and Metabolic Care, 20 (6). doi:10.1097/MCO.0000000000000411

Bruyère, O., Cooper, C., Arden, N., Branco, J., Brandi, M. L., Herrero-Beaumont, G., Berenbaum, F., Dennison, E., Devogelaer, J.-P., Hochberg, M., Kanis, J., Laslop, A., McAlindon, T., Reiter, S., Richette, P., Rizzoli, R., & Reginster, J.-Y. (2017). Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis (Drugs & Aging, (2015), 32, 3, (179-187), 10.1007/s40266-015-0243-3). Drugs and Aging, 34, 411. doi:10.1007/s40266-017-0456-8

Bruyère, O., Cooper, C., Cutolo, M., & Reginster, J.-Y. (2017). International endorsement of the ESCEO algorithm for management of knee osteoarthritis in clinical practice [letter to the editor]. Seminars in Arthritis and Rheumatism, 47 (2), 10. doi:10.1016/j.semarthrit.2017.07.002

Buckinx, F., ALLEPAERTS, S., PAQUOT, N., Reginster, J.-Y., De Cock, C., PETERMANS, J., & Bruyère, O. (2017). Energy and nutrient content of food served and consumed by nursing home residents. Journal of Nutrition, Health and Aging, 21 (6), 727-32. doi:10.1007/s12603-016-0782-2

Buckinx, F., Croisier, J.-L., Reginster, J.-Y., Dardenne, N., Beaudart, C., Slomian, J., Leonard, S., & Bruyere, O. (2017). Reliability of muscle strength measures obtained with a hand-held dynamometer in an elderly population. Clinical Physiology and Functional Imaging, 37 (3), 332-40. doi:10.1111/cpf.12300

Buckinx, F., Lenaerts, C., Brunois, T., Reginster, J.-Y., PETERMANS, J., & Bruyère, O. (2017). Intérêt de 10 définitions actuelles de la fragilité pour prédire l'incidence des décès chez des sujets âgés résidant en maison de repos. L'Année Gérontologique, 31 (1), 11-12.

Buckinx, F., Lenaerts, C., Brunois, T., Reginster, J.-Y., PETERMANS, J., & Bruyère, O. (2017). Interest in 10 current definitions of frailty to predict the incidence of death among elderly nursing home residents. Journal of Frailty and Aging, 6 Suppl 1, 72-73.

Buckinx, F., Reginster, J.-Y., BRUNOIS, T., Lenaerts, C., Beaudart, C., Croisier, J.-L., PETERMANS, J., & Bruyère, O. (2017). Prevalence of sarcopenia in a population of nursing home residents according to their frailty status: results of the SENIOR cohort. Journal of Musculoskeletal and Neuronal Interactions, 17 (3), 209-17.

Buckinx, F., Reginster, J.-Y., GILLAIN, S., PETERMANS, J., Brunois, T., & Bruyère, O. (2017). Prevalence of Frailty in Nursing Home Residents According to Various Diagnostic Tools. Journal of Frailty and Aging, 6 (3), 122-8. doi:10.14283/jfa.2017.20

Cooper, C., Rannou, F., Richette, P., Bruyère, O., Al-Daghri, N., Altman, R. D., Brandi, M. L., Collaud Basser, S., Herrero-Beaumont, G., Migliore, A., Pavelka, K., Uebelhart, D., & Reginster, J.-Y. (2017). Use of Intra-Articular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice. Arthritis Care and Research, 69 (9), 1287-96. doi:10.1002/acr.23204

DELANAYE, P., QUINONEZ, K., Buckinx, F., Bruyère, O., & CAVALIER, E. (2017). Intérêt de nouveaux marqueurs biologiques dans l’évaluation de la sarcopénie en dialyse. Néphrologie et Thérapeutique, 13 (5), 269.

DELANAYE, P., QUINONEZ, K., Buckinx, F., KRZESINSKI, J.-M., & Bruyère, O. (2017). Mesure de la force de préhension chez le patient dialysé: quand l'effectuer? Néphrologie et Thérapeutique, 13 (5), 296.

Demoulin, C., Brasseur, P., Roussel, N., Brereton, C., Humblet, F., Flynn, D., Van Beveren, J., Osinsky, T., Donneau, A.-F., Crielaard, J.-M., Vanderthommen, M., & Bruyère, O. (2017). Cross-cultural translation, validity, and reliability of the French version of the Neurophysiology of Pain Questionnaire. Physiotherapy Theory and Practice, 33 (11), 880-7. doi:10.1080/09593985.2017.1359865

Dierks, R. M. L., Bruyère, O., & Reginster, J.-Y. (2017). Micro Factors Bringing the Pharmaceutical Industry to a Seismic Shaking A Qualitative Research. Expert Review of Pharmacoeconomics and Outcomes Research, 17 (3), 267-74. doi:10.1080/14737167.2017.1351877

DOUPAGNE, G., WEBER, J., Buckinx, F., Bruyère, O., PAQUOT, N., PETERMANS, J., MAES, C., & ALLEPAERTS, S. (2017). Dépenses et apports énergétiques chez les patients de plus de 75 ans hospitalisés en salle de gériatrie au CHU de Liège. Poster session presented at XXèmes Journées d'Automne de la SBGG, Liège, Belgium.

Gasparik, A. I., Mihai, G., Beaudart, C., Bruyère, O., Pop, R. M., Reginster, J.-Y., & Pascanu, I. M. (2017). Psychometric performance of the Romanian version of the SarQoL®, a health-related quality of life questionnaire for sarcopenia. Archives of Osteoporosis, 12, 103. doi:10.1007/s11657-017-0397-1

Gielen, E., Bergmann, P., Bruyère, O., Cavalier, E., DELANAYE, P., Goemaere, S., Kaufman, J.-M., Locquet, M., Reginster, J.-Y., Rozenberg, S., Vandenbroucke, A.-M., & Body, J.-J. (2017). Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club. Calcified Tissue International, 101 (2), 111-31. doi:10.1007/s00223-017-0266-3

GILLAIN, S., Boutaayamou, M., Dardenne, N., Schwartz, C., Demonceau, M., Gerontitis, C., DEPIERREUX, F., Salmon, E., GARRAUX, G., Bruyère, O., Bruls, O., Croisier, J.-L., & PETERMANS, J. (2017). Data set of healthy old people assessed for three walking conditions using accelerometric and opto-electronic methods. Aging Clinical and Experimental Research, 29 (6), 1201-1209. doi:10.1007/s40520-017-0730-y

Harvey, N. C.* , Biver, E.* , Kaufman, J.-M., Bauer, J., Branco, J., Brandi, M. L., Bruyère, O., Coxam, V., Cruz-Jentoft, A., Czerwinski, E., Dimai, H., Fardellone, P., Landi, F., Reginster, J.-Y., Dawson-Hughes, B., Kanis, J. A., Rizzoli, R.* , & Cooper, C.*. (2017). The role of calcium supplementation in healthy musculoskeletal ageing - An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis ans Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF). Osteoporosis International, 28 (2), 447-62. doi:10.1007/s00198-016-3773-6

Locquet, M., Beaudart, C., Delandsheere, L., Reginster, J.-Y., & Bruyère, O. (2017). Subjective sleep quality in sarcopenic versus non-sarcopenic older adults from the SarcoPhAge study. Journal of Frailty and Aging, 6 Suppl 1, 56.

Locquet, M., Beaudart, C., Delandsheere, L., Reginster, J.-Y., & Bruyère, O. (2017). Sensibility and sensitivity of the SARC-F questionnaire according to different definitions of sarcopenia: results from the SarcoPhAge study. Journal of Frailty and Aging, 6 Suppl 1, 119-120.

Locquet, M., Beaudart, C., Delandsheere, L., Reginster, J.-Y., & Bruyère, O. (2017). Sensibilité et spécificité du questionnaire SARC-F selon les différentes définitions de la sarcopénie: résultats de l'étude SarcoPhAge. L'Année Gérontologique, 31 (1), 44.

Locquet, M., Beaudart, C., Larbuisson, R., Leclercq, V., Buckinx, F., Kaux, J.-F., Reginster, J.-Y., & Bruyère, O. (January 2017). Self-Administration of Medicines and Dietary Supplements Among Female Amateur Runners: A Cross-Sectional Analysis. Advances in Therapy, 33 (12), 2257-2268. doi:10.1007/s12325-016-0426-2

Locquet, M., Beaudart, C., Reginster, J.-Y., PETERMANS, J., GILLAIN, S., Quabron, A., Slomian, J., Buckinx, F., & Bruyère, O. (2017). Prevalence of concomitant bone and muscle wasting in elderly women from the SarcoPhAge cohort: preliminary results. Journal of Frailty and Aging, 6 (1), 18-23. doi:10.14283/jfa.2016.111

Locquet, M., Honvo, G., Rabenda, V., Van Hees, T., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2017). Adverse Health Events Related to Self-Medication Practices Among Elderly: A Systematic Review. Drugs and Aging, 34 (5), 359-365. doi:10.1007/s40266-017-0445-y

Mouton, A., Gillet, N., Mouton, F., Bruyère, O., Cloes, M., & Buckinx, F. (2017). Effects of a giant exercising board game intervention on ambulatory physical activity among nursing home residents: a preliminary study. Osteoporosis International, 28 (S1), 318. doi:10.2147/CIA.S134760

Mouton, A., Gillet, N., Mouton, F., Van Kann, D., Bruyère, O., Cloes, M., & Buckinx, F. (2017). Effects of a giant exercising board game intervention on ambulatory physical activity among nursing home residents: a preliminary study. Clinical Interventions in Aging, 12, 847-58. doi:10.2147/CIA.S134760

Pavelka, K., Bruyère, O., Cooper, C., Kanis, J. A., Leeb, B. F., Maheu, E., Martel-Pelletier, J., Monfort, J., Pelletier, J.-P., Rizzoli, R., & Reginster, J.-Y. (2017). Erratum to: Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO (Drugs & Aging, (2016), 33, 2, (75-85), 10.1007/s40266-016-0347-4). Drugs and Aging, 34, 413. doi:10.1007/s40266-017-0457-7

QUINONEZ, K., Buckinx, F., KRZESINSKI, J.-M., Bruyère, O., & DELANAYE, P. (2017). Concept de fragilité chez le patient hémodialysé. Néphrologie et Thérapeutique, 13 (5), 296.

Reginster, J.-Y., Al-Daghri, N., & Bruyère, O. (2017). Abaloparatide Comparator Trial In Vertebral Endpoints (ACTIVE) confirms that abaloparatide is a valuable addition to the armamentarium against osteoporosis. Expert Opinion on Pharmacotherapy, 18 (17), 1811-1813. doi:10.1080/14656566.2017.1395021

Reginster, J.-Y., Al-Daghri, N., Kaufman, J.-M., & Bruyère, O. (2017). Effect of a sequential treatment combining abaloparatide and alendronate for the management of postmenopausal osteoporosis. Expert Opinion on Pharmacotherapy, 1-3. doi:10.1080/14656566.2017.1418857

ROUSSEAU, A.-F., Bawin, M., CAVALIER, E., Reginster, J.-Y., DAMAS, P., & Bruyère, O. (2017). Occurrence of bone fracture in the 2 years following a prolonged ICU stay: a retrospective study including a control group. Osteoporosis International, 28 (Suppl 1), 504.

ROUSSEAU, A.-F., CAVALIER, E., Reginster, J.-Y., DAMAS, P., & Bruyère, O. (2017). Occurrence of Clinical Bone Fracture Following a Prolonged Stay in Intensive Care Unit: A Retrospective Controlled Study. Calcified Tissue International, 101 (5), 465-472. doi:10.1007/s00223-017-0300-5

Slomian, J., EMONTS, P., Erpicum, M., Vigneron, L., Reginster, J.-Y., & Bruyère, O. (2017). What should a website dedicated to the postnatal period contain? A Delphi survey among parents and professionals. Midwifery, 53, 9-14. doi:10.1016/j.midw.2017.07.004

Slomian, J., EMONTS, P., Vigneron, L., Acconcia, A., Glowacz, F., Reginster, J.-Y., Oumourgh, M., & Bruyère, O. (2017). Identifying maternal needs following childbirth: A qualitative study among mothers, fathers and professionals. BMC Pregnancy and Childbirth, 17 (1), 213. doi:10.1186/s12884-017-1398-1

Slomian, J., Emonts, P., Vigneron, L., Acconcia, A., Reginster, J.-Y., Oumourgh, M., & Bruyère, O. (2017). Meeting the Needs of Mothers During the Postpartum Period: Using Co-Creation Workshops to Find Technological Solutions. JMIR Research Protocols, 6 (5), 76. doi:10.2196/resprot.6831

WEBER, J., ALLEPAERTS, S., DOUPAGNE, G., Buckinx, F., Bruyère, O., PAQUOT, N., & PETERMANS, J. (2017). Les besoins nutritionnels chez les patients sarcopéniques : une étude utilisant la calorimétrie indirecte. Poster session presented at 20èmes Journées d'Automne, Liège, Belgium.

Zaaria, M., Pasleau, F., Reginster, J.-Y., & Bruyère, O. (2017). Health outcomes of sarcopenia: a systematic review and meta-analysis. Journal of Frailty and Aging, 6 Suppl 1, 25.

Neuprez, A., Delcour, J.-P., Fatemi, F., Gillet, P., Crielaard, J.-M., Bruyère, O., & Reginster, J.-Y. (15 December 2016). Patients' expectations impact their satisfaction following total hip or knee arthroplasty. PLoS ONE, 11 (12), 1-14. doi:10.1371/journal.pone.0167911

Demoulin, C., Duvallon, L., Roussel, N., Humblet, F., Bornheim, S., Harry, E., SALAMUN, I., Lambert, A., Koch, D., Mahieu, G., Crielaard, J.-M., Vanderthommen, M., & Bruyère, O. (December 2016). Traduction en français du « Brief Illness Perceived Questionnaire » adapté aux patients lombalgiques et étude de ses qualités métrologiques. Revue du Rhumatisme, 83S, 209. doi:10.1016/S1169-8330(16)30511-7

Kaux, J.-F., Delvaux, F., Oppong-Kyei, J., Dardenne, N., Beaudart, C., Buckinx, F., Croisier, J.-L., Forthomme, B., Crielaard, J.-M., & Bruyère, O. (December 2016). Validity and reliability of the French translation of the VISA-A questionnaire for Achilles tendinopathy. Disability and Rehabilitation, 38 (26), 2593-2599. doi:10.3109/09638288.2016.1138553

Kaux, J.-F., DELVAUX, F., SCHAUS, J., Demoulin, C., Locquet, M., Buckinx, F., Beaudart, C., Dardenne, N., Van Beveren, J., Croisier, J.-L., FORTHOMME, B., & Bruyère, O. (December 2016). Cross-cultural adaptation and validation of the Patient-Rated Tennis Elbow Evaluation (PRTEE) questionnaire on lateral elbow tendinopathy for French-speaking patients. Journal of Hand Therapy, 29 (4), 496-504. doi:10.1016/j.jht.2016.06.007

Marquet, M., Schwartz, C., Boutaayamou, M., Locquet, M., Bruyère, O., & Adam, S. (16 November 2016). Does negative information about aging influence older adults’ physical performance and felt age? Poster session presented at 69th Annual Scientific Meeting of The Gerontological Society of America, Nouvelle-Orléans, United States.

Buckinx, F., PAQUOT, N., FADEUR, M., Bacus, L., Reginster, J.-Y., ALLEPAERTS, S., PETERMANS, J., Biquet, S., & Bruyère, O. (10 November 2016). Assessment of energy expenditure of nursing home residents with indirect calorimetry. Paper presented at International Nursing Home Research Conference - International Working Group, Barcelone, Spain.

Demoulin, C., Brasseur, P., Crielaard, J.-M., Vanderthommen, M., & Bruyère, O. (2016). A single group session of pain physiology education is effective to improve the understanding of neurophysiology of pain in patients with chronic low back pain. In A. Vleeming, 9th Interdisciplinary World Congress on Low Back and Pelvic Girdle Pain - Progress in Evidence based diagnosis and treatment (pp. 446-447).

Demoulin, C., Duvallon, L., Roussel, N., Humblet, F., Bornheim, S., Harry, E., SALAMUN, I., Lambert, A., Koch, D., Mahieu, G., Crielaard, J.-M., Vanderthommen, M., & Bruyère, O. (2016). CROSS-CULTURAL TRANSLATION, VALIDITY AND RELIABILITY OF THE FRENCH VERSION OF THE « PAIN BELIEFS QUESTIONNAIRE ». In Back to Specific Low Back Pain (pp. 37-38).

Nejjar, B., Bour, A., Beaudart, C., Bruyère, O., & CAVALIER, E. (November 2016). Prevalence of the hypovitaminosis D among Moroccan woman consulting in ambulatory medicine. Journal of Innovative Research and Applied Sciences, 3 (2), 476-483.

Beaudart, C., McCloskey, E., Bruyère, O., Cesari, M., Rolland, Y., Rizzoli, R., Araujo de Carvalho, I., Amuthavalli Thiyagarajan, J., Bautmans, I., Bertière, M.-C., Brandi, M. L., Al-Daghri, N. M., Burlet, N., CAVALIER, E., Cerreta, F., Cherubini, A., Fielding, R., Gielen, E., Landi, F., & Cooper, C. (October 2016). Sarcopenia in daily practice: assessment and management. BMC Geriatrics, 16 (170). doi:10.1186/s12877-016-0349-4

Dierks, R. M. L., Bruyère, O., Reginster, J.-Y., & Richy, F. (October 2016). Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry. Expert Review of Pharmacoeconomics and Outcomes Research, 16 (5), 571-8. doi:10.1080/14737167.2016.1239534

Buckinx, F., Morelle, A., Adam, S., Reginster, J.-Y., Labeye, N., Locquet, M., & Bruyère, O. (29 September 2016). Influence of environmental factors on food intakes of nursing home residents: a survey combined to a video approach. Paper presented at Journée des Doctorants de l'Ecole Doctorale "SPSS", Bruxelles, Belgium.

Locquet, M., Beaudart, C., Reginster, J.-Y., PETERMANS, J., GILLAIN, S., Quabron, A., Slomian, J., Buckinx, F., & Bruyère, O. (29 September 2016). Prevalence of concomitant bone and muscle wasting in patients from the SarcoPhAge Study. Paper presented at Journée des Doctorants de l'Ecole Doctorale "SPSS", Bruxelles, Belgium.

Slomian, J., EMONTS, P., Reginster, J.-Y., Vigneron, L., Acconcia, A., & Bruyère, O. (29 September 2016). Identification de solutions technologiques potentielles en réponse aux besoins des mères dans l'année suivant leur accouchement. Paper presented at Journée des Doctorants de l'Ecole Doctorale "SPSS", Bruxelles, Belgium.

Beaudart, C., Rabenda, V., & Bruyère, O. (September 2016). Il n'est jamais trop tard pour apprendre à (bien) lire ... La revue systématique. Medi-Sphere, 525, 35-38.

Kaux, J.-F., Bornheim, S., Remy, G., DELVAUX, F., Beaudart, C., Van Beveren, J., Croisier, J.-L., & Bruyère, O. (2016). Traduction inter-culturelle et validation du Kujala Anterior Knee Pain Scale (AKPS) en français. In 9ème Congrès commun SFMES - SFTS (pp. 25).

Kaux, J.-F., DELVAUX, F., SCHAUS, J., Beaudart, C., Buckinx, F., Van Beveren, J., Croisier, J.-L., Forthomme, B., CRIELAARD, J.-M., & Bruyère, O. (2016). Adaptation interculturelles du questionnaire "Patient-Rated Tennis Elbow Evaluation" pour les patients francophones. In 9ème Congrès commun SFMES - SFTS (pp. 33).

Cavalier, E., Bergmann, P., Bruyère, O., DELANAYE, P., Durnez, A., Devogelaer, J.-P., Ferrari, S. L., Gielen, E., Goemaere, S., Kaufman, J.-M., Nzeusseu Toukap, A., Reginster, J.-Y., ROUSSEAU, A.-F., Rozenberg, S., Scheen, A., & Body, J.-J. (July 2016). The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club. Osteoporosis International, 27, 2181-2195. doi:10.1007/s00198-016-3561-3

Kaux, J.-F., DELVAUX, F., SCHAUS, J., DEMOULIN, C., Locquet, M., Buckinx, F., Beaudart, C., Van Beveren, J., CROISIER, J.-L., FORTHOMME, B., & Bruyère, O. (2016). Validity and reliability of the French translation of the Patient-Related Tennis Elbow Evaluation Questionnaire. In Crossing borders through sport science (pp. 694-695).

Bruyère, O., Beaudart, C., Reginster, J.-Y., Buckinx, F., Schoene, D., Hirani, V., Cooper, C., Kanis, J. A., Rizzoli, R., McCloskey, E., Cederholm, T., Cruz-Jentoft, A., & Freiberger, E. (June 2016). Assessment of muscle mass, muscle strength and physical performance in clinical practice: An international survey. European Geriatric Medicine, 7 (3), 243-6. doi:10.1016/j.eurger.2015.12.009

Buckinx, F., & Bruyère, O. (June 2016). Il n'est jamais trop tard pour apprendre à (bien) lire ... Les essais de non-infériorité et d'équivalence. Medi-Sphere, 522, 39-41.

Kucharz, E. J., Kovalenko, V., Szanto, S., Bruyère, O., Cooper, C., & Reginster, J.-Y. (June 2016). A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Current Medical Research and Opinion, 32 (6), 997-1004. doi:10.1185/03007995.2016.1154521

Kaux, J.-F., Delvaux, F., Oppong-Kyei, J., Beaudart, C., Buckinx, F., Croisier, J.-L., Forthomme, B., Crielaard, J.-M., & Bruyère, O. (May 2016). Cross-cultural adaptation and validation of the victorian institute of sport assessment-patella questionnaire for French-speaking patients with patellar tendinopathy. Journal of Orthopaedic and Sports Physical Therapy, 46 (5), 384-393. doi:10.2519/jospt.2016.5937

Locquet, M., Beaudart, C., LARBUISSON, R., Buckinx, F., KAUX, J.-F., Reginster, J.-Y., & Bruyère, O. (May 2016). Self-Medication Practice among Amateur Runners: Prevalence and Associated Factors. Journal of Sports Science and Medicine, 15 (2), 387-8.

Slomian, J., & Bruyère, O. (May 2016). Il n'est jamais trop tard pour apprendre à (bien) lire ... Les essais croisés. Medi-Sphere, 516, 41-43.

Slomian, J., Bruyère, O., Reginster, J.-Y., & EMONTS, P. (May 2016). Quelle est la place d’internet pour combler le besoin d’information des nouvelles mères ? Poster session presented at 44èmes Assises Nationales des Sages-Femmes.

Slomian, J., EMONTS, P., Vigneron, L., Acconcia, A., Glowacz, F., Reginster, J.-Y., Oumourgh, M., & Bruyère, O. (May 2016). Identification des besoins des mères dans l’année suivant leur accouchement : une étude qualitative. Poster session presented at 44èmes Assises Nationales des Sages-Femmes, Saint-Malo, France.

CAVALIER, E., WATAR, F., KOVACS, S., Beaudart, C., Buckinx, F., Bruyère, O., LE GOFF, C., & Reginster, J.-Y. (16 April 2016). Evaluation of the intra-individual variability of Myostatin and Activin A (and PIIINP): impact on the least significant change and follow-up of the patients. Paper presented at World Congresse on Osteoporosis Osteoarthritis and musculoskeletal diseases, Malaga, Spain.

Delvaux, F., Rochcongar, P., Bruyère, O., Bourlet, G., DANIEL, C., Diverse, P., Reginster, J.-Y., & Croisier, J.-L. (09 April 2016). Return-to-play criteria after anterior cruciate ligament reconstruction: actual medicine practice in professional soccer teams. Poster session presented at FIFA - Football Medicine Strategies, London, United Kingdom.

Beaudart, C., Edwards, M., Dennison, E. M., Moss, C., Bruyère, O., Reginster, J.-Y., Moon, R. J., Cooper, C., & Demoulin, C. (April 2016). English translation and cross-cultural adaptation of the SarQuoL® questionnaire. Osteoporosis International, 27 (Supplement 1), 221-222.

Buckinx, F., Reginster, J.-Y., Beaudart, C., Croisier, J.-L., PETERMANS, J., & Bruyère, O. (April 2016). Prevalence of sarcopenia in a population of nursing home residents according to their frailty status: results of the Senior cohort. Osteoporosis International, 27 (supplement 1), 55-56.

Buckinx, F., Reginster, J.-Y., Croisier, J.-L., PETERMANS, J., & Bruyère, O. (April 2016). Physical and muscle performances among elderly nursing home residents. Osteoporosis International, 27 (Supplement 1), 217.

Buckinx, F., Reginster, J.-Y., GILLAIN, S., PETERMANS, J., Brunois, T., & Bruyère, O. (April 2016). Prevalence of frailty among nursing home, according to different operational definitions. Osteoporosis International, 27 (Supplement 1), 216-217.

CAVALIER, E., CARLISI, I., KOVACS, S., WATAR, F., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J.-Y. (April 2016). Brain-derived neurotrophic factor (BDNF) in normal healthy and hemodialyzed populations. Osteoporosis International, 27 (Supplement 1), 512.

CAVALIER, E., Piron, C., WATAR, F., KOVACS, S., Beaudart, C., Buckinx, F., Bruyère, O., LE GOFF, C., & Reginster, J.-Y. (April 2016). Evaluation of the intra-individual variability of myostatin and activin A, two biomarkers of sarcopenia: impact on the least significant change and followup of the patients. Osteoporosis International, 27 (supplement 1), 56.

Deschildre, A., Elegbédé, C., Just, J., Bruyère, O., Van der Brempt, X., Papadopoulos, A., Beaudouin, E., Renaudin, J., Crepet, A., & Moneret-Vautrin, D. (April 2016). Peanut-allergic patients in the MIRABEL survey: characteristics, allergists' dietary advice and lessons from real life. Clinical and Experimental Allergy, 46 (4), 610-20. doi:10.1111/cea.12681

Ethgen, O., Tchoconte, C., Beaudart, C., Buckinx, F., Reginster, J.-Y., & Bruyère, O. (April 2016). The future prevalence of sarcopenia in Europe. Osteoporosis International, 27 (Supplement 1), 53-54.

Kaux, J.-F., Delvaux, F., Oppong-Kyei, J., Beaudart, C., Buckinx, F., BARTSCH, V., & Bruyère, O. (April 2016). Adaptation transculturelle et validation des questionnaires VISA-P et VISA-A en français. Science et Sports, 31 (2), 65-72. doi:10.1016/j.scispo.2016.01.003

Locquet, M., Beaudart, C., Reginster, J.-Y., PETERMANS, J., GILLAIN, S., Quabron, A., Slomian, J., Buckinx, F., & Bruyère, O. (April 2016). Prevalence of concomitant bone and muscle wasting in patients from the SarcoPhAge study. Osteoporosis International, 27 (supplement 1), 129.

Neuprez, A., KURTH, W., THIRION, T., DANIEL, C., HUSKIN, J.-P., GILLET, P., Bruyère, O., & Reginster, J.-Y. (April 2016). Age-standardized quality of life after hip or knee arthoplasty. Osteoporosis International, 27 (Supplement 1), 541-542.

Pavelka, K., Bruyère, O., Cooper, C., Kanis, J. A., Leeb, B. F., Maheu, E., Martel-Pelletier, J., Monfort, J., Pelletier, J.-P., Rizzoli, R., & Reginster, J.-Y. (February 2016). Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO. Drugs and Aging, 33 (2), 75-85. doi:10.1007/s40266-016-0347-4

Amisi Kitoko, R., Asolanyongo, M. K., Losimba, J. L., GEORIS, P., GILLET, P., & Bruyère, O. (2016). Pratique de l'ostéosynthèse des fractures de jambe en République démocratique du Congo. Revue de Chirurgie Orthopédique et Traumatologique, 102 (3), 306-9. doi:10.1016/j.rcot.2015.10.022

Beaudart, C., Edwards, M., Dennisson, E., Moss, C., Bruyère, O., Reginster, J.-Y., Moon, R., Demoulin, C., & Cooper, C. (2016). English translation and cross-cultural adaptation of the SARQOL Questionnaire. Journal of Frailty and Aging, 5 (Supplement 1), 58.

Beaudart, C., Rabenda, V., & Bruyère, O. (2016). Il n'est jamais trop tard pour apprendre à (bien) lire ... La revue systématique. Ortho-Rhumato, 14 (6), 37-40.

Beaudart, C., Rabenda, V., & Bruyère, O. (2016). Het is nooit te laat om (goed) te leren lezen ... Systematic review. Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 21 (9), 37-40.

Blain, H., Masud, T., Dargent-Molina, P., Martin, F., Rosendahl, E., van der Velde, N., Bousquet, J., Benetos, A., Cooper, C., Kanis, J. A., Reginster, J.-Y., Rizzoli, R., Cortet, B., Barbagallo, M., Dreinhöfer, K., Vellas, B., Maggi, S., Strandberg, T., Alvarez, M. N., & Adachi, R. (2016). A comprehensive fracture prevention strategy in older adults: The European union geriatric medicine society (EUGMS) statement. European Geriatric Medicine, 7 (6), 519-525. doi:10.1016/j.eurger.2016.04.012

Bruyère, O., Altman, R. D., & Reginster, J.-Y. (2016). Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Seminars in Arthritis and Rheumatism, 45 (4 Suppl), 12-S17. doi:10.1016/j.semarthrit.2015.11.011

Bruyère, O., Beaudart, C., Locquet, M., Buckinx, F., PETERMANS, J., & Reginster, J.-Y. (2016). Sarcopenia as a public health problem. European Geriatric Medicine, 7 (3), 272-5. doi:10.1016/j.eurger.2015.12.002

Bruyère, O., Cooper, C., Pelletier, J. P., Maheu, E., Rannou, F., Branco, J., Brandi, M. L., Kanis, J. A., Altman, R. D., Hochberg, M. C., Martel-Pelletier, J., & Reginster, J.-Y. (2016). A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis - From evidence-based medicine to the real-life setting. Seminars in Arthritis and Rheumatism, 45 (4 Suppl), 3-S11. doi:10.1016/j.semarthrit.2015.11.010

Buckinx, F., & Bruyère, O. (2016). Les essais de non-infériorité et d'équivalence. Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 10, 14-16.

Buckinx, F., Reginster, J.-Y., Beaudart, C., CROISIER, J.-L., PETERMANS, J., & Bruyère, O. (2016). Prevalence of sarcopenia in a population of nursing home residents according to their frailty status: Results of the senior cohort. Journal of Frailty and Aging, 5 (Supplement 1), 34.

Buckinx, F., Reginster, J.-Y., Cavalier, E., PETERMANS, J., RICOUR, C., Dardenne, C., & Bruyère, O. (January 2016). Determinants of vitamin D supplementation prescription in nursing homes: a survey among general practitioners. Osteoporosis International, 27, 881-6. doi:10.1007/s00198-015-3469-3

Buckinx, F., Reginster, J.-Y., CROISIER, J.-L., PETERMANS, J., & Bruyère, O. (2016). Physical and muscle performances among elderly nursing home residents. Results fo the senior cohort. Journal of Frailty and Aging, 5 (Supplement 1), 69.

Buckinx, F., Reginster, J.-Y., GILLAIN, S., PETERMANS, J., BRUNOIS, T., & Bruyère, O. (2016). Prevalence of frailty among nursing home, according to different operational definitions. Journal of Frailty and Aging, 5 (Supplement 1), 69.

Buckinx, F., Reginster, J.-Y., Petermans, J., Croisier, J.-L., Beaudart, C., BRUNOIS, T., & Bruyère, O. (2016). Relationship between frailty, physical performance and quality of life among nursing home residents: the SENIOR cohort. Aging Clinical and Experimental Research, 28 (6), 1149-57. doi:10.1007/s40520-016-0616-4

Cavalier, E., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J.-Y. (2016). Critical analytical evaluation of promising markers for sarcopenia. European Geriatric Medicine, 7 (3), 239-242. doi:10.1016/j.eurger.2015.11.002

CAVALIER, E., Carlisi, A. S., WATAR, F., KOVACS, S., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J.-Y. (2016). Brain-derived neurotrophic factor (BDNF) in normal healthy and hemodialyzed populations. Journal of Frailty and Aging, 5 (Supplement 1), 116.

CAVALIER, E., Piron, C., WATAR, F., KOVACS, S., Beaudart, C., Buckinx, F., Bruyère, O., LE GOFF, C., & Reginster, J.-Y. (2016). Evaluation of the intra-individual variability of myostatin and activin A, two biomarkers of sarcopenia. Impact of the least significant change and follow-up of the patients. Journal of Frailty and Aging, 5 (Supplement 1), 82.

Demoulin, C., Brasseur, P., Roussel, N., GROSDENT, S., Wolfs, S., Osinski, T., Bornheim, S., CRIELAARD, J.-M., Vanderthommen, M., & Bruyère, O. (2016). DOES IMPROVEMENT OF KNOWLEDGE ABOUT NEUROPHYSIOLOGY OF PAIN OCCUR AND PERSIST IN PATIENTS WITH CHRONIC LOW BACK PAIN AFTER A SINGLE GROUP SESSION OF PAIN PHYSIOLOGY EDUCATION ? Paper presented at IFOMPT 2016, United Kingdom.

Detilleux, J., REGINSTER, J.-Y., Chines, A., & Bruyère, O. (2016). A Bayesian path analysis to estimate causal effects of bazedoxifene acetate on incidence of vertebral fractures, either directly or through non-linear changes in bone mass density. Statistical Methods in Medical Research, 25 (1), 400-412. doi:10.1177/0962280212456655

Edwards, M. H., Parsons, C., Bruyère, O., Petit Dop, F., Chapurlat, R., Roemer, F. W., Guermazi, A., Zaim, S., Genant, H., Reginster, J.-Y., Dennison, E. M., Cooper, C., & The SEKOIA Study Group. (2016). High Kellgren-Lawrence Grade and Bone Marrow Lesions Predict Worsening Rates of Radiographic Joint Space Narrowing; The SEKOIA Study. Journal of Rheumatology, 43 (3), 657-65. doi:10.3899/jrheum.150053

Locquet, M., Beaudart, C., Reginster, J.-Y., PETERMANS, J., GILLAIN, S., Quabron, A., Slomian, J., Buckinx, F., & Bruyère, O. (2016). Prevalence of concomitant bone and muscle wasting in patients from the SarcoPhAge Study. Journal of Frailty and Aging, 5 (Supplement 1), 84.

Locquet, M., Bruyère, O., Beaudart, C., & Reginster, J.-Y. (2016). Ostéoporose et sarcopénie: un même combat ? Ortho-Rhumato, 14 (4), 34-36.

Pitance, L., Brasseur, P., Rondeaux, C., Roussel, N., Meeus, M., Bruyère, O., & Demoulin, C. (2016). DOES A TWO-DAY POSTGRADUATE COURSE ON THE MANAGEMENT OF CHRONIC MUSCULO-SKELETAL PAIN INCREASES THE PHYSIOTHERAPISTS’ PAIN NEUROPHYSIOLOGY KNOWLEDGE? Paper presented at IFOMPT 2016, United Kingdom.

Reginster, J.-Y., Beaudart, C., Buckinx, F., & Bruyère, O. (January 2016). Osteoporosis and sarcopenia: two diseases or one? Current Opinion in Clinical Nutrition and Metabolic Care, 19 (1), 31-6. doi:10.1097/MCO.0000000000000230

Reginster, J.-Y., Cooper, C., & Bruyère, O. (2016). Re: Kucharz EJ, Kovalenko V, Szántó S, et al. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin 2016;32:997-1004 [letter to the editor]. Current Medical Research and Opinion, 32 (11), 1771-1772. doi:10.1080/03007995.2016.1239575

Reginster, J.-Y., Cooper, C., Rizzoli, R., Kanis, J. A., Appelboom, G., Bautmans, I., Bischoff-Ferrari, H. A., Boers, M., Brandi, M. L., Bruyère, O., Cherubini, A., Flamion, B., Fielding, R. A., Gasparik, A. I., Van Loon, L., McCloskey, E., Mitlak, B. H., Pilotto, A., Reiter-Niesert, S., & Cruz-Jentoft, A. J. (2016). Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clinical and Experimental Research, 28 (1), 47-58. doi:10.1007/s40520-015-0517-y

ROUSSEAU, A.-F., Michel, L., Bawin, M., CAVALIER, E., Reginster, J.-Y., DAMAS, P., & Bruyère, O. (2016). Incidence of bone fractures after critical illness. Intensive Care Medicine Experimental, 4 (Suppl 1), 1131.

Rozenberg, S., Body, J.-J., Bruyère, O., Bergmann, P., Brandi, M. L., Cooper, C., Devogelaer, J.-P., Gielen, E., Goemaere, S., Kaufman, J.-M., Rizzoli, R., & Reginster, J.-Y. (2016). Effects of Dairy Products Consumption on Health: Benefits and Beliefs-A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. Calcified Tissue International, 98 (1), 1-17. doi:10.1007/s00223-015-0062-x

Runhaar, J., DEROISY, R., van Middelkoop, M., Barbetta, F., Barbetta, B., Oei, E. H., Vroeginddeweij, D., Giacovelli, G., Bruyère, O., Rovati, L. C., Reginster, J.-Y., & Bierma-Zeinstra, S. M. A. (2016). The role of diet and exercise and of glucosamine sulfate in the prevention of knee osteoarthritis: Further results from the PRevention of knee Osteoarthritis in Overweight Females (PROOF) study. Seminars in Arthritis and Rheumatism, 45 (4 Suppl), 42-S48. doi:10.1016/j.semarthrit.2015.11.001

Schaap, L. A., Fox, B., Henwood, T., Bruyère, O., Reginster, J.-Y., Beaudart, C., Buckinx, F., Roberts, H., Cooper, C., Cherubini, A., Dell'Aquilla, G., Maggio, M., & Volpato, S. (2016). Grip strength measurement: Towards a standardized approach in sarcopenia research and practice. European Geriatric Medicine, 7 (3), 247-255. doi:10.1016/j.eurger.2015.11.012

Slomian, J., & Bruyère, O. (2016). Il n'est jamais trop tard pour apprendre à (bien) lire ... Les essais croisés. Vaisseaux, Coeur, Poumons, 21 (9), 34-36.

Slomian, J., EMONTS, P., Glowacz, F., Reginster, J.-Y., Bruyère, O., Vigneron, L., & Acconcia, A. (2016). Identification des besoins des mères dans l’année suivant leur accouchement : une étude qualitative. In De l'expertise scientifique à l'expertise profane : postures, enjeux et méthodes dans le champ de la psychologie de la santé.

SMOLEN, J. S., COLLAUD BASSET, S., BOERS, M., BREEDVELD, F., EDWARDS, C. J., KVIEN, T. K., MIOSSEC, P., SOKKA-ISLER, T., van VOLLENHOVEN, R. F., Abadie, E. C., Bruyère, O., COOPER, C., MÄKINEN, H., THOMAS, T., TUGWELL, P., & Reginster, J.-Y. (2016). Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease. Annals of the Rheumatic Diseases, 75, 1268-1271. doi:10.1136/annrheumdis-2016-209429

Manzambi Kuwekita, J., Gosset, C., Guillaume, M., Balula Semutsari, M.-P., Tshiama Kabongo, E., Bruyère, O., & Reginster, J.-Y. (30 December 2015). Le couplage « Micro-crédit, Micro-assurance santé et Offre des soins » peut améliorer l’accessibilité aux soins de santé de qualité en milieu urbain africain : Résultats d’une expérience menée dans la zone de santé de Bandalungwa à Kinshasa, Congo. Médecine et Santé Tropicales, 25, 381-385. doi:10.1684/mst.2015.0520

Beaudart, C., Reginster, J.-Y., PETERMANS, J., & Bruyère, O. (December 2015). Qualité de vie du patient sarcopénique : apport de l’étude liégeoise SarcoPhAge. Gériatrie et Psychologie Neuropsychiatrie du Vieillissement, 13 (4), 391-5. doi:10.1684/pnv.2015.0571

Bruyère, O., DEROISY, R., Dardenne, N., Cavalier, E., COFFINER, M., da silva, S., De Niet, S., & Reginster, J.-Y. (December 2015). A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods. Osteoporosis International, 26 (12), 2863-8. doi:10.1007/s00198-015-3205-z

Demoulin, C., Brasseur, P., Roussel, N., Humblet, F., Brereton, C., Flynn, D., Van Beveren, J., Thomas, O., Donneau, A.-F., Crielaard, J.-M., Vanderthommen, M., & Bruyère, O. (December 2015). Qualités métrologiques de la version courte du Neurophysiology of Pain Questionnaire. Revue du Rhumatisme, 82S, 70-A71.

Manzambi Kuwekita, J., Mbadu Kivuidi, V., Bruyère, O., & Reginster, J.-Y. (2015). Le tradipraticien est un acteur incontournable dans l’offre des soins de santé en territoire péri-urbain : équilibre entre légitimité et illégalité ? In J.-M. Halleux & J. Bogaert (Ed.), Territoires Périurbains (Cette oeuvre est sous licence Creative Commons. Vous êtes libre de reproduire, de modifier, de distribuer et de communiquer cette création au public selon les conditions suivantes : • paternité (BY) : vous devez citer le nom de l’auteur original de la manière indiquée par l’auteur de l’oeuvre ou le titulaire des droits qui vous confère cette autorisation (mais pas d’une manière qui suggérerait qu’ils vous soutiennent ou approuvent votre utilisation de l’oeuvre) ; • pas d’utilisation commerciale (NC) : vous n’avez pas le droit d’utiliser cette création à des fins commerciales ; • partage des conditions initiales à l’identique (SA) : si vous modifiez, transformez ou adaptez cette création, vous n’avez le droit de distribuer la création qui en résulte que sous un contrat identique à celui-ci. À chaque réutilisation ou distribution de cette création, vous devez faire apparaître clairement au public les conditions contractuelles de sa mise à disposition. Chacune de ces conditions peut être levée si vous obtenez l’autorisation du titulaire des droits sur cette oeuvre. Rien dans ce contrat ne diminue ou ne restreint le droit moral de l’auteur, pp. 184-193). Gembloux, Belgium: Presses Agronomiques de Gembloux.

Beaudart, C., Biver, E., Reginster, J.-Y., Rizzoli, R., Rolland, Y., Bautmans, I., PETERMANS, J., GILLAIN, S., Buckinx, F., & Bruyère, O. (17 November 2015). Development and validation of a self-administrated quality of life questionnaire specific to sarcopenia: the SarQoL. Paper presented at Journée des Doctorants de l'Ecole Doctorale "SPSS", Liège, Belgium.

Bruyère, O., Reginster, J.-Y., Dardenne, N., Nelis, J., Lambert, E., Appelboom, G., & Buckinx, F. (17 November 2015). Relationship between ambulatory physical activity assessed by activity trackers and physical frailty among nursing home residents. Paper presented at Journée des Doctorants de l'Ecole Doctorale "SPSS", Liège, Belgium.

Locquet, M., Beaudart, C., LARBUISSON, R., Buckinx, F., KAUX, J.-F., Reginster, J.-Y., & Bruyère, O. (17 November 2015). Prevalence and factors associated with self-medication practice among amateur runners. Paper presented at Journée des Doctorants de l'Ecole Doctorale "SPSS", Liège, Belgium.

Slomian, J., EMONTS, P., Reginster, J.-Y., Vigneron, L., Acconcia, A., & Bruyère, O. (17 November 2015). Identification des besoins d'une mère dans l'année suivant son accouchement : comparaison entre les femmes ayant vécu au moins un épisode de détresse psychologique et celles n'en ayant pas vécu. Paper presented at Journée des Doctorants de l'Ecole Doctorale "SPSS", Liège, Belgium.

Kaux, J.-F., Bruyère, O., Croisier, J.-L., Forthomme, B., LE GOFF, C., & Crielaard, J.-M. (08 October 2015). Platelet-Rich Plasma Infiltration To Treat Chronic Proximal Patellar Tendinopathies: A One-Year Follow-Up. Poster session presented at 4st Congress of the ECOSEP, Barcelona, Spain.

Kaux, J.-F., Delvaux, F., Oppong-Kyei, J., Beaudart, C., Buckinx, F., Croisier, J.-L., Forthomme, B., Crielaard, J.-M., & Bruyère, O. (08 October 2015). VISA-PF: A Cross-Cultural Adaptation And Validation Of The VISA-P Questionnaire In French. Poster session presented at 4st Congress of the ECOSEP, Barcelona, Spain.

Kaux, J.-F., DELVAUX, F., Oppong-Kyei, J., Beaudart, C., Buckinx, F., Croisier, J.-L., Forthomme, B., Crielaard, J.-M., & Bruyère, O. (08 October 2015). Cross-Cultural Adaptation And Validation Of The VISA-A Questionnaire In French. Poster session presented at 4st Congress of the ECOSEP, Barcelona, Spain.

Beaudart, C., Reginster, J.-Y., Petermans, J., GILLAIN, S., Quabron, A., Locquet, M., Slomian, J., Buckinx, F., & Bruyère, O. (September 2015). Quality of life and physical components linked to sarcopenia: baseline data of the SarcoPhAge study. European Geriatric Medicine, 6S1, 7-s8.

Beaudart, C., Reginster, J.-Y., Rizzoli, R., Biver, E., Rolland, Y., Bautmans, I., Petermans, J., GILLAIN, S., Buckinx, F., Van Beveren, J., Jacquemain, M., Italiano, P., Dardenne, N., & Bruyère, O. (September 2015). Development and validation of a self-administrated quality of life questionnaire specific to sarcopenia: the SarQol. European Geriatric Medicine, 6S1, 84.

Buckinx, F., Croisier, J.-L., Reginster, J.-Y., Petermans, J., & Bruyère, O. (September 2015). Impact of the frailty status on muscle mass and muscle strength of nursing home residents. European Geriatric Medicine, 6S1, 85.

Buckinx, F., Croisier, J.-L., Reginster, J.-Y., Petermans, J., & Bruyère, O. (September 2015). Correlation between muscle mass and muscle strength among nursing home residents. European Geriatric Medicine, 6S1, 84-s85.

Buckinx, F., Paquot, N., Allepaerts, S., Reginster, J.-Y., Petermans, J., & Bruyère, O. (September 2015). Energy and nutrient contents of food served and consumed by nursing home residents. European Geriatric Medicine, 6S1, 124.

Buckinx, F., Reginster, J.-Y., Cavalier, E., Petermans, J., Dardenne, C., & Bruyère, O. (September 2015). Derteminants of prescription of vitamin D supplementations in nursing homes: an online survey among general practitioners. European Geriatric Medicine, 6S1, 139.

GILLAIN, S., WOJTASIK, V., DEPIERREUX, F., Schwartz, C., Boutaayamou, M., Demonceau, M., SCHMITZ, X., Dardenne, N., Bruyère, O., Garraux, G., & PETERMANS, J. (September 2015). PHYSICAL AND MENTAL DETERMINANTS OF FALLS IN HEALTHY OLD PEOPLE: BASELINE DATE OF THE GABI STUDY. Poster session presented at 11E Congrès de l'EUGMS.

GILLAIN, S., WOJTASIK, V., DEPIERREUX, F., Schwartz, C., Boutaayamou, M., DEMONCEAU, M., SCHMITZ, X., Dardenne, N., Bruyère, O., GARRAUX, G., & PETERMANS, J. (September 2015). Baseline characteristics of a two-year prospective study aiming to link clinical components, cognitive and gait performances in healthy old people : the GABY Study. Poster session presented at 11th International Congress of the European Union Geriatric Medicine Society, Oslo, Norway.

Kaux, J.-F., Bruyère, O., Croisier, J.-L., Forthomme, B., LE GOFF, C., & Crielaard, J.-M. (September 2015). One-year follow-up of platelet-rich plasma infiltration to treat chronic proximal patellar tendinopathies. European Journal of Sports Medicine, 3 (Suppl 1), 113.

Kaux, J.-F., Croisier, J.-L., Bruyère, O., Rodriguez de la Cruz, C., Forthomme, B., Brabant, G., Lapraille, S., Lonneux, V., Noel, D., Le Goff, C., Gothot, A., COLLETTE, J., & Crielaard, J.-M. (September 2015). One injection of platelet-rich plasma associated to a submaximal eccentric protocol to treat chronic jumper's knee. Journal of Sports Medicine and Physical Fitness, 55 (9), 953-61.

Kaux, J.-F., Delvaux, F., Oppong-Kyei, J., Beaudart, C., Buckinx, F., Croisier, J.-L., Forthomme, B., Crielaard, J.-M., & Bruyère, O. (September 2015). Validation of the French translation of the VISA-A. European Journal of Sports Medicine, 3 (Suppl 1), 112-113.

Kaux, J.-F., Delvaux, F., Oppong-Kyei, J., Beaudart, C., Buckinx, F., Croisier, J.-L., Forthomme, B., Crielaard, J.-M., & Bruyère, O. (September 2015). Cross-cultural adaptation and validation of the VISA-P questionnaire in French. European Journal of Sports Medicine, 3 (Suppl 1), 112.

Kaux, J.-F., Bruyère, O., Croisier, J.-L., Forthomme, B., LE GOFF, C., & Crielaard, J.-M. (July 2015). One-year follow-up of platelet-rich plasma infiltration to treat chronic proximal patellar tendinopathies. Acta Orthopaedica Belgica, 81 (2), 251-256.

GILLAIN, S., Petermans, J., Dardenne, N., Beaudart, C., Buckinx, F., GARRAUX, G., REGINSTER, J.-Y., Bruyère, O., DEMONCEAU, M., WOJTASIK, V., & Schwartz, C. (April 2015). Comparison of body composition, muscle force and physical performances between faller and non-faller people included in a cohort of 100 community dwelling volunteers : the Gaby Study. Journal of Frailty and Aging, 4 (S1), 106.

Manzambi Kuwekita, J., Eloko Eya Matangelo, G., Bruyère, O., Gosset, C., Guillaume, M., & Reginster, J.-Y. (31 March 2015). Financement de la santé et recouvrement des coûts : le lourd fardeau des ménages congolais. Résultats des comptes nationaux de la santé. Journal d’Épidémiologie et de Santé Publique, 15 (Mars 2015), 15-27.

Manzambi Kuwekita, J., Bruyère, O., Guillaume, M., Gosset, C., & Reginster, J.-Y. (23 March 2015). Comment optimiser l’efficience de l’aide internationale, dans le domaine de la santé, en République Démocratique du Congo. Santé Publique: Revue Multidisciplinaire pour la Recherche et l'Action, 27 (Janvier-Févier), 129-134. doi:10.3917/spub.151.0129

Bruyère, O. (March 2015). Physical rehabilitation in musculoskeletal conditions: which method? Osteoporosis International, 26 (S1), 68.

Bruyère, O. (March 2015). Dairy products & Bone Health: Turning facts and beliefs into clinical practice. Osteoporosis International, 26 (S1), 383.

Buckinx, F., Reginster, J.-Y., Dardenne, N., Croisier, J.-L., Kaux, J.-F., Beaudart, C., Slomian, J., & Bruyère, O. (March 2015). Concordance between muscle mass assessed by bioelectrical impedance analysis and by dual energy X-ray absorptionmetry among elderly people: a cross-sectional study. Osteoporosis International, 26 (S1), 53.

Buckinx, F., Reginster, J.-Y., Dardenne, N., Croisier, J.-L., Kaux, J.-F., Beaudart, C., Slomian, J., & Bruyère, O. (March 2015). Concordance between muscle mass assessed by bioelectrical impedance analysis and by dual energy X-ray absorptionmetry among elderly people: a cross-sectional study. BMC Musculoskeletal Disorders, 16 (1), 60-67. doi:10.1186/s12891-015-0510-9

Neuprez, A., Bruyère, O., Dardenne, N., Distèche, S., Maheu, E., Burlet, N., & Reginster, J.-Y. (March 2015). Assessment and determinants of aesthetic discomfort in hand osteoarthritis: The Liège Hand Osteoarthritis Cohort (LICOH). Osteoporosis International, 26 (S1), 43-S44.

Castiglione, V., JOURET, F., Bruyère, O., DUBOIS, B., THOMAS, A., WALTREGNY, D., BEKAERT, A.-C., CAVALIER, E., & GADISSEUR, R. (February 2015). Epidémiologie de la lithiase urinaire sur base d'une analyse morpho-constitutionnelle. Néphrologie et Thérapeutique, 11, 42-49. doi:10.1016/j.nephro.2014.08.003

APPELBOOM, G., TAYLOR, B. E., BRUCE, E., BASSILE, C. C., MALAKIDIS, C., YANG, A., YOUNGERMAN, B., D'AMICO, R., BRUCE, S., Bruyère, O., Reginster, J.-Y., DUMONT, E., & CONNOLLY, E. S. (2015). Mobile phone-connected wearable motion sensors to assess postoperative mobilization. Journal of Medical Internet Research Mobile and Ubiquitous Health, 3 (3), 78.

Arden, N., Richette, P., Cooper, C., Bruyère, O., Abadie, E., Branco, J., Brandi, M.-L., Berenbaum, F., Clerc, C., Dennison, E., Devogelaer, J.-P., Hochberg, M., D'Hooghe, P., Herrero-Baumont, G., Kanis, J. A., Laslop, A., Leblanc, V., Maggi, S., Mautone, G., & Reginster, J.-Y. (2015). Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on biomarkers ans frailty. Drugs and Aging, 32, 529-535. doi:10.1007/s40266-015-0276-7

Arden, N. K., Richette, P., Cooper, C., Bruyère, O., Abadie, E. C., Branco, J., Brandi, M., Berenbaum, F., Clerc, C., Dennison, E., Devogelaer, J., Hochberg, M., Herrero-Beaumont, G., Kanis, J., Laslop, A., Leblanc, V., Maggi, S., Mautone, G., Pelletier, J., & Reginster, J.-Y. (2015). Can we identify patients to be treated in osteoarthritis? Osteoporosis International, 26 (S1), 61-62.

Beaudart, C., Biver, E., Reginster, J.-Y., Rizzoli, R., Rolland, Y., Bautmans, I., PETERMANS, J., GILLAIN, S., Buckinx, F., van beveren, J., Jacqemain, M., Italiano, P., Dardenne, N., & Bruyère, O. (2015). Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQol. Age and Ageing, 44, 960-966. doi:10.1093/ageing/afv133

Beaudart, C., Biver, E., Reginster, J.-Y., Rizzoli, R., Rolland, Y., Bautmans, I., Petermans, J., GILLAIN, S., Buckinx, F., Van Beveren, J., Jacquemain, M., Italiano, P., & Bruyère, O. (2015). Development of a self-administrated quality of life questionnaire specific to sarcopenia in elderly aged 65 years and older: the SARQOL. Osteoporosis International, 26 (S1), 145.

Beaudart, C., Reginster, J.-Y., Bautmans, I., Croisier, J.-L., Slomian, J., Buckinx, F., Locquet, M., Quabron, A., & Bruyère, O. (2015). Muscle fatigue resistance and self-perceived fatigue in relation with sarcopenia and quality of life. Journal of Frailty and Aging, 4 (S1), 61-62.

Beaudart, C., Reginster, J.-Y., Bautmans, I., Croisier, J.-L., Slomian, J., Buckinx, F., Locquet, M., Quabron, A., & Bruyère, O. (2015). Grip fatigue resistance and self-perceived fatigue in relation with sarcopenia and quality of life. Osteoporosis International, 26 (S1), 147-S148.

Beaudart, C., Reginster, J.-Y., Croisier, J.-L., Slomian, J., Buckinx, F., Locquet, M., Quabron, A., & Bruyère, O. (2015). Is there a specific pattern of lean/fat mass ratio in sarcopenic subjects? Osteoporosis International, 26 (S1), 145-S146.

Beaudart, C., Reginster, J.-Y., Croisier, J.-L., Slomian, J., Buckinx, F., Locquet, M., Quabron, A., & Bruyère, O. (2015). Is there a specific pattern of lean/fat mass ratio in sarcopenic subjects? Journal of Frailty and Aging, 4 (S1), 61.

Beaudart, C., Reginster, J.-Y., Croisier, J.-L., Slomian, J., Buckinx, F., Locquet, M., Quabron, A., & Bruyère, O. (2015). Correlation between muscle mass and muscle strength and their association with physical performance and gait speed. Osteoporosis International, 26 (S1), 49.

Beaudart, C., Reginster, J.-Y., Croisier, J.-L., Slomian, J., Buckinx, F., Locquet, M., Quabron, A., & Bruyère, O. (2015). Correlation between muscle mass and muscle strength and their association with physical performance and gait speed. Journal of Frailty and Aging, 4 (S1), 61.

Beaudart, C., Reginster, J.-Y., Petermans, J., GILLAIN, S., Quabron, A., Locquet, M., Slomian, J., Buckinx, F., & Bruyère, O. (2015). Quality of life and physical components linked to sarcopenia: The SarcoPhAge study. Experimental Gerontology, 69, 103-110. doi:10.1016/j.exger.2015.05.003

Beaudart, C., Reginster, J.-Y., Petermans, J., GILLAIN, S., Quabron, A., Locquet, M., Slomian, J., Buckinx, F., & Bruyère, O. (2015). Clinical components linked to sarcopenia: the sarcophage study. Osteoporosis International, 26 (S1), 144.

Beaudart, C., Reginster, J.-Y., Petermans, J., GILLAIN, S., Quabron, A., Locquet, M., Slomian, J., Buckinx, F., & Bruyère, O. (2015). Clinical components linked to sarcopenia: the sarcophage study. Journal of Frailty and Aging, 4 (S1), 89.

Beaudart, C., Reginster, J.-Y., Rizzoli, R., Rolland, Y., Bautmans, I., Biver, E., Petermans, J., GILLAIN, S., Van Beveren, J., Jacquemain, M., Italiano, P., Dardenne, N., & Bruyère, O. (2015). Development of a self-administrated quality of life questionnaire specific to sarcopenia in elderly aged 65 and older : the SarQol. Journal of Frailty and Aging, 4 (S1), 31-32.

Beaudart, C., Reginster, J.-Y., Slomian, J., Buckinx, F., Locquet, M., Quabron, A., & Bruyère, O. (2015). Health related quality of life in sarcopenia. Osteoporosis International, 26 (S1), 148-149.

Beaudart, C., Reginster, J.-Y., Slomian, J., Buckinx, F., Locquet, M., Quabron, A., & Bruyère, O. (2015). Health related quality of life in sarcopenia. Journal of Frailty and Aging, 4 (S1), 61.

Beaudart, C., Reginster, J.-Y., Slomian, J., Dardenne, N., Quabron, A., SLANGEN, C., GILLAIN, S., Petermans, J., & Bruyère, O. (2015). Estimation of sarcopenia prevalence using various assessment tools. Experimental Gerontology, 61, 31-37. doi:10.1016/j.exger.2014.11.014

Bruyère, O. (2015). Statistiques : quand un biais - le biais de confusion - donne une illusion de causalité ... (partie 2). Onco: Revue Multidisciplinaire d'Oncologie, 9 (7), 96-97.

Bruyère, O. (2015). Statistiques : où il est question de se faire une idée juste de la réalité ... (partie 1). Onco: Revue Multidisciplinaire d'Oncologie, 9 (6), 30-32.

Bruyère, O. (2015). Statistiques : il n'est jamais trop tard pour apprendre à (bien) lire. Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 20 (2), 15-16.

Bruyère, O., Ahmed, S. H., Atlan, C., Belegaud, J., Bortolotti, M., Canivenc-Lavier, M.-C., Charrière, S., Girardet, J.-P., Houdart, S., Kalonji, E., Nadaud, P., Rajas, F., Slama, G., & Margaritis, I. (2015). Review of the nutritional benefits and risks related to intense sweeteners. Archives of Public Health, 73 (41). doi:10.1186/s13690-015-0092-x

Bruyère, O., Ahmed, S. H., Atlan, C., Belegaud, J., Bortolotti, M., Canivenc-Lavier, M.-C., Charrière, S., Girardet, J.-P., Houdart, S., Kalonji, E., Nadaud, P., Rajas, F., Slama, G., & Margaritis, I. (2015). Erratum to: Review of the nutritional benefits and risks related to intense sweeteners. Archives of Public Health. doi:10.1186/s13690-015-0102-z

Bruyère, O., & Boutron-Ruault, M.-C. (2015). Statistiques: évaluer la force de l'association. Onco: Revue Multidisciplinaire d'Oncologie, 9 (5), 14-16.

Bruyère, O., Cooper, C., Arden, N., Branco, J., Brandi, M., Herrero-Beaumont, G., Berenbaum, F., Dennison, E., Devogelaer, J., Hochberg, M., Kanis, J., Laslop, A., McAlindon, T., Reiter, S., Richette, P., Rizzoli, R., & Reginster, J.-Y. (2015). Can we identify patients with high risk of osteoarthritis progression who will respond to treatment ? A focus on epidemiology and phenotype of osteoarthritis. Drugs and Aging, 32 (3), 179-187. doi:10.1007/s40266-015-0243-3

Bruyère, O., & Reginster, J.-Y. (2015). Quels types d'étude pour quels objectifs ? Onco: Revue Multidisciplinaire d'Oncologie, 9 (1), 34-36.

Bruyère, O., & Reginster, J.-Y. (2015). Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome. Endocrine, 48 (1), 65-68. doi:10.1007/s12020-014-0357-0

Bruyère, O., & Reginster, J.-Y. (2015). Letter to the Editor. Seminars in Arthritis and Rheumatism, 44 (5), 15. doi:10.1016/j.semarthrit.2014.09.001

Bruyère, O., Reginster, J.-Y., & Cooper, C. (2015). Should your Algorithm Include Plasma Rich in Growth Factors in the Light of Its Clinical Efficacy and Safety?: By Vaquerizo V. et al. Seminars in Arthritis and Rheumatism, 44 (4), 12-e13. doi:10.1016/j.semarthrit.2014.09.008

Bruyère, O., Reginster, J.-Y., Dardenne, N., Nelis, J., Lambert, E., Appelboom, G., & Buckinx, F. (2015). Relationship between ambulatory physical activity assessed by activity trackers and physical frailty among nursing home residents. The Journal of Nursing Home Research Sciences, 1, 28.

Bruyère, O., Reginster, J.-Y., & Ethgen, O. (2015). La médecine personnalisée : aspects pharmacoéconomiques. Revue Médicale de Liège, 70 (5-6), 339-342.

Buckinx, F., Beaudart, C., Slomian, J., Maquet, D., Demonceau, M., Gillain, S., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2015). Added value of a triaxial accelerometer assessing gait parameters to predict falls and mortality among nursing home residents: A two-year prospective study. Technology and Health Care, 23, 195-203. doi:10.3233/THC-140883

Buckinx, F., Croisier, J.-L., Reginster, J.-Y., Dardenne, N., Beaudart, C., Slomian, J., & Bruyère, O. (2015). Reliability of muscle strength measures obtained with a hand-held dynamometer in an elderly population. Osteoporosis International, 26 (S1), 161. doi:10.1111/cpf.12300

Buckinx, F., Croisier, J.-L., Reginster, J.-Y., Dardenne, N., Beaudart, C., Slomian, J., & Bruyère, O. (2015). Reliability of eight muscle strength measures obtained with a hand-held dynamometer in an elderly population. Journal of Frailty and Aging, 4 (S1), 60-1. doi:10.1111/cpf.12300

Buckinx, F., Croisier, J.-L., Reginster, J.-Y., PETERMANS, J., Goffart, E., & Bruyère, O. (2015). Relationship between isometric strength of six lower limb muscle groups and motor skills among nursing home residents. Journal of Frailty and Aging, 4 (4), 184-7. doi:10.14283/jfa.2015.70

Buckinx, F., PAQUOT, N., ALLEPAERTS, S., Reginster, J.-Y., PETERMANS, J., Backes, C., & Bruyère, O. (2015). Energy and nutrient contents of food served and consumed by nursing home residents. The Journal of Nursing Home Research Sciences, 1, 43.

Buckinx, F., Reginster, J.-Y., CAVALIER, E., PETERMANS, J., RICOUR, C., Dardenne, C., & Bruyère, O. (2015). Determinants of prescription of vitamin D supplementation in nursing homes: a survey among general practitioners. The Journal of Nursing Home Research Sciences, 1, 43.

Buckinx, F., Reginster, J.-Y., CROISIER, J.-L., PETERMANS, J., Goffart, E., & Bruyère, O. (2015). Relationship between isometric strength of 6 muscle groups of the lower limbs and motor skills among nursing home residents. The Journal of Nursing Home Research Sciences, 1, 44.

Buckinx, F., Reginster, J.-Y., CROISIER, J.-L., PETERMANS, J., Goffart, E., & Bruyère, O. (2015). Physical abilities of elderly nursing home residents: The SENIOR cohort. The Journal of Nursing Home Research Sciences, 1, 43-44.

Buckinx, F., Reginster, J.-Y., Dardenne, N., Beaudart, C., Slomian, J., GILLAIN, S., Petermans, J., RICOUR, C., Goffart, E., & Bruyère, O. (2015). Prevalence of frailty in nursing home residents according to various diagnostic tools. Osteoporosis International, 26 (S1), 160-S161.

Buckinx, F., Reginster, J.-Y., Dardenne, N., Beaudart, C., Slomian, J., GILLAIN, S., Petermans, J., RICOUR, C., Goffart, E., & Bruyère, O. (2015). Prevalence of frailty in nursing home residents according to various diagnostic tools. Journal of Frailty and Aging, 4 (S1), 61.

Buckinx, F., Rolland, Y., Reginster, J.-Y., RICOUR, C., Petermans, J., & Bruyère, O. (2015). Burden of frailty in the elderly population: perspectives for a public health challenge. Archives of Public Health, 73 (1), 19-25. doi:10.1186/s13690-015-0068-x

CAVALIER, E., GADISSEUR, R., GEBOES, S., BEKAERT, A.-C., CARLISI, I., Bruyère, O., & Reginster, J.-Y. (2015). Critical evaluation of promising markers for sarcopenia. Osteoporosis International, 26 (S1), 49-S50.

Crépet, A., Papadopoulos, A., Elegbede, C. F., Ait-Dahmane, S., Loynet, C., Millet, G., Van Der Brempt, X., Bruyère, O., Marette, S., & Moneret-Vautrin, D. A. (January 2015). Mirabel: An integrated project for risk and cost/benefit analysis of peanut allergy. Regulatory Toxicology and Pharmacology, 71, 178-83. doi:10.1016/j.yrtph.2014.12.006

Delvaux, F., Rochcongar, P., Bruyère, O., DANIEL, C., Reginster, J.-Y., & Croisier, J.-L. (2015). Retour au sport après plastie du ligament croisé antérieur : critères utilisés dans les cubs professionnels de football. Science et Sports, 30, 33-40.

Delvaux, F., Rochcongar, P., Bruyère, O., DANIEL, C., Reginster, J.-Y., & Croisier, J.-L. (2015). Retour au sport après plastie du ligament croisé antérieur: Critères utilisés dans les clubs professionnels de football. Science et Sports, 30 (1), 33-40. doi:10.1016/j.scispo.2014.11.001

Demoulin, C., Bruyère, O., SOMVILLE, P.-R., & Vanderthommen, M. (2015). Low back pain-related meta-analysis: Caution is needed when interpreting published research results. World Journal of Meta-Analysis, 26 (3(2)), 93-96. doi:10.13105/wjma.v3.i2.93

Ethgen, O., Hiligsmann, M., Bruyère, O., & Reginster, J.-Y. (2015). Cost-effectiveness of dairy products supplemented with vitamin D in the prevention of osteoporotic fractures. Osteoporosis International, 26 (S1), 372-S373.

Eymard, F., Parsons, C., Edwards, M., Petit-Dop, F., Reginster, J.-Y., Bruyère, O., Richette, P., Cooper, C., & Chevalier, X. (2015). Diabetes is a risk factor for knee osteoarthritis progression. Osteoarthritis and Cartilage, 23, 851-859. doi:10.1016/j.joca.2015.01.013

FOX, B., HENWOOD, T., SCHAAP, L., Bruyère, O., Reginster, J.-Y., Beaudart, C., Buckinx, F., ROBERTS, H., COOPER, C., CHERUBINI, A., dell'AQUILLA, G., MAGGIO, M., & VOLPATO, S. (2015). Adherence to a standardized protocol for measuring grip strength and appropriate cut-off values in adults over 65 years with sarcopenia: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports, 13 (10), 50-59. doi:10.11124/jbisrir-2015-2256

Hiligsmann, M., Ben Sedrine, W., Bruyère, O., Evers, S. M., Rabenda, V., & Reginster, J.-Y. (2015). Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis. European Journal of Public Health, 25 (1), 20-25. doi:10.1093/eurpub/cku119

Lo Presti, M.* , Abraham, M.* , Appelboom, G., Bruyère, O., Slomian, J., Reginster, J.-Y., & Connolly Jr, E. S. (2015). Clinical Trials Using Mobile Health Applications. Pharmaceutical Medicine, 29 (1), 17-25. doi:10.1007/s40290-015-0085-7

Neuprez, A., Bruyère, O., Dardenne, N., DISTECHE, S., MAHEU, E., BURLET, N., D'HOOGHE, P., & Reginster, J.-Y. (2015). Assessment and determinants of aesthetic discomfort in hand osteoarthritis. Annals of the Rheumatic Diseases, 74, 1942. doi:10.1136/annrheumdis-2015-207718

NEUPREZ, A., Bruyère, O., Dardenne, N., DISTECHE, S., Maheu, E., Burlet, N., & Reginster, J.-Y. (2015). Baseline characteristics of the Liège Hand Osteoarthritis Cohort (LIHOC). Annals of the Rheumatic Diseases, 74 (Supp2), 1346. doi:10.1136/annrheumdis-2015-eular.3393

Neuprez, A., Bruyère, O., Dardenne, N., DISTECHE, S., Maheu, E., Burlet, N., & Reginster, J.-Y. (2015). Baseline characteristics of the Liège hand osteoarthritis cohort (LIHOC). Osteoporosis International, 26 (S1), 167.

Neuprez, A., Bruyère, O., Dardenne, N., DISTECHE, S., Maheu, E., Burlet, N., & Reginster, J.-Y. (2015). Assessment and determinants of aesthetic discomfort in hand osteoarthritis: the LIège Hand Osteoarthritis Cohort (LIHOC). Annals of the Rheumatic Diseases, 74 (Supp2), 110. doi:10.1136/annrheumdis-2015-eular.2778

Neuprez, A., Bruyère, O., MAHEU, E., Dardenne, N., Burlet, N., D'HOOGHE, P., DISTECHE, S., & Reginster, J.-Y. (2015). Aesthetic discomfort in hand osteoarthritis: results from the LIège Hand Osteoarthritis Cohort (LIHOC). Arthritis Research and Therapy, 17, 346. doi:10.1186/s13075-015-0807-y

NEUPREZ, A., Delcour, J.-P., Fatemi, F., GILLET, P., Mawet, M., François, G., Bruyère, O., CRIELAARD, J.-M., Gosset, C., & Reginster, J.-Y. (2015). Development and validation of the French version of a tool assessing patient's expectations in lower limb osteoarthritis. Journal of Orthopaedics, 12, 46-57. doi:10.1016/j.jor.2014.06.002

Osinski, T., Barde-Cabusson, Brasseur, P., Bruyère, O., & Demoulin, C. (2015). Traduction française du Neurophysiology of Pain Questionnaire. Paper presented at JFK.

Rabenda, V., Bruyère, O., Cavalier, E., DEROISY, R., LECART, M.-P., COLLETTE, J., & Reginster, J.-Y. (2015). Serum concentrations of osteoprotegerin (OPG) and dickkope-1 (DKK1) poorly predict bone mineral density changes and fracture incidence in postmenopausal osteoporotic women. Osteoporosis International, 26 (S1), 240.

Rabenda, V., Bruyère, O., Cooper, C., Rizzoli, R., Buckinx, F., Quabron, A., & Reginster, J.-Y. (2015). Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11) : A position paper of the European Society for Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ESCEO) and the International Osteoporosis and Other Skeletal Diseases Foundation (IOF). Archives of Osteoporosis, 10 (1). doi:10.1007/s11657-015-0216-5

Rabenda, V., Bruyère, O., Kanis, J., Cooper, C., Rizzoli, R., Buckinx, F., Quabron, A., & Reginster, J.-Y. (2015). Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-skeletal Diseases (ECCEO-IOF11). Osteoporosis International, 26 (S1), 211.

Reginster, J.-Y., & Bruyère, O. (2015). Recommendation for the management of knee osteoarthritis. Bone, Muscle and Joint Diseases, (S35), 40.

Reginster, J.-Y., Cooper, C., Hochberg, M., Pelletier, J.-P., Rizzoli, R., Kanis, J., Abadie, E., Maheu, E., Brandi, M. L., Devogelaer, J.-P., Branco, J., Herrero-Beaumont, G., D'Hooghe, P., & Bruyère, O. (2015). Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis. Current Medical Research and Opinion, 31 (5), 1041-1045. doi:10.1185/03007995.2015.1027183

Reginster, J.-Y., Cooper, C., Rizzoli, R., Kanis, J., Appelboom, G., Bautmans, I., Bischoff-Ferrari, H., Boers, M., Brandi, M., Bruyère, O., Cherubini, A., Flamion, B., Fielding, R., Van Loon, L., McCloskey, E., Mitlak, B., Pilotto, A., Reiter-Niesert, S., Rolland, Y., & Cruz-Jentoft, A. (2015). Recommendations for the registration of drugs to treat sarcopenia. Osteoporosis International, 26 (S1), 62.

Reginster, J.-Y., NEUPREZ, A., LECART, M.-P., Beaudart, C., Buckinx, F., Slomian, J., & Bruyère, O. (2015). Ostéoporose et Médecine Personnalisée. Revue Médicale de Liège, 70 (5-6), 321-324.

Reginster, J.-Y., REITER-NIESERT, S., Bruyère, O., BERENBAUM, F., BRANDI, M. L., BRANCO, J., DEVOGELAER, J. P., HERRERO-BAUMONT, G., KANIS, J., MAGGI, S., MAHEU, E., RICHETTE, P., RIZZOLI, R., & COOPER, C. (2015). Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medical products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement. Osteoarthritis and Cartilage, 23, 2086-2093. doi:10.1016/j.joca.2015.07.001

Reginster, J.-Y., Reiter-Niesert, S., Bruyère, O., Berenbaum, F., Brandi, M., Branco, J., Devogelaer, J., Herrero-Beaumont, G., Kanis, J., Maggi, S., Maheu, E., Richette, P., Rizzoli, R., & Cooper, C. (2015). Recommendations for an update of the current (2010) European Regulatory Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes. Osteoporosis International, 26 (S1), 59.

Slomian, J., LECLERC, A.-F., Maquet, D., JERUSALEM, G., LIFRANGE, E., COUCKE, P., Bury, T., TOMASELLA, M., Reginster, J.-Y., Bruyère, O., & Crielaard, J.-M. (2015). Prevalence of endocrine therapies that could affect bone health in women following a rehabilitation program after surgery for breast cancer. Osteoporosis International, 26 (S1), 375.

Slomian, J., Reginster, J.-Y., Gaspard, U., Streel, S., Beaudart, C., Appelboom, G., Buckinx, F., & Bruyère, O. (2015). Exploring the Interest in and the Usage of the Internet Among Patients Eligible for Osteoporosis Screening. Calcified Tissue International, 96, 518-526. doi:10.1007/s00223-015-9987-3

Streel, S., Donneau, A.-F., Dardenne, N., Hoge, A., Bruyère, O., Albert, A., Guillaume, M.* , & Schoenen, J.*. (2015). Validation of an extended French version of ID MigraineTM as a migraine-screening tool. Cephalalgia, 35 (5), 437-442. doi:10.1177/0333102414544910

Buckinx, F., Reginster, J.-Y., Dardenne, N., Croisier, J.-L., Kaux, J.-F., Slomian, J., Beaudart, C., & Bruyère, O. (November 2014). Concordance entre la masse musculaire mesurée par impédance bioélectrique et par absorptiométrie radiologique à double énergie. Cahiers de l'Année Gérontologique, 6 (Suppl. 1), 182.

Castiglione, V., Jouret, F., Bruyère, O., BEKAERT, A.-C., DUBOIS, B., THOMAS, A., CAVALIER, E., & GADISSEUR, R. (18 October 2014). Epidemiology of urolithiasis in Liège on the basis of a morpho-constitutional classification. Poster session presented at BVKB, Leuven, Belgium.

Castiglione, V., JOURET, F., Bruyère, O., BEKAERT, A.-C., THOMAS, A., DUBOIS, B., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (17 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège. Paper presented at Confrontations clinico-biologiques autour de la lithiase urinaire, Paris, France.

Castiglione, V., Jouret, F., Bruyère, O., BEKAERT, A.-C., DUBOIS, B., THOMAS, A., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (01 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège. Néphrologie et Thérapeutique, 10 (5), 270.

Bruyère, O. (September 2014). Où il est question de se faire une idée juste de la réalité... (partie 1). Medi-Sphere, 454, 50-2.

GADISSEUR, R., Castiglione, V., JOURET, F., Bruyère, O., BEKAERT, A.-C., THOMAS, A., DUBOIS, B., WALTREGNY, D., & CAVALIER, E. (September 2014). Epidémiologie de la lithiase urinaire en Province de Liège. Néphrologie et Thérapeutique, 10 (5), 270.

Oppong-Kyei, J., Bruyère, O., Delvaux, F., Croisier, J.-L., Forthomme, B., Crielaard, J.-M., & Kaux, J.-F. (2014). Adaptation interculturelle et validation du questionnaire VISA-P en français. In 7ème Congrès National SFMES & SFTS 2014 (pp. 96).

Oppong-Kyei, J., Bruyère, O., Delvaux, F., Croisier, J.-L., Forthomme, B., Crielaard, J.-M., & Kaux, J.-F. (2014). Adaptation interculturelle et validation du questionnaire VISA-A en français. In 7ème Congrès National SFMES & SFTS 2014 (pp. 96).

Bruyère, O., & Boutron-Ruault, M.-C. (August 2014). Évaluer la force de l’association. Medi-Sphere, 451, 34-36.

Kaux, J.-F., Croisier, J.-L., Bruyère, O., Forthomme, B., LE GOFF, C., Gothot, A., DELCOUR, S., & Crielaard, J.-M. (June 2014). Platelet-rich plasma to treat patellar tendinopathies: a 1 year follow-up. Clinical Chemistry and Laboratory Medicine, 52 (Special Suppl), 1285.

Bruyère, O., & Reginster, J.-Y. (May 2014). Quels types d'étude pour quels objectifs? Medi-Sphere, 445, 38-9.

Kaux, J.-F., Croisier, J.-L., Bruyère, O., Rohr, N., LE GOFF, C., & Crielaard, J.-M. (May 2014). One-year follow-up of platelet-rich plasma to treat chronic upper patellar tendinopathies. European Journal of Physical and Rehabilitation Medicine, 50 (Suppl. 1 to No. 3), 227 (P250.

Manzambi Kuwekita, J., Bruyère, O., & REGINSTER, J.-Y. (31 March 2014). Le rôle du tradipraticien dans l’offre des soins de sante de proximité en zones de sante semi-rurales : résultats d’une étude menée dans la commune périphérique de Kisenso à Kinshasa, Congo. Journal d’Épidémiologie et de Santé Publique, XIII, 59-66.

Bruyère, O., & Dardenne, N. (March 2014). Mais ce "p", que veut-il dire finalement ? Medi-Sphere, 437, 1-3.

Bruyère, O., Reginster, J.-Y., Bellamy, N., Chapurlat, R., Richette, P., & Cooper, C. (March 2014). Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis. Rheumatology, 53, 1457-64. doi:10.1093/rheumatology/keu018

Appelboom, G., Camacho, E., Abraham, M., Bruce, S., Dumont, E., Zacharia, B., D'Amico, R., Slomian, J., Reginster, J.-Y., Bruyère, O., & Connolly, E. (2014). Smart wearable body sensors for patient self-assessment and monitoring. Archives of Public Health, 72, 28-44. doi:10.1186/2049-3258-72-28

Appelboom, G., Yang, A. H., Christophe, B. R., Bruce, E. M., Slomian, J., Bruyère, O., Bruce, S. S., Zacharia, B. E., Reginster, J.-Y., & Sander Connolly, E. J. (2014). The promise of wearable activity sensors to define patient recovery. Journal of Clinical Neuroscience, 21, 1089-1093. doi:10.1016/j.jocn.2013.12.003

Beaudart, C., Buckinx, F., Rabenda, V., CAVALIER, E., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014). The effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a meta-analysis of randomized controlled trials. Journal of Frailty and Aging, 3 (1), 27.

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., Cavalier, E., Slomian, J., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014). The effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Endocrinology and Metabolism, 99 (11), 4336-4345. doi:10.1210/jc.2014-1742

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., CAVALIER, E., Slomian, J., PETERMANS, J., Reginster, J.-Y., & Bruyère, O. (2014). The effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a meta-analysis of randomized controlled trials. Osteoporosis International, 25 (2), 46.

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., CAVALIER, E., Slomian, J., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014). Les effets d'une supplémentation en vitamine D sur la force, la masse et la puissance musculaire : une méta-analyse d'essais randomisés contrôlés. Gériatrie et Psychologie Neuropsychiatrie du Vieillissement, 12 (1), 73.

Beaudart, C., Buckinx, F., Slomian, J., Quabron, A., Petermans, J., GILLAIN, S., Reginster, J.-Y., & Bruyère, O. (2014). Prevalence of sarcopenia according to different diagnostic tools. Journal of Frailty and Aging, 3 (1), 43.

Beaudart, C., Buckinx, F., Slomian, J., Quabron, A., PETERMANS, J., Reginster, J.-Y., Bruyère, O., & GILLAIN, S. (2014). Prevalence of sarcopenia according to different diagnostic tools. Osteoporosis International, 25 (2), 115.

Beaudart, C., GILLAIN, S., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014). Sarcopénie. Quoi de neuf en 2014 ? Revue Médicale de Liège, 69 (5-6), 251-257.

Beaudart, C., Reginster, J.-Y., Cavalier, E., & Bruyère, O. (2014). Les effets d'une supplémentation en vitamine D sur la fonction musculaire. Ortho-Rhumato, 12 (5), 33-37.

Beaudart, C., Reginster, J.-Y., Slomian, J., Buckinx, F., & Bruyère, O. (2014). Association entre la masse musculaire totale et la densité minérale osseuse de la hanche. Cahiers de l'Année Gérontologique, 6 (Suppl. 1), 125-6.

Beaudart, C., Reginster, J.-Y., Slomian, J., Buckinx, F., & Bruyère, O. (2014). Association between lean mass and hip bone mineral density. Arthritis and Rheumatism, 66 (11), 95.

Beaudart, C., Reginster, J.-Y., Slomian, J., Buckinx, F., Locquet, M., & Bruyère, O. (2014). Prevalence of sarcopenia: the impact of different diagnostic cut-off limits. Journal of Musculoskeletal and Neuronal Interactions, 14 (4), 425-31.

Beaudart, C., Reginster, J.-Y., Slomian, J., Buckinx, F., Quabron, A., Dardenne, N., & Bruyère, O. (2014). Prévalence de la sarcopénie : impact de l'utilisation de différentes valeurs seuils de diagnostic. Cahiers de l'Année Gérontologique, 6 (Suppl. 1), 126.

Beaudart, C., Rizzoli, R., Bruyère, O., Reginster, J.-Y., & Biver, E. (2014). Sarcopenia: burden and challenges for public health. Archives of Public Health, 72, 45-60. doi:10.1186/2049-3258-72-45

Beaudart, C., SLANGEN, C., Buckinx, F., Slomian, J., Quabron, A., Petermans, J., GILLAIN, S., Reginster, J.-Y., & Bruyère, O. (2014). Evaluation de la prévalence de la sarcopénie selon différents outils de diagnostic. Gériatrie et Psychologie Neuropsychiatrie du Vieillissement, 12 (1), 42.

Bruyère, O. (2014). Il n'est jamais trop tard pour apprendre à (bien) lire. Onco: Revue Multidisciplinaire d'Oncologie, 8 (6), 87-88.

Bruyère, O., Cavalier, E., & Reginster, J.-Y. (2014). La prévalence du déficit en vitamine D en Belgique et en Europe chez les femmes âgées. Ortho-Rhumato, 12 (4), 3.

Bruyère, O., CAVALIER, E., Souberbielle, J.-C., Bischoff-Ferrari, H., Beaudart, C., Buckinx, F., Reginster, J.-Y., & Rizzoli, R. (2014). Effects of vitamin D in the elderly population : current status and perspectives. Archives of Public Health, 72, 32-42. doi:10.1186/2049-3258-72-32

Bruyère, O., Cooper, C., Pelletier, J., Branco, J., Brandi, L., Guillemin, F., Hochberg, M., Kanis, J., Kvien, T., Martel-Pelletier, J., Rizzoli, R., Silverman, S., & Reginster, J.-Y. (2014). An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Seminars in Arthritis and Rheumatism, 44, 253-263. doi:10.1016/j.semarthrit.2014.05.014

Bruyère, O., & Dardenne, N. (2014). Mais ce "p", que veut-il dire finalement ? Onco: Revue Multidisciplinaire d'Oncologie, 8 (7), 61-63.

Bruyère, O., & Dardenne, N. (2014). Mais ce "p", que veut-il dire finalement ? Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 19 (3), 25-27.

Bruyère, O., Demoulin, M., Beaudart, C., Hill, J. C., Maquet, D., Genevay, S., Mahieu, G., REGINSTER, J.-Y., Crielaard, J.-M., & Demoulin, C. (2014). Validity and Reliability of the French Version of the STarT Back Screening Tool for Patients With Low Back Pain. Spine, 39 (2), 123-E128. doi:10.1097/BRS.0000000000000062

Bruyère, O., & Reginster, J.-Y. (2014). Vitamine D et sujet âgé. Gériatrie et Psychologie Neuropsychiatrie du Vieillissement, 12 (1), 5-6.

Bruyère, O., & Reginster, J.-Y. (2014). Monitoring of osteoporosis therapy. Best Practice and Research. Clinical Endocrinology and Metabolism, 28, 835-41. doi:10.1016/j.beem.2014.07.001

Bruyère, O., Slomian, J., Beaudart, C., Buckinx, F., Cavalier, E., GILLAIN, S., Petermans, J., & Reginster, J.-Y. (2014). Prevalence of vitamin D inadequacy in European women aged over 80 years. Archives of Gerontology and Geriatrics, 59, 78-82. doi:10.1016/j.archger.2014.03.010

Bruyère, O., Slomian, J., Beaudart, C., Buckinx, F., CAVALIER, E., GILLAIN, S., PETERMANS, J., & Reginster, J.-Y. (2014). Prevalence of vitamin D inadequacy in European women aged over 80 years. Osteoporosis International, 25 (2), 196. doi:10.1016/j.archger.2014.03.010

Buckinx, F., Beaudart, C., Maquet, D., Demonceau, M., Crielaard, J.-M., Reginster, J.-Y., & Bruyère, O. (2014). Evaluation of the impact of 6-month training by whole body vibration on the risk of falls among nursing home residents, observed over a 12-month period: a single blind, randomized controlled trial. Aging Clinical and Experimental Research, 26 (4), 369-376. doi:10.1007/s40520-014-0197-z

Buckinx, F., Beaudart, C., Slomian, J., Maquet, D., Demonceau, M., GILLAIN, S., PETERMANS, J., Reginster, J.-Y., & Bruyère, O. (2014). Risk factors for falls among elderly nursing home residents: a 2-year prospective study. Osteoporosis International, 25 (2), 36-37.

Buckinx, F., Beaudart, C., Slomian, J., Maquet, D., Demonceau, M., GILLAIN, S., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014). Prognostic factors of death among nursing homes residents followed prospectively for a period of 2 years. Journal of Frailty and Aging, 3 (1), 40.

Buckinx, F., Beaudart, C., Slomian, J., Maquet, D., Demonceau, M., GILLAIN, S., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014). Facteurs pronostiques de décès chez des sujets résidant en maison de repos suivis d'une manière prospective pendant une période de 2 ans. Gériatrie et Psychologie Neuropsychiatrie du Vieillissement, 12 (1), 73-74.

Buckinx, F., Beaudart, C., Slomian, J., Maquet, D., Demonceau, M., GILLAIN, S., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014). Facteurs de risque de chute chez des sujets résidant en maison de repos : étude prospective d'une durée de 2 ans. Gériatrie et Psychologie Neuropsychiatrie du Vieillissement, 12 (1), 164-165.

Buckinx, F., Beaudart, C., Slomian, J., Maquet, D., Demonceau, M., GILLAIN, S., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014). Evolution sur deux ans des capacités fonctionnelles et motrices de sujets âgés résidant en maison de repos. Gériatrie et Psychologie Neuropsychiatrie du Vieillissement, 12 (1), 57-58.

Buckinx, F., Beaudart, C., Slomian, J., Maquet, D., Demonceau, M., GILLAIN, S., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014). Evolution over two years of functional and motor abilities among nursing home residents. Journal of Frailty and Aging, 3 (1), 45.

Buckinx, F., Beaudart, C., Slomian, J., Maquet, D., Demonceau, M., GILLAIN, S., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014). Evolution over two years of functional and motor abilities among nursing home residents. Osteoporosis International, 25 (2), 121.

Buckinx, F., Reginster, J.-Y., Cavalier, E., Slomian, J., Beaudart, C., & Bruyère, O. (2014). Evaluation du nombre de résidents en maison de retraite médicalisée bénéficiant d'une supplémentation en vitamine D. Cahiers de l'Année Gérontologique, 6 (Suppl. 1), 68.

Buckinx, F., Reginster, J.-Y., Petermans, J., Beaudart, C., & Bruyère, O. (2014). Effets de la vibrotonie corporelle totale sur le risque de chute de la personne âgée: Mise au point. Ortho-Rhumato, 12 (6), 6-9.

Buckinx, F., Slomian, J., Maquet, D., Demonceau, M., GILLAIN, S., PETERMANS, J., Reginster, J.-Y., & Bruyère, O. (2014). Prognostic factors of death among nursing homes residents followed prospectively for a period of 2 years. Osteoporosis International, 25 (2), 121-122.

Chevalier, X., Richette, P., Bruyère, O., Chapurlat, R., Cooper, C., & Reginster, J.-Y. (2014). Strontium ranelate decreases the number of rapid radiological progressors from the first year in SEKOIA study. Osteoarthritis and Cartilage, 22 (1), 461.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Moonen, M., Smelten, N., Médart, M., Bruyère, O., REGINSTER, J.-Y., Pottel, H., & CAVALIER, E. (2014). Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients. Nephron. Clinical Practice, 128, 127-134. doi:10.1159/000366449

Delvaux, F., Rochcongar, P., Bruyère, O., Bourlet, G., DANIEL, C., Diverse, P., Reginster, J.-Y., & Croisier, J.-L. (2014). Return-to-play criteria after hamstring injury: Actual medicine practice in professional soccer teams. Journal of Sports Science and Medicine, 13, 721-723.

Douxfils, J., Buckinx, F., Mullier, F., Minet, V., Rabenda, V., Reginster, J.-Y., Hainaut, P., Bruyère, O., & Dogne, J.-M. (2014). Dabigatran Etexilate and Risk of Myocardial Infarction, Other Cardiovascular Events, Major Bleeding, and All-Cause Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Journal of the American Heart Association, 3 (3), 000515. doi:10.1161/JAHA.113.000515

Edwards, M., Parsons, C., Eymard, F., Reginster, J.-Y., Bruyère, O., Petit-Dop, F., Richette, P., Chavalier, X., Dennison, E., & Cooper, C. (2014). Impact of components of the metabolic syndrome on progression of knee osteoarthritis in the SEKOIA study. Rheumatology, 53 (1), 31.

Eymard, F., Edwards, M., Parsons, C., Cooper, C., Petit-Dop, F., Reginster, J.-Y., Bruyère, O., Richette, P., & Chevalier, X. (2014). Impact of components of the metabolic syndrome on knee osteoarthritis progression in the SEKOIA study. Osteoarthritis and Cartilage, 22 (1), 376.

Eymard, F., Parsons, C., Edwards, M., Petit-Dop, F., Reginster, J.-Y., Bruyère, O., Richette, P., Cooper, C., & Chevalier, X. (2014). Implication des troubles métaboliques dans la progression radiologique de la gonarthrose : analyse post-hoc issue de l'essai randomisé SEKOIA. Revue du Rhumatisme, 81 (Suppl. 1), 92.

GILLAIN, S., ELBOUZ, L., Beaudart, C., Bruyère, O., Reginster, J.-Y., & PETERMANS, J. (2014). Les chutes de la personne âgée. Revue Médicale de Liège, 69 (5-6), 258-264.

GILLAIN, S., Schwartz, C., Dramé, M., Demonceau, M., Bruyère, O., Croisier, J.-L., Bruls, O., Garraux, G., Reginster, J.-Y., & Petermans, J. (2014). Validation des paramètres de marche par un système accélérométrique (Locométrix ®) à l’aide d’un système opto-électronique 3D (Coda Motion ®). Cahiers de l'Année Gérontologique, 6 (Suppl. 1), 186.

Hiligsmann, M., Ben Sedrine, W., Bruyère, O., Jeholet, P., Misson, V., Pire, G., & Reginster, J.-Y. (2014). Economic evaluation of an osteoporosis screening campaign: using FRAX as a prescreening tool. Osteoporosis International, 25 (2), 38-39.

Hiligsmann, M., Cooper, C., Guillemin, F., Hochberg, M. C., Tugwell, P., Arden, N., Berenbaum, F., Boers, M., Boonen, A., Branco, J. C., Maria-Luisa, B., Bruyère, O., Gasparik, A., Kanis, J. A., Kvien, T. K., Martel-Pelletier, J., Pelletier, J.-P., Pinedo-Villanueva, R., Pinto, D., & Reginster, J.-Y. (2014). A reference case for economic evaluations in osteoarthritis: An expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Seminars in Arthritis and Rheumatism, 44, 271-282. doi:10.1016/j.semarthrit.2014.06.005

LoPresti, M., Appelboom, G., Bruyère, O., Reginster, J.-Y., Klug, E., & Connolly Jr, E. S. (2014). Patient engagement in clinical research through mobile technology. Clinical Practice, 11 (6), 549-51. doi:10.2217/CPR.14.68

Lotz, M., Martel-Pelletier, J., Christiansen, C., Brandi, M.-L., Bruyère, O., Chapurlat, R., Collette, J., Cooper, C., Giacovelli, G., Kanis, J. A., Karsdal, M. A., Kraus, V., Lems, W. F., Meulenbelt, I., Pelletier, J.-P., Raynauld, J.-P., Reiter-Niesert, S., Rizzoli, R., Sandell, L. J., & Reginster, J.-Y. (2014). Republished: Value of biomarkers in osteoarthritis: current status and perspectives. Postgraduate Medical Journal, 90 (1061), 171-8.

Parsons, C., Edwards, M., Bruyère, O., Belissa, P., Genant, H., Guermazi, A., Roemer, F., Zaim, S., Reginster, J.-Y., Dennison, E., & Cooper, C. (2014). Impact of bone marrow lesion on the progression of knee osteoarthritis in the SEKOIA study. Rheumatology, 53 (1), 130.

Parsons, C., Edwards, M., Bruyère, O., Petit-Dop, F., Beliaa, P., Genant, H., Guermazi, A., Roemer, F., Zaim, S., Chapurlat, R., Reginster, J.-Y., Dennison, E., & Cooper, C. (2014). Impact of bone marrow lesion on the progression of knee osteoarthritis in the Sekoia study. Osteoporosis International, 25 (2), 142.

Parsons, C., Edwards, M., Eymard, F., Reginster, J.-Y., Bruyère, O., Petit-Dop, F., Richette, P., Chevalier, X., Dennison, E., & Cooper, C. (2014). Impact of components of the metabolic syndrome on progression of knee osteoarthritis in the Sekoia study. Osteoporosis International, 25 (2), 230.

Reginster, J.-Y., NEUPREZ, A., Beaudart, C., Buckinx, F., Slomian, J., Distèche, S., & Bruyère, O. (2014). Bone forming agents for the management of osteoporosis. Panminerva Medica, 56 (2), 97-114.

Reginster, J.-Y., NEUPREZ, A., Beaudart, C., LECART, M.-P., Sarlet, N., Bernard, D., Distèche, S., & Bruyère, O. (2014). Antiresorptive Drugs Beyond Bisphosphonates and Selective Oestrogen Receptor Modulators for the Management of Postmenopausal Osteoporosis. Drugs and Aging, 31, 413-424. doi:10.1007/s40266-014-0179-z

Reginster, J.-Y., NEUPREZ, A., Dardenne, N., Beaudart, C., & Bruyère, O. (2014). Efficacy and safety of currently marketed anti-osteoporosis medications. Best Practice and Research. Clinical Endocrinology and Metabolism, 28, 809-34. doi:10.1016/j.beem.2014.09.003

Reginster, J.-Y., NEUPREZ, A., LECART, M.-P., Sarlet, N., Distèche, S., & Bruyère, O. (2014). Traitement de l'osteoporose post-menopausique: quoi de neuf en 2014? Revue Médicale de Liège, 69 (7-8), 441-53.

Rizzoli, R., Branco, J., Brandi, M.-L., Boonen, S., Bruyère, O., Cacoub, P., Cooper, C., Diez-Perez, A., Duder, J., Fielding, R. A., Harvey, N. C., Hiligsmann, M., Kanis, J. A., Petermans, J., Ringe, J. D., Tsouderos, Y., Weinman, J., & Reginster, J.-Y. (2014). Management of osteoporosis of the oldest old. Osteoporosis International, 25, 2507-2529. doi:10.1007/s00198-014-2755-9

Rizzoli, R., Branco, J., Brandi, M., Boonen, S., Bruyère, O., Cacoub, P., Cooper, C., Diez-Perez, A., Duder, J., Fielding, R., Harvey, N., Hiligsmann, M., Kanis, J., Petermans, J., Ringe, J., Tsouderos, Y., Weinman, J., & Reginster, J.-Y. (2014). Erratum to: Management of osteoporosis of the oldest old. Osteoporosis International, 25, 2531. doi:10.1007/s00198-014-2830-2

Slomian, J., Appelboom, G., Ethgen, O., Reginster, J.-Y., & Bruyère, O. (2014). Can new information and communication technologies help in the management of osteoporosis ? Women's Health, 10 (3), 229-232. doi:10.2217/whe.14.15

Slomian, J., GASPARD, U., Reginster, J.-Y., Streel, S., Beaudart, C., Appelboom, G., Buckinx, F., & Bruyère, O. (2014). Des interventions de prévention ou de promotion de la santé utilisant Internet pourraient-elles être prometteuses chez des femmes aux alentours de la ménopause ? Cahiers de l'Année Gérontologique, 6 (Suppl. 1), 205.

Slomian, J., Reginster, J.-Y., Ethgen, O., Appelboom, G., & Bruyère, O. (2014). Opportunity and challenges of eHealth and mHealth for patients and caregivers. Austin Journal of Public Health and Epidemiology, 1 (2), 3-5.

Slomian, J., Streel, S., Appleboom, G., Beaudart, C., Buckinx, F., Reginster, J.-Y., & Bruyère, O. (2014). Internet as a tool for health: survey on the interest and the use of the internet among subjects from an osteoporosis centre - A preliminary report. Osteoporosis International, 25 (2), 64.

Slomian, J., Streel, S., Appleboom, G., Beaudart, C., Buckinx, F., Reginster, J.-Y., & Bruyère, O. (2014). Could internet use be promising in health prevention and promotion in menopausal women ? A preliminary report. Osteoporosis International, 25 (2), 309.

Streel, S., Donneau, A.-F., Dardenne, N., Hoge, A., Bruyère, O., Albert, A., Guillaume, M., & SCHOENEN, J. (2014). Validation of an extended French version of ID Migraine™ as a migraine-screening tool. Paper presented at Journée des Doctorants de l'Ecole Doctorale "SPSS" - Ecole de Santé publique -ULB.

Manzambi Kuwekita, J., Bruyère, O., REGINSTER, J.-Y., Buhendwa, E., Bokanga, R., & Mwanyimi, P. (19 December 2013). Les acteurs non étatiques jouent un rôle déterminant dans le fonctionnement des services publics en territoires périurbains. Poster session presented at Territoires périurbains: développement, enjeux et perspectives dans les pays du Sud, Gembloux, Belgium.

Manzambi Kuwekita, J., Mbadu Kivuidi, V., Bruyère, O., & Reginster, J.-Y. (19 December 2013). Le tradipraticien est un acteur crédible dans l'offre des soins en territoire périurbain: Résultats d'une étude menée dans la commune de Kisenso à Kinshasa, Congo. Paper presented at Colloque Territoires périurbains: Développement, Enjeux et Perspectives dans les Pays du Sud, Gembloux, Belgium.

Manzambi Kuwekita, J., Guillaume, M., Balula Semutsari, M.-P., Tshiama Kabongo, E., Mayamba Kilela, J., Bruyère, O., & Reginster, J.-Y. (December 2013). Étude des conditions de vie et d’accessibilité aux soins de santé de qualité des populations en situation de précarité, dans la zone de sante de Bandalungwa à Kinshasa (Congo) grâce à la micro-assurance santé en 2008. Journal d’Épidémiologie et de Santé Publique, 12, 47-61.

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., CAVALIER, E., Slomian, J., PETERMANS, J., Reginster, J.-Y., & Bruyère, O. (28 November 2013). Les effets d’une supplémentation en vitamine D sur la force musculaire : une méta-analyse d’essais randomisés contrôlés. Paper presented at Journée des Doctorants de l'Ecole Doctorale "SPSS", Bruxelles, Belgium.

Buckinx, F., Beaudart, C., Maquet, D., Demonceau, M., CRIELAARD, J.-M., Reginster, J.-Y., & Bruyère, O. (28 November 2013). Etude de l'impact d'un entraînement de 6 mois par vibrothérapie sur le risque de chute, observé pendant une durée d'un an, chez les patients résidant en maison de repos. Etude randomisée contrôlée menée en simple aveugle. Paper presented at Journée des Doctorants de l'Ecole Doctorale "SPSS", Bruxelles, Belgium.

Slomian, J., De Gottal, E., Servais, M., Bruyère, O., & Masson, V. (28 November 2013). Etude de l'influence du tabagisme maternel, actif ou passif, sur le pH artériel ombilical à la naissance. Poster session presented at Journée des Doctorants de l'Ecole Doctorale "SPSS", Bruxelles, Belgium.

Bruyère, O. (October 2013). Il n'est jamais trop tard pour apprendre à (bien) lire. Medi-Sphere, 421, 27-28.

Foidart-Dessalle, M., MICHALET, A., BOURSE, J., Demonceau, M., DUVIVIER, E., Croisier, J.-L., Crielaard, J.-M., Coucke, P., Bruyère, O., & Maquet, D. (October 2013). Statut algofonctionnel chez les femmes belges après traitement pour néoplasie mammaire. Annals of Physical and Rehabilitation Medicine, 56 (Suppl. 1), 244.

Foidart-Dessalle, M., MICHALET, A., BOURSE, J., Demonceau, M., DUVIVIER, E., Croisier, J.-L., Crielaard, J.-M., Coucke, P., Bruyère, O., & Maquet, D. (October 2013). Algofunctional status in Belgian women one year after completion of therapy for breast cancer. Annals of Physical and Rehabilitation Medicine, 56 (Suppl. 1), 246-e247. doi:10.1016/j.rehab.2013.07.645

Kaux, J.-F., Croisier, J.-L., Bruyère, O., Rodriguez de la Cruz, C., SIMONI, P., ALVAREZ MIEZENTSEVA, V., LE GOFF, C., & Crielaard, J.-M. (October 2013). Une infiltration de plasma riche en plaquettes (PRP) pour traiter les tendinopathies rotuliennes supérieures chroniques. Annals of Physical and Rehabilitation Medicine, 56 (Sup 1).

Manzambi Kuwekita, J., Gosset, C., Guillaume, M., Nsita Zaya Nsita, B., Tshefu Pongo, G., Eloko Eya Matangelo, G., Balula Semutsari, M.-P., Tshiama Kabongo, E., Bruyère, O., & REGINSTER, J.-Y. (30 September 2013). Micro-crédit, Augmentation du pouvoir d’achat et Amélioration des conditions de vie des populations précaires en milieu urbain africain : Résultats d’une expérience menée dans la zone de santé de Bandalungwa à Kinshasa, Congo. Psychologie et Société Nouvelle, XII (3), 3-14.

Beaudart, C., Buckinx, F., Maquet, D., Crielaard, J.-M., Reginster, J.-Y., & Bruyère, O. (September 2013). Caractéristiques cliniques des sujets répondeurs à la vibrotonie corporelle totale. Cahiers de l'Année Gérontologique, 5 (1-2), 118-119.

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., CAVALIER, E., Petermans, J., Reginster, J.-Y., & Bruyère, O. (September 2013). Les effets d'une supplémentation en vitamine D sur la force musculaire : une méta-analyse d'essais randomisés contrôlés. Cahiers de l'Année Gérontologique, 5 (1-2), 38.

Bruyère, O., Hiligsmann, M., Zegels, B., NEUPREZ, A., & Reginster, J.-Y. (September 2013). Risk of hip fracture in community-dwelling and institutionalized osteoporotic patients: A 3-year study. International Journal of Gerontology, 7 (3), 167-70. doi:10.1016/j.ijge.2012.11.015

Bruyère, O., Slomian, J., Beaudart, C., Buckinx, F., Cavalier, E., GILLAIN, S., Petermans, J., & Reginster, J.-Y. (September 2013). Importance du déficit en vitamine D chez les femmes françaises ostéoporotiques et ostéopéniques âgées de plus de 80 ans. Cahiers de l'Année Gérontologique, 5 (1-2), 75.

Buckinx, F., Beaudart, C., Demonceau, M., Maquet, D., Crielaard, J.-M., Reginster, J.-Y., & Bruyère, O. (September 2013). Evaluation de l'impact d'un entraînement de six mois par vibrotonie corporelle sur le risque de chute des patients résidant en maison de repos, observé pendant une période de 12 mois. Cahiers de l'Année Gérontologique, 5 (1-2), 119-120.

Croisier, J.-L., Rochcongar, P., Bruyère, O., Reginster, J.-Y., Bourlet, G., Diverse, P., DANIEL, C., & Delvaux, F. (September 2013). Critères de retour sur le terrain après plastie LCA chez le footballeur professionnel. European Journal of Sports Medicine, 1 (1).

Kaux, J.-F., Croisier, J.-L., Bruyère, O., Rodriguez de la Cruz, C., DANIEL, C., GODON, B., SIMONI, P., ALVAREZ MIEZENTSEVA, V., BRABANT, G., Lapraille, S., Lonneux, V., Noël, D., COLLETTE, J., LE GOFF, C., Gothot, A., & Crielaard, J.-M. (July 2013). Platelet-rich plasma (PRP) to treat chronic upper patellar tendinopathies. British Journal of Sports Medicine, 47 (10 (e3)), 15. doi:10.1136/bjsports-2013-092558.15

Rizzoli, R., Reginster, J.-Y., Arnal, J.-F., Bautmans, I., Beaudart, C., Bischoff-Ferrari, H., Biver, E., Boonen, S., Brandi, M.-L., Chines, A., Cooper, C., Epstein, S., Fielding, R. A., Goodpaster, B., Kanis, J. A., Kaufman, J.-M., Laslop, A., Malafarina, V., Rodriguez Mañas, L., & Bruyère, O. (July 2013). Quality of life in sarcopenia and frailty. Calcified Tissue International, 93, 101-120. doi:10.1007/s00223-013-9758-y

Bruyère, O., Beaudart, C., Buckinx, F., Reginster, J.-Y., Maquet, D., & Mourey, F. (June 2013). Effets de la Whole body vibration sur le risque de chute de la personne âgée : une mise au point. Kinésithérapie Scientifique, 544, 55-58.

Cooper, C., Adachi, J. D., Bardin, T., Berenbaum, F., Flamion, B., Jonsson, H., Kanis, J. A., Pelousse, F., Lems, W. F., Pelletier, J.-P., Martel-Pelletier, J., Reiter, S., Reginster, J.-Y., Rizzoli, R., & Bruyère, O. (June 2013). How to define responders in osteoarthritis. Current Medical Research and Opinion, 29 (6), 719-29. doi:10.1185/03007995.2013.792793

Bruyère, O. (2013). Selective Serotonin Reuptake Inhibitor and Fracture: an epidemiologic perspective. In Proceedings of the 8th Interantional Congress (GIO).

DELANAYE, P., Bruyère, O., Moranne, O., LUTTERI, L., KRZESINSKI, J.-M., & CAVALIER, E. (May 2013). Creatinine-or cystatin C-based equations to estimate glomerular filtration: impact on the epidemiology of chronic kidney disease. Poster session presented at 20th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab), Milan, Italy.

DELANAYE, P., Cavalier, E., Moranne, O., Bruyère, O., LUTTERI, L., & Krzesinski, J.-M. (May 2013). Creatinine- or cystatin C-based equations to estimate glomerular filtration rate in the general population: impact on the epidemiology of chronic kidney disease. Poster session presented at 50th ERA-EDTA Congress, Istanbul, Turkey.

Delvaux, F., Rochcongar, P., Bruyère, O., Bourlet, G., DANIEL, C., Diverse, P., Reginster, J.-Y., & Croisier, J.-L. (25 April 2013). Return-To-Play criteria after hamstring injury: actual medicine practice in professional soccer. Poster session presented at 3rd congress of the European College of Sport and Exercise Physicians, Frankfurt am Main, Germany.

Beaudart, C., Buckinx, F., Demonceau, M., Maquet, D., Crielaard, J.-M., Reginster, J.-Y., & Bruyère, O. (April 2013). Evaluation of the impact of a 6-month training by whole body vibration on the risk of falls among nursing home residents. Osteoporosis International, 24 (Suppl.1), 246-247.

Beaudart, C., Buckinx, F., Maquet, D., Crielaard, J.-M., Reginster, J.-Y., & Bruyère, O. (April 2013). Clinical characteristics of patients responsive to whole body vibration. Osteoporosis International, 24 (Suppl.1), 243.

Bruyère, O. (April 2013). Role of nutraceuticals in the symptomatic and structural management of osteoarthritis. Osteoporosis International, 24 (Suppl.1), 82-83.

Bruyère, O. (April 2013). Nonpharmacological management. Osteoporosis International, 24 (Suppl.1), 76.

Bruyère, O., Cooper, C., Pavelka, K., Rabenda, V., Buckinx, F., Beaudart, C., & Reginster, J.-Y. (April 2013). Changes in the structure and the symptoms of the osteoarthritis knee and prediction of future knee replacement over an 8-year follow-up period. Osteoporosis International, 24 (Suppl.1), 209.

Bruyère, O., Detalle, A.-S., Demonceau, M., Beaudart, C., Croisier, J.-L., Crielaard, J.-M., Reginster, J.-Y., & Maquet, D. (April 2013). Quantitative gait assessment using an accelerometer technology as a predictive tool of falls among nursing home residents: a 6-month prospective study. Osteoporosis International, 24 (Suppl.1), 210.

Bruyère, O., Fossi, M., Zegels, B., LEONORI, L., Hiligsmann, M., Neuprez, A., & Reginster, J.-Y. (April 2013). Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security and the new suggested FRAX criteria. Rheumatology International, 33 (4), 973-8. doi:10.1007/s00296-012-2460-y

Bruyère, O., Nicolet, D., Compère, S., Rabenda, V., Jeholet, P., Zegels, B., Maassen, P., Pire, G., & Reginster, J.-Y. (April 2013). Perception, knowledge, and use by general practitioners of Belgium of a new WHO tool (FRAX ) to assess the 10-year probability of fracture. Rheumatology International, 33 (4), 979-83. doi:10.1007/s00296-012-2461-x

Bruyère, O., Richette, P., Bellamy, N., Brown, J., Chapurlat, R., Chevalier, X., Czerwinski, E., Devogelaer, J., March, L., Pavelka, K., Punzi, L., Cooper, C., & Reginster, J.-Y. (April 2013). Strontium ranelate improves osteoarthritis symptoms compared to placebo in patients with knee OA: The SEKOIA study. Osteoporosis International, 24 (Suppl.1), 49-51.

DEROISY, R., Reginster, J.-Y., & Bruyère, O. (April 2013). Reproducibility of joint space width assessment when external calibration on the radiograph is missing. Osteoporosis International, 24 (Suppl.1), 379.

Hiligsmann, M., Ben Sedrine, W., Rabenda, V., Bruyère, O., & Reginster, J.-Y. (April 2013). Cost-effectiveness of vitamin D and calcium supplementation in the treatment of postmenopausal women. Osteoporosis International, 24 (Suppl.1), 198.

Hiligsmann, M., Cooper, C., Arden, N., Boers, M., Branco, J., Brandi, M. L., Bruyère, O., Guillemin, F., Hochberg, M., Hunter, D., Kanis, J. A., Kvien, T., Laslop, A., Petit-Dop, F., Pelletier, J.-P., Pinto, D., Reiter, S., Rizzoli, R., Rovati, L. C., & Reginster, J.-Y. (April 2013). Health economics in osteoarthritis. Osteoporosis International, 24 (Suppl.1), 79-80.

Lotz, M., Martel-Pelletier, J., Christiansen, C., Berenbaum, F., Brandi, M. L., Bruyère, O., Chapurlat, R., COLLETTE, J., Cooper, C., Heinegard, D., Kanis, J. A., Kraus, V., Laslop, A., Lems, W., Lohmander, S., Meulenbelt, I., Pelletier, J.-P., Raynauld, J.-P., Reiter, S., & Reginster, J.-Y. (April 2013). What is the value of biomarkers for drug development in osteoarthritis? Osteoporosis International, 24 (Suppl.1), 77-78.

NEUPREZ, A., François, G., Delcour, J., Fatemi, F., Bruyère, O., Gosset, C., Mancuso, C., Gillet, P., & Reginster, J.-Y. (April 2013). Validity of the French hip and knee replacement expectations surveys. Osteoporosis International, 24 (Suppl.1), 374.

Pelletier, J.-P., Peterfy, C., Brandi, M. L., Bruyère, O., Chapurlat, R., Cicuttini, F., Conaghan, P., Doherty, M., Genant, H. K., Guermazi, A., Hochberg, M., Hunter, D., Kanis, J. A., Kloppenburg, M., Laredo, J., Martel-Pelletier, J., McAlindon, T., Nevitt, M., Raynauld, J.-P., & Cooper, C. (April 2013). What is the predictive value of MRI for the occurrence of hard clinical endpoints in knee osteoarthritis? Osteoporosis International, 24 (Suppl.1), 84-85.

Reginster, J.-Y., Pelousse, F., & Bruyère, O. (April 2013). Safety concerns with the long-term management of osteoporosis. Expert Opinion on Drug Safety, 12 (4), 507-22. doi:10.1517/14740338.2013.793669

Rizzoli, R., Reginster, J.-Y., Arnal, J.-F., Bautmans, I., Bischoff-Ferrari, H., Biver, E., Boonen, S., Brandi, M. L., Chines, A., Cooper, C., Dahlin-Ivanoff, S., Epstein, S., Kanis, J. A., Fielding, R. A., Goodpaster, B., Laslop, A., Malafarina, V., Rodriguez Mañas, L., Mitlak, B., & Bruyère, O. (April 2013). Quality of life in sarcopenia and frailty. Osteoporosis International, 24 (Suppl.1), 76-77. doi:10.1007/s00223-013-9758-y

Zegels, B., LEONORI, L., Crozes, P., Uebelhart, D., Bruyère, O., & Reginster, J.-Y. (April 2013). Equivalence of a single dose (1200mg) compared to a 3-time a day dose (400mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis: Results of a randomized double blind placebo controlled study. Osteoporosis International, 24 (Suppl.1), 383.

DELANAYE, P., CAVALIER, E., Moranne, O., LUTTERI, L., KRZESINSKI, J.-M., & Bruyère, O. (12 March 2013). Creatinine - or cystatin C - based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease. BMC Nephrology, 14, 57. doi:10.1186/1471-2369-14-57

Hiligsmann, M., Kanis, J. A., Compston, J., Cooper, C., Flamion, B., Bergmann, P., Body, J.-J., Boonen, S., Bruyère, O., Devogelaer, J.-P., Goemaere, S., Kaufman, J.-M., Rozenberg, S., & Reginster, J.-Y. (March 2013). Health Technology Assessment in Osteoporosis. Calcified Tissue International, 93 (1), 1-14. doi:10.1007/s00223-013-9724-8

Beaudart, C., Maquet, D., Mannarino, M., Crielaard, J.-M., Reginster, J.-Y., & Bruyère, O. (2013). Effects of 3 months of controlled whole body vibrations with low exposure period on the risk of falls among nursing home residents. In Proceeding of the meeting.

Bruyère, O., Detalle, A.-S., Demonceau, M., Beaudart, C., Croisier, J.-L., Crielaard, J.-M., Reginster, J.-Y., & Maquet, D. (2013). Quantitative gait assessment using an accelerometer technology as a predictive tool of falls among nursing home residents: a 6-month prospective study. In Proceedings of the meeting.

Hiligsmann, M., Ben Sedrine, W., Bruyère, O., & Reginster, J.-Y. (February 2013). Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis. Osteoporosis International, 24 (8), 2291-300. doi:10.1007/s00198-013-2272-2

Reginster, J.-Y. (Ed.), Bruyère, O. (Ed.), Cianferotti, L. (Other coll.), Brandi, M. L. (Other coll.), Griffith, J. F. (Other coll.), Genant, H. K. (Other coll.), Gielen, E. (Other coll.), Laurent,, M. (Other coll.), Milisen, K. (Other coll.), Boonen, S. (Other coll.), Holroyd, C. R. (Other coll.), Jagannath, D. (Other coll.), Cooper, C. (Other coll.), & McClung, M. R. (Other coll.). (2013). Osteoporosis. London, United Kingdom: Future Medicine Ltd. doi:10.2217/9781780841687

Beaudart, C., Buckinx, F., Maquet, D., Crielaard, J.-M., Reginster, J.-Y., & Bruyère, O. (2013). What are the clinical characteristics of patients improving their gait and body balance with whole body vibration ? Results of a 3-month randomized controlled trial. European Geriatric Medicine, 4 (S1), 53.

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., Cavalier, E., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2013). The effects of vitamin D on skeletal muscle strenght : a meta-analysis of randomized controlled trials. European Geriatric Medicine, 4 (S1), 72.

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., Cavalier, E., Slomian, J., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2013). Les effets d'une supplémentation en vitamine D sur la force, la masse et la puissance musculaire : une méta-analyse d'essais randomisés contrôlés. Revue du Rhumatisme, 80 (S1), 180-A181.

Beaudart, C., Maquet, D., Mannarino, M., Buckinx, F., Demonceau, M., Crielaard, J.-M., Reginster, J.-Y., & Bruyère, O. (2013). Effects of 3 months of short sessions of controlled whole body vibrations on the risk of falls among nursing home residents. BMC Geriatrics, 13 (42). doi:10.1186/1471-2318-13-42

Bruyère, O., Cooper, C., Pavelka, K., Rabenda, V., Buckinx, F., Beaudart, C., & REGINSTER, J.-Y. (2013). Changes in Structure and Symptoms in Knee Osteoarthritis and Prediction of Future Knee Replacement Over 8 Years. Calcified Tissue International, 93, 502-507. doi:10.1007/s00223-013-9781-z

Bruyère, O., Slomian, J., Beaudart, C., Buckinx, F., CAVALIER, E., GILLAIN, S., Petermans, J., & REGINSTER, J.-Y. (2013). Prevalence of vitamin D inadequacy in European postmenopausal women aged over 80 years. European Geriatric Medicine, 4 (S1), 13-S14.

Bruyère, O., Zegels, B., Crozes, P., Uebelhart, D., & Reginster, J.-Y. (2013). Evaluation de l'amélioration cliniquement pertinente ressentie par les patients sous différents modes d'administration de sulfate de chondroïtine : résultats d'une étude randomisée, contrôlée et en double insu. Revue du Rhumatisme, 80 (S1), 123-A124.

Buckinx, F., Beaudart, C., Demonceau, M., Maquet, D., Crielaard, J.-M., Reginster, J.-Y., & Bruyère, O. (2013). Impact of a 6-month training by whole body vibration on functional and motor abilities among nursing home residents observed over a 12-months period. European Geriatric Medicine, 4 (S1), 54-S55.

Chevalier, X., Richette, P., Bruyère, O., Chapurlat, R., Cooper, C., & Reginster, J.-Y. (2013). Le ranélate de strontium diminue la proportion de patients progressant rapidement dès la première année : une analyse post hoc de l'étude SEKOIA. Revue du Rhumatisme, 80 (S1), 59-A60.

Ethgen, O., De Lemos Esteves, F., Bruyère, O., & REGINSTER, J.-Y. (2013). What do we know about the safety of corticosteroids in rheumatoid arthritis? Current Medical Research and Opinion, 29 (9), 1147-60. doi:10.1185/03007995.2013.818531

Hiligsmann, M., Cooper, C., Arden, N., Boers, M., Branco, J. C., Luisa Brandi, M., Bruyère, O., Guillemin, F., Hochberg, M. C., Hunter, D. J., Kanis, J. A., Kvien, T. K., Laslop, A., Pelletier, J.-P., Pinto, D., Reiter-Niesert, S., Rizzoli, R., Rovati, L. C., Severens, J. L. H., & REGINSTER, J.-Y. (2013). Health economics in the field of osteoarthritis: An Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Seminars in Arthritis and Rheumatism, 43 (3), 303-313. doi:10.1016/j.semarthrit.2013.07.003

Lotz, M., Martel-Pelletier, J., Christiansen, C., Brandi, M.-L., Bruyère, O., Chapurlat, R., Collette, J., Cooper, C., Giacovelli, G., Kanis, J. A., Karsdal, M. A., Kraus, V., Lems, W. F., Meulenbelt, I., Pelletier, J.-P., Raynauld, J.-P., Reiter-Niesert, S., Rizzoli, R., Sandell, L. J., & REGINSTER, J.-Y. (2013). Value of biomarkers in osteoarthritis: current status and perspectives. Annals of the Rheumatic Diseases, 72, 1756-1763. doi:10.1136/annrheumdis-2013-203726

NEUPREZ, A., Delcour, J., Fatemi, F., GILLET, P., Mawet, M., François, G., Bruyère, O., Crielaard, J.-M., Gosset, C., & Reginster, J.-Y. (2013). Développement et validation de la version française d'un questionnaire traitant des attentes des patients dans l'arthrose des membres inférieurs. Revue du Rhumatisme, 80 (S1), 181.

Pelletier, J.-P., Cooper, C., Peterfy, C., REGINSTER, J.-Y., Brandi, M.-L., Bruyère, O., Chapurlat, R., Cicuttini, F., Conaghan, P. G., Doherty, M., Genant, H., Giacovelli, G., Hochberg, M. C., Hunter, D. J., Kanis, J. A., Kloppenburg, M., Laredo, J.-D., McAlindon, T., Nevitt, M., & Guermazi, A. (2013). What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis? Annals of the Rheumatic Diseases, 72 (10), 1594-1604. doi:10.1136/annrheumdis-2013-203631

Rabenda, V., Nicolet, D., Beaudart, C., Bruyère, O., & Reginster, J.-Y. (2013). Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporosis International, 24, 121-137. doi:10.1007/s00198-012-2015-9

REGINSTER, J.-Y., Beaudart, C., NEUPREZ, A., & Bruyère, O. (2013). Strontium ranelate in the treatment of knee osteoarthritis: new insights and emerging clinical evidence. Therapeutic Advances in Musculoskeletal Disease, 5 (5), 268-276. doi:10.1177/1759720X13500862

Reginster, J.-Y., Pelousse, F., & Bruyère, O. (2013). Is there potential for strontium ranelate in the management of osteoarthritis ? Clinical Practice, 10 (2), 201-207. doi:10.2217/cpr.12.83

Rizzoli, R., Boonen, S., Brandi, M.-L., Bruyère, O., Cooper, C., Kanis, J. A., Kaufman, J.-M., Ringe, J. D., Weryha, G., & Reginster, J.-Y. (2013). Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Current Medical Research and Opinion, 29 (4), 305-13. doi:10.1185/03007995.2013.766162

Zegels, B., Crozes, P., Uebelhart, D., Bruyère, O., & REGINSTER, J.-Y. (2013). Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study. Osteoarthritis and Cartilage, 21 (1), 22-27. doi:10.1016/j.joca.2012.09.017

Bruyère, O. (26 November 2012). L'organisation du statut et de la formation des kinésithérapeutes: des idées à prendre en Belgique. Paper presented at Conférences sous l'égide de l'ISTR et du RECIF, Lyon, France.

Beaudart, C., Maquet, D., Mannarino, M., Buckinx, F., Demonceau, M., CRIELAARD, J.-M., Reginster, J.-Y., & Bruyère, O. (20 November 2012). Evaluation de l'impact d'un entraînement de trois mois par vibrotonie sur le risque de chute chez des patients résidant en maison de repos. Paper presented at Journée des Doctorants de l'Ecole Doctorale "SPSS", Liège, Belgium.

Demoulin, C., Mahieu, G., Hill, J., Vanderthommen, M., & Bruyère, O. (2012). Intérêt du Start Back Screening Tool pour les médecins généralistes. In Abstract Book of 6th Biennial Congress Belgian Back Society.

Bruyère, O. (04 October 2012). Résider en institution: un facteur de risque indépendant des fractures de hanche? Une étude prospective d'une durée de 3 ans. Paper presented at 32ÈMES JOURNÉES ANNUELLES DE LA SOCIÉTÉ FRANÇAISE DE GÉRIATRIE ET GÉRONTOLOGIE, Paris, France.

Bruyère, O., Bergmann, P., Body, J.-J., Boonen, S., Devogelaer, J.-P., Goemaere, S., Kaufman, J.-M., Rozenberg, S., & Reginster, J.-Y. (October 2012). Nécessité de nouveaux critères de remboursement pour traiter l'ostéoporose en Belgique. Ortho-Rhumato, 10 (5), 3.

REGINSTER, J.-Y., Neuprez, A., LECART, M.-P., SARLET, N., & Bruyère, O. (October 2012). Role of glucosamine in the treatment for osteoarthritis. Rheumatology International, 32 (10), 2959-67. doi:10.1007/s00296-012-2416-2

Bruyère, O., Detilleux, J., Chines, A., & Reginster, J.-Y. (September 2012). Relationships Between Changes in Bone Mineral Density or Bone Turnover Markers and Vertebral Fracture Incidence in Patients Treated with Bazedoxifene. Calcified Tissue International, 91 (4), 244-9. doi:10.1007/s00223-012-9629-y

Bruyère, O., Ethgen, O., Neuprez, A., Zegels, B., Gillet, P., HUSKIN, J.-P., & Reginster, J.-Y. (2012). Health-related quality of life after total knee or hip replacement for osteoarthritis: a 7-year prospective study. Archives of Orthopaedic and Trauma Surgery. doi:10.1007/s00402-012-1583-7

Bruyère, O., Buckinx, F., & Reginster, J.-Y. (June 2012). A very high prevalence of vitamin D inadequacy combined with low dietary calcium intake is found in European postmenopausal women. Annals of the Rheumatic Diseases, 71 (Suppl.3), 716.

Bruyère, O., Demoulin, M., Brereton, C., Humblet, F., Flynn, D., Hill, J. C., Maquet, D., Van Beveren, J., Reginster, J.-Y., CRIELAARD, J.-M., & Demoulin, C. (June 2012). Translation validation of a new back pain screening questionnaire (the STarT Back Screening Tool) in French. Archives of Public Health, 70. doi:10.1186/0778-7367-70-12

Bruyère, O., Nicolet, D., Compère, S., Rabenda, V., Jeholet, P., ZEGELS, B., Maassen, P., Pire, G., & Reginster, J.-Y. (June 2012). Perception, knowledge and use by general practitioners of Belgium of the FRAX tool. Annals of the Rheumatic Diseases, 71 (Suppl.3), 716.

Bruyère, O., & Reginster, J.-Y. (June 2012). Relationships between changes in bone mineral density and vertebral fractures incidence: an analysis of the last 2 years of a 10-year treatment with strontium ranelate. Annals of the Rheumatic Diseases, 71 (Suppl.3), 590.

Bruyère, O., Roux, C., Nicolet, D., Fechtenbaum, J., DEROISY, R., & Reginster, J.-Y. (June 2012). Severity of incident vertebral fracture and future fracture risk: a 3-year prospective study. Annals of the Rheumatic Diseases, 71 (Suppl.3), 716.

Bruyère, O., Roux, C., Nicolet, D., Fechtenbaum, J., DEROISY, R., & Reginster, J.-Y. (June 2012). Severe prevalent vertebral fractures predict subsequent vertebral and nonvertebral fractures: a 3-year prospective study. Annals of the Rheumatic Diseases, 71 (Suppl.3), 588.

Neuprez, A., François, G., Bruyère, O., Kovats, V., KURTH, W., HUSKIN, J.-P., GILLET, P., & Reginster, J.-Y. (June 2012). Radiological and clinical profil of osteoarthritic patients undergoing of total joint replacement. Annals of the Rheumatic Diseases, 71 (Suppl.3), 693.

Neuprez, A., François, G., Bruyère, O., Kovats, V., THIRION, T., VAN CAUWENBERGE, H., DANIEL, C., GILLET, P., & Reginster, J.-Y. (June 2012). Assessment of quality of life in patients undergoing total joint replacement for OA of the lower limb. Annals of the Rheumatic Diseases, 71 (Suppl.3), 693.

Hiligsmann, M., Bruyère, O., Roberfroid, D., Dubois, C., Parmentier, Y., Carton, J., Detilleux, J., GILLET, P., & Reginster, J.-Y. (May 2012). Trends in hip fracture incidence and in the prescription of anti-osteoporosis medications during same time period in Belgium (2000-2007). Arthritis Care and Research, 64 (5), 744-750.

Boutron-Ruault, M.-C., Bruyère, O., Charriere, S., Crenn, P., Leonil, J., Maubois, J.-L., Raul, F., Sauvant, P., Servin, A., & Vasson, M.-P. (2012). Étude des liens entre facteurs de croissance, consommation de lait et de produits laitiers et cancers. (Saisine 2009-SA-0261). Maisons-Alfort, France: ANSES.

Bruyère, O., Avouac, B., Richette, P., Maheu, E., Bruel, P., Coxam, V., Guillou, G. B., Lugrin, A.-E., Merceron, C., Pauquai, T., Rannou, F., Ythier-Moury, P., Tsouderos, Y., Urban, N., Rovati, L., Guicheux, J., & Reginster, J.-Y. (April 2012). Health claims assessment in the field of joint and cartilage: a consensus viewpoint of the Group for the Respect of Ethics and Excellence in Science. Current Medical Research and Opinion, 28 (4), 611-6. doi:10.1185/03007995.2012.674934

Bruyère, O. (27 March 2012). Mensonge et vérité sur la vibrotonie. Paper presented at Les Mardis de la Kinésithérapie, Bruxelles, Belgium.

Bruyère, O. (24 March 2012). Antidepressant use and fracture risk: a meta-analysis. Paper presented at European Congress on Osteoporosis and Osteoarthritis IOF-ECCEO12, Bordeaux, France.

Bruyère, O. (23 March 2012). Novel perspectives in the definition of responders in trials of osteoarthritis. Paper presented at European Congress on Osteoporosis and Osteoarthritis IOF-ECCEO12, Bordeaux, France.

Bruyère, O. (23 March 2012). How to define responders in osteoarthritis? Paper presented at European Congress on Osteoporosis and Osteoarthritis IOF-ECCEO12, Bordeaux, France.

Bruyère, O. (23 March 2012). Health claims in the field of joint and cartilage: the recommendations of the GREES. Paper presented at European Congress on Osteoporosis and Osteoarthritis IOF-ECCEO12, Bordeaux, France.

Bruyère, O. (23 March 2012). Health claims for nutriceuticals products in the field of cartilage and joint. Paper presented at European Congress on Osteoporosis and Osteoarthritis IOF-ECCEO12, Bordeaux, France.

Bruyère, O., Buckinx, F., & Reginster, J.-Y. (March 2012). A very high prevalence of vitamin D inadequacy combined with low dietary calcium intake is found in European postmenopausal women. Osteoporosis International, 23 (Suppl. 2), 361.

Bruyère, O., Nicolet, D., Compère, S., Rabenda, V., Jeholet, P., Zegels, B., Maassen, P., Pire, G., & Reginster, J.-Y. (March 2012). Perception, knowledge and use by general practitioners of Belgium of the FRAX tool. Osteoporosis International, 23 (Suppl. 2), 363-364.

Bruyère, O., Rabenda, V., & Reginster, J.-Y. (March 2012). Prediction of future knee surgery in patient with osteoarhtritis by the use of a new definition of x-ray progression. Osteoporosis International, 23 (Suppl. 2), 363.

Bruyère, O., & Reginster, J.-Y. (March 2012). Relationships between changes in bone mineral density and vertebral fractures incidence: an analysis of the last 2 years of a 10-year treatment with strontium ranelate. Osteoporosis International, 23 (Suppl. 2), 362.

Bruyère, O., Roux, C., Nicolet, D., Fechtenbaum, J., DEROISY, R., & Reginster, J.-Y. (March 2012). Severity of incident vertebral fracture and future fracture risk: a 3-year prospective study. Osteoporosis International, 23 (Suppl. 2), 60-61.

Bruyère, O., Roux, C., Nicolet, D., Fechtenbaum, J., DEROISY, R., & Reginster, J.-Y. (March 2012). Severe prevalent vertebral fractures predict subsequent vertebral and nonvertebral fractures: a 3-year prospective study. Osteoporosis International, 23 (Suppl. 2), 361-362.

Bruyère, O., Zegels, B., LEONORI, L., Rabenda, V., Janssen, A., Bourges, C., & Reginster, J.-Y. (March 2012). Effect of collagen hydrolysate in articular pain: A 6-month randomized, double-blind, placebo controlled study. Osteoporosis International, 23 (Suppl. 2), 362-363. doi:10.1016/j.ctim.2011.12.007

Demoulin, C., Bruyère, O., & Hill, J. C. (2012). Intérêt du Start Back Screening Tool pour proposer une prise en charge adaptée aux patients souffrant de lombalgie. Actu Kiné.

DEROISY, R., Bruyère, O., Gensburger, D., Chapurlat, R., & Reginster, J.-Y. (March 2012). Long-term (3 years) reproducibility for the radiological assessment of knee osteoarthritis. Osteoporosis International, 23 (Suppl. 2), 219-220.

Gensburger, D., DEROISY, R., Arlot, M., Bruyère, O., Chapurlat, R., & Reginster, J.-Y. (March 2012). Assessment of joint space narrowing in knee osteoarthritis has good long-term intercentre reproducibility when read in pairs with a semi-automated device. Osteoporosis International, 23 (Suppl. 2), 247-248.

Hiligsmann, M., Ben Sedrine, W., Bruyère, O., & Reginster, J.-Y. (March 2012). Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women. Osteoporosis International, 23 (Suppl. 2), 312-313.

Hiligsmann, M., Ben Sedrine, W., Bruyère, O., & Reginster, J.-Y. (March 2012). An economic evaluation of strontium ranelate for the treatment of male osteoporosis. Osteoporosis International, 23 (Suppl. 2), 305-306.

Neuprez, A., François, G., Bruyère, O., Kovats, V., KURTH, W., HUSKIN, J.-P., Gillet, P., & Reginster, J.-Y. (March 2012). Radiological and clinical profil of osteoarthritic patients undergoing of total joint replacement. Osteoporosis International, 23 (Suppl. 2), 129-130.

Bruyère, O. (24 February 2012). Antidépresseurs et risque fracturaire. Paper presented at Colloques Cliniques du Service des Maladies Osseuses, Genève, Switzerland.

Bruyère, O., Rizzoli, R., Coxam, V., Avouac, B., Chevalier, T., Fabien-Soulé, V., Kanis, J. A., Kaufman, J.-M., Tsouderos, Y., & Reginster, J.-Y. (February 2012). Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES). Osteoporosis International, 23, 193-199. doi:10.1007/s00198-011-1561-x

Demoulin, C., Bruyère, O., & Hill, J. C. (2012). Quel traitement pour les patients souffrant de lombalgies ? Axxon Exclusif, 12-14.

Demoulin, C., Bruyère, O., & Hill, J. C. (2012). Quel traitement pour les patients souffrant de lombalgie ? Axxon Journal.

Bruyère, O., Bellamy, N., Brown, J., Richette, P., Punzi, L., Chevalier, X., Cooper, C., & Reginster, J.-Y. (2012). Clinically meaningful effect of strontium ranelate on knee osteoarthritis symptoms. Arthritis and Rheumatism, 64 (S10), 110.

Bruyère, O., Rabenda, V., & Reginster, J.-Y. (2012). Utilisation d'une nouvelle définition de la progression radiologique pour prédire la future chirurgie du genou chez des patients arthrosiques. Revue du Rhumatisme, 79 (S1), 266.

Bruyère, O., Zegels, B., Leonori, L., Rabenda, V., Janssen, A., Bourges, C., & Reginster, J.-Y. (2012). Effect of collagen hydrolysate in articular pain: A 6-month randomized, double-blind, placebo controlled study. Complementary Therapies in Medicine, 20, 124-130. doi:10.1016/j.ctim.2011.12.007

Collette, J., Bruyère, O., & Reginster, J.-Y. (2012). Strontium ranelate decreases the level of urinary CTX-II in patients with knee osteoarthritis. Arthritis and Rheumatism, 64 (S10), 111.

NEUPREZ, A., François, G., Bruyère, O., Kovats, V., KURTH, W., HUSKIN, J.-P., GILLET, P., & Reginster, J.-Y. (2012). Evolution temporelle du profil clinique des patients arthrosiques allant bénéficier d’une arthroplastie de hanche ou de genou. Revue du Rhumatisme, 79 (S1), 272.

NEUPREZ, A., François, G., Bruyère, O., Kovats, V., THIRION, T., Van Cauwenberghe, H., DANIEL, C., GILLET, P., & Reginster, J.-Y. (2012). Profils clinique et radiologique des patients arthrosiques allant bénéficier d'une arthroplastie de hanche ou de genou. Revue du Rhumatisme, 79 (S1), 272.

Rabenda, V., Bruyère, O., & REGINSTER, J.-Y. (2012). Risk of nonvertebral fractures among elderly postmenopausal women using antidepressants. BONE, 51 (4), 674-679. doi:10.1016/j.bone.2012.07.030

Reginster, J.-Y., Bruyère, O., & COLLETTE, J. (2012). Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women [letter to the editor]. BONE, 50, 1201-2. doi:10.1016/j.bone.2011.12.024

Reginster, J.-Y., Kaufman, J. M., Goemaere, S., Devogelaer, J. P., Benhamou, C. L., Felsenberg, D., Diaz-Curiel, M., Brandi, M. L., Badurski, J., Wark, J., Balogh, A., Bruyère, O., & Roux, C. (2012). Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis. Osteoporosis International, 23, 1115-1122. doi:10.1007/s00198-011-1847-z

Rizzoli, R., Cooper, C., Reginster, J.-Y., Abrahamsen, B., Adachi, J., Brandi, M., Bruyère, O., Compston, J., Ducy, P., Ferrari, S., Harvey, N., Kanis, J., Karsenty, G., Laslop, A., Rabenda, V., & Vestergaard, P. (2012). Antidepressant medications and osteoporosis. BONE, 51, 606-613. doi:10.1016/j.bone.2012.05.018

Bruyère, O. (12 December 2011). Intérêts des traitements symptomatiques anti-arthrosiques. Paper presented at symposium de la SFR sur les « Actualités sur la prise en charge de l’arthrose », Paris, France.

Hiligsmann, M., Bruyère, O., Roberfroid, D., Dubois, C., Parmentier, Y., Carton, J., Detilleux, J., Gillet, P., & Reginster, J.-Y. (December 2011). Evolution récente de l'incidence des fractures de hanche et de la consommation de médicaments anti-ostéoporotiques en Belgique. Revue du Rhumatisme, 78 (Suppl. 5), 43-44.

Bruyère, O. (25 November 2011). Health claims for food products in the field of bone and joint: the interest of bone and cartilage turnover markers. Paper presented at Focus conference : Non-infectious serology, Bruxelles, Belgium.

Bruyère, O. (16 November 2011). Étude de cas : allégations de santé dans le domaine de la santé osseuse. Paper presented at Allégations nutritionnelles et de santé : état des lieux et perspectives ?, Liège, Belgium.

Bruyère, O. (27 October 2011). Applying Clinical Research Methodology from Pharma to Food: Osteoporosis Claims. Paper presented at 7th International Workshop "Nutrition & Health Claims Europe Designing Clinical Studies for Success, Bruxelles, Belgium.

Van Oyen, H., & Bruyère, O. (October 2011). Words, words, words. Archives of Public Health, 69 (1). doi:10.1186/0778-7367-69-1

Hiligsmann, M., Bruyère, O., Pire, G., & Reginster, J.-Y. (June 2011). Economic evaluation of osteoporosis screening strategy conducted in the Province of Liège with the cooperation of Liège Province Santé. Paper presented at WHO European Healthy Cities Networks Phase V (2009-2013). Third Annual Business & Technical Conference, Liège, Belgium.

Bruyère, O. (25 March 2011). Recommendations for the design of clinical trials to be conducted by food and food supplements, in order to be granted the right to use health claims in osteoporosis (in collaboration with GREES). Paper presented at European Congress on Osteoporosis and Osteoarthritis ECCEO11-IOF, Valencia, Spain.

Bruyère, O. (24 March 2011). Guidelines for the management of osteoarthritis. Paper presented at European Congress on Osteoporosis and Osteoarthritis ECCEO11-IOF, Valencia, Spain.

Bruyère, O., Detilleux, J., Chines, A., & Reginster, J.-Y. (March 2011). Relationship between changes in bone mineral density or bone turnover markers and vertebral fracture incidence in patients treated with Bazedoxifene. Osteoporosis International, 22 (Suppl.1), 324.

Bruyère, O., Hiligsmann, M., Zegels, B., Neuprez, A., & Reginster, J.-Y. (March 2011). Risk of hip fracture in community-dwelling and institutionalized osteoporotic patients: a 3-year study. Osteoporosis International, 22 (Suppl.1), 332-333.

Bruyère, O., Neuprez, A., Fossi, M., Zegels, B., LEONORI, L., Hiligsmann, M., & Reginster, J.-Y. (March 2011). Reimbursement of drugs against osteoporosis based on FRAX® instead of the current criteria would reduce by 30% the cost (in a societal perspective) of anti-osteoporosis treatment in Belgium. Osteoporosis International, 22 (Suppl.1), 333-334.

Bruyère, O., Rabenda, V., & Reginster, J.-Y. (March 2011). A new definition of progressor in osteoarthritis clinical trial that takes into account intermediate visits: a proof of concept study. Osteoporosis International, 22 (Suppl.1), 367-368.

DEROISY, R., Bruyère, O., & Reginster, J.-Y. (March 2011). Stable precision over time when assessing the cartilage loss on knee osteoarthritis radiograph. Paper presented at 1st IOF-ESCEO Pre-clinical Symposium (2011), European Congress on Osteoporosis and Osteoarthritis ECCEO11-IOF, Valencia, Spain.

Hiligsmann, M., Bruyère, O., Detilleux, J., Gillet, P., Parmentier, Y., Dercq, J.-P., Carton, J., & Reginster, J.-Y. (March 2011). Incidence of hip fracture in Belgium between 2000 and 2007 and future projections. Osteoporosis International, 22 (Suppl.1), 145.

Hiligsmann, M., Gathon, H.-J., Bruyère, O., Beaudart, C., Kolh, P., JACQUES, J., Gillet, P., & Reginster, J.-Y. (March 2011). Patient out-of-pocket contributions related to hip fracture hospital costs in Belgium. Osteoporosis International, 22 (Suppl.1), 333.

Hiligsmann, M., Gathon, H.-J., Bruyère, O., Daubie, M., Parmentier, Y., Dercq, J.-P., & Reginster, J.-Y. (March 2011). Hospitalisation costs of hip fractures in Belgium. Osteoporosis International, 22 (Suppl.1), 332.

Merville, M.-P., Deroyer, C., Bruyère, O., & Reginster, J.-Y. (March 2011). Strontium ranelate increases cell viability in IL-1 beta stimulated human chondrocytes. Paper presented at 1st IOF-ESCEO Pre-clinical Symposium (2011), European Congress on Osteoporosis and Osteoarthritis ECCEO11-IOF, Valencia, Spain.

Body, J. J., Bergmann, P., Boonen, S., Boutsen, Y., Bruyère, O., Devogelaer, J.-P., Goemaere, S., Hollevoet, N., Kaufman, J.-M., Milisen, K., Rozenberg, S., & Reginster, J.-Y. (2011). Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club. Osteoporosis International, 22 (11), 2769-88. doi:10.1007/s00198-011-1545-x

Bruyère, O. (2011). Méthodologie des essais cliniques et Notion d'Evidence Based Medicine. (ULiège - Université de Liège, EPID0752-1).

Bruyère, O. (2011). La rédaction d'un protocole. (Haute Ecole de la Province de Liège André Vésale).

Bruyère, O. (2011). Evidence Based Practice. (ULiège - Université de Liège, KINE0003-1).

Bruyère, O. (2011). Épidémiologie appliquée aux déterminants de la Santé - Partim II : Épidémiologie Clinique. (ULiège - Université de Liège, SANT0757-2).

Bruyère, O. (2011). Complément d'épidémiologie. (ULiège - Université de Liège, EPID0750-2).

Bruyère, O., Nicolet, D., Compère, S., Rabenda, V., Jeholet, P., Maassen, P., Pire, G., & Reginster, J.-Y. (2011). Perception, connaissance et utilisation de l'outil FRAX auprès des médecins généralistes de la Province de Liège (Belgique). Revue du Rhumatisme, 78 (S5), 142.

Bruyère, O., & Reginster, J.-Y. (2011). Relation entre les variations de densité minérale osseuse et l'incidence des fractures vertébrales : analyse des 2 dernières années de 10 ans de traitement par ranélate de strontium. Revue du Rhumatisme, 78 (S5), 217.

Bruyère, O., & Reginster, J.-Y. (2011). Les allégations de santé dans le domaine de la santé osseuse. Ortho-Rhumato, 9 (6), 215.

Johansson, H., Kanis, J. A., McCloskey, E. V., Oden, A., Devogelaer, J. P., Kaufman, J. M., Neuprez, A., Hiligsmann, M., Bruyère, O., & Reginster, J.-Y. (2011). A FRAX(R) model for the assessment of fracture probability in Belgium. Osteoporosis International, 22 (2), 453-61. doi:10.1007/s00198-010-1218-1

Rabenda, V., Bruyère, O., & Reginster, J.-Y. (2011). Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression. Osteoporosis International, 22, 893-901. doi:10.1007/s00198-010-1469-x

Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., Trenti, T., Wahl, D. A., Cooper, C., & Kanis, J. A. (2011). Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporosis International, 22, 391–420. doi:10.1007/s00198-010-1501-1

Bruyère, O. (2010). Rehabilitation in osteoporosis. Proceedings of the annual congress of the Royal Belgian Society of Physical and Rehabilitation medicine, 16.

Delvaux, F., Rochcongar, P., Bruyère, O., Bourlet, G., Diverse, P., DANIEL, C., & Croisier, J.-L. (2010). Critères de retour sur le terrain. In Abstract book du 7ème Congrès du GIBL (pp. 19).

Bruyère, O., Collette, J., & Reginster, J.-Y. (November 2010). Effet à long terme du ranélate de strontium sur le taux sérique de propeptide C-terminal du collagène de type I (PICP) et sur le taux urinaire de télopeptide N-terminal du collagène de type I (U-NTX) chez des femmes ménopausées atteintes d’ostéoporose. Revue du Rhumatisme, 77 (Suppl.3), 183.

Bruyère, O., Ethgen, O., Neuprez, A., Zegels, B., Gillet, P., Huskin, J.-P., & Reginster, J.-Y. (November 2010). Etude de la qualité de vie après la mise en place d’une prothèse de hanche ou de genou pour cause d’arthrose : une étude de cohorte avec un suivi de 7 ans. Revue du Rhumatisme, 77 (Suppl.3), 141.

Bruyère, O., Hiligsmann, M., Zegels, B., Neuprez, A., & Reginster, J.-Y. (November 2010). Résider en institution : un facteur de risque indépendant de fractures de hanche ? Une étude prospective d’une durée de 3 ans. Revue du Rhumatisme, 77 (Suppl.3), 67-68.

Bruyère, O., Neuprez, A., Fossi, M., Beaudart, C., Zegels, B., Leonori, L., Hiligsmann, M., & Reginster, J.-Y. (November 2010). Le remboursement des traitements contre l'ostéoporose basé sur l'utilisation de l'outil FRAX plutôt que sur les critères actuels permettrait de réduire de 30% le coût, dans une perspective sociétale, du traitement de l'ostéoporose en Belgique. Revue du Rhumatisme, 77 (Suppl.3), 66-67.

Collette, J., Bruyère, O., & Reginster, J.-Y. (November 2010). Effet du ranélate de strontium sur le taux d’ostéoprotégérine sérique chez des femmes ménopausées ostéoporotiques traitées pendant 3 ans. Revue du Rhumatisme, 77 (Suppl.3), 184.

Hiligsmann, M., Bruyère, O., Detilleux, J., Gillet, P., Parmentier, Y., Dercq, J.-P., Carton, J., & Reginster, J.-Y. (November 2010). Trend of hip fracture incidence in Belgium between 2000 and 2007 and future projections. Value in Health, 13 (7), 303. doi:10.1016/S1098-3015(11)72162-3

Merville, M.-P., Deroyer, C., Bruyère, O., & Reginster, J.-Y. (November 2010). Le ranélate de strontium augmente la viabilité de chondrocytes humains stimulés par IL-1 bêta. Revue du Rhumatisme, 77 (Suppl.3), 222.

Bruyère, O., Detilleux, J., Akadi, C., & Reginster, J.-Y. (October 2010). Relationship between changes in bone mineral density or bone turnover markers and vertebral fracture incidence in patients treated with bazedoxifene. Arthritis and Rheumatism, 62 (10), 406-S407.

Bruyère, O., Collette, J., & Reginster, J.-Y. (June 2010). Long-term effect of strontium ranelate on serum C-terminal propeptide of type I Procollagen (PICP) and urine cross-linked N-telopeptide (U-NTX) in women with postmenopausal osteoporosis. Annals of the Rheumatic Diseases, 69 (Suppl.3), 602.

Bruyère, O., Vanoverberghe, M., Neuprez, A., Ethgen, O., Zegels, B., Gillet, P., Huskin, J.-P., & Reginster, J.-Y. (June 2010). Health-related quality of life after total knee or hip replacement: a 7-year prospective study. Annals of the Rheumatic Diseases, 69 (Suppl.3), 469.

Collette, J., Bruyère, O., Vanoverberghe, M., & Reginster, J.-Y. (June 2010). Effect of strontium ranelate on serum osteoprotegerin in women with postmenopausal osteoporosis treated over three years. Annals of the Rheumatic Diseases, 69 (Suppl.3), 602.

Reginster, J.-Y., Hiligsmann, M., & Bruyère, O. (June 2010). Strontium ranelate: long-term efficacy against vertebral, nonvertebral and hip fractures in patients with postmenopausal osteoporosis. Therapeutic Advances in Musculoskeletal Disease, 2 (3), 133-143. doi:10.1177/1759720X10362824

Bruyère, O., Vanoverberghe, M., Neuprez, A., Ethgen, O., Zegels, B., Gillet, P., Huskin, J.-P., & Reginster, J.-Y. (May 2010). Health-related quality of life after total knee or hip replacement : a 7-year prospective study. Osteoporosis International, 21 (Suppl.1), 26.

Deroisy, R., Roux, J. P., Bruyère, O., Gensburger, D., Chapurlat, R., & Reginster, J.-Y. (May 2010). Long term agreement between two different centres regarding joint space narrowing measurement in knee osteoarthritis. Osteoporosis International, 21 (Suppl.1), 233-234.

Hiligsmann, M., Rabenda, V., Bruyère, O., & Reginster, J.-Y. (May 2010). The burden of non-adherence with oral bisphosphonates and the potential cost-effectiveness of adherence-enhancing interventions. Osteoporosis International, 21 (S1), 381.

Neuprez, A., Johansson, H., Kanis, J., McCloskey, E. V., Oden, A., Bruyère, O., Hiligsmann, M., Devogelaer, J., Kaufman, J., & Reginster, J.-Y. (May 2010). A FRAX® model for the assessment of fracture probability in Belgium. Osteoporosis International, 21 (Suppl.1), 255.

SCHOLTISSEN, S., Bruyère, O., Neuprez, A., Severens, H., Herrero-Beaumont, G., Rovati, L., Hiligsmann, M., & Reginster, J.-Y. (May 2010). Cost-effectiveness of glucosamine sulfate compared to acetaminophen in the treatment of knee osteoarthrits: a French health care perspective. Osteoporosis International, 21 (Suppl.1), 167.

Reginster, J.-Y., Neuprez, A., Hiligsmann, M., & Bruyère, O. (February 2010). Oral calcitonin in the management of osteoarthritis: hope or fantasy ? International Journal of Clinical Rheumatology, 5 (1), 53-58. doi:10.2217/ijr.09.68

Bruyère, O. (2010). Large review finds no clinically important effect of glucosamine or chondroitin on pain in people with osteoarthritis of the knee or hip but results are questionable and likely due to heterogeneity. Evidence-Based Medicine. doi:10.1136/ebm1164

Bruyère, O., Cavalier, E., Collette, J., & Reginster, J.-Y. (2010). La vitamine D en association avec le calcium dans le traitement de l’ostéoporose. Ortho-Rhumato, 8, 53-55.

Bruyère, O., Collette, J., & Reginster, J.-Y. (2010). The effects of strontium ranelate on biochemical markers of bone turnover and their relationship with bone mineral density: reply to Stepan et al. Osteoporosis International, 21, 1039-1040. doi:10.1007/s00198-009-1156-y

Bruyère, O., Collette, J., & Reginster, J.-Y. (2010). Long-term effect of strontium ranealte on serum C-terminal propeptide of type I procollagen (PICP) and urine cross-linked N-telopeptide (U-NTX) in women with postmenopausal osteoporosis. Osteoporosis International, 21 (Suppl.1), 312.

Bruyère, O., Collette, J., Rizzoli, R., Decock, C., Ortolani, S., Cormier, C., Detilleux, J., & Reginster, J.-Y. (2010). Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years. Osteoporosis International, 21, 1031-1036. doi:10.1007/s00198-009-1078-8

Bruyère, O., Kanis, J. A., Ibar-Abadie, M.-E., Alsayed, N., Brandi, M. L., Burlet, N., Cahall, D. L., Chines, A., Devogelaer, J.-P., Dere, W., Goel, N., Hughes, N., Kaufman, J.-M., Korte, S., Mitlak, B. H., Niese, D., Rizzoli, R., Rovati, L. C., & Reginster, J.-Y. (2010). The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES). Osteoporosis International, 21 (5), 713-22. doi:10.1007/s00198-010-1190-9

Bruyère, O., Reginster, J.-Y., Croisier, J.-L., Crielaard, J.-M., & Maquet, D. (2010). Rehabilitation in osteoporotic subjects - Myth or reality? European Musculoskeletal Review, 5 (1), 36-39.

Bruyère, O., Reginster, J.-Y., Croisier, J.-L., Crielaard, J.-M., & Maquet, D. (2010). Rehabilitation in osteoarthritis. Therapy, 7 (6), 669-674. doi:10.2217/thy.10.76

Collette, J., Bruyère, O., Kaufman, J. M., Lorenc, R., Felsenberg, D., Spector, T. D., Diaz-Curiel, M., Boonen, S., & Reginster, J.-Y. (2010). Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover. Osteoporosis International, 21 (2), 233-41. doi:10.1007/s00198-009-0940-z

Collette, J., Bruyère, O., Vanoverberghe, M., & Reginster, J.-Y. (2010). Effect of strontium ranelate on serum osteoprotegerin in women with postmenopausal osteoporosis treated over three years. Osteoporosis International, 21 (Suppl.1), 311-312.

Hiligsmann, M., Bruyère, O., & Reginster, J.-Y. (2010). Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women. Osteoporosis International, 21, 157-165. doi:10.1007/s00198-009-0924-z

Hiligsmann, M., Bruyère, O., & Reginster, J.-Y. (2010). Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years. BONE, 46 (2), 440-6. doi:10.1016/j.bone.2009.08.052

Hiligsmann, M., Gathon, H.-J., Bruyère, O., Ethgen, O., Rabenda, V., & Reginster, J.-Y. (2010). Cost-Effectiveness of Osteoporosis Screening Followed by Treatment: The Impact of Medication Adherence. Value in Health, 13 (4), 394-401. doi:10.1111/j.1524-4733.2009.00687.x

Hiligsmann, M., Rabenda, V., Bruyère, O., & Reginster, J.-Y. (2010). The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients. Health Policy, 96, 170-176. doi:10.1016/j.healthpol.2010.01.014

Hiligsmann, M., Vanoverberghe, M., Neuprez, A., Bruyère, O., & Reginster, J.-Y. (2010). Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis. Expert Review of Pharmacoeconomics and Outcomes Research, 10 (4), 359-366. doi:10.1586/erp.10.53

Rabenda, V., Bruyère, O., & Reginster, J.-Y. (2010). Relationship between bone mineral density changes and risk of nonvertebral fractures among women receiving calcium with or without vitamin D supplementation: a meta-analysis. Osteoporosis International, 21 (Suppl.1), 268.

SCHOLTISSEN, S., Bruyère, O., NEUPREZ, A., Severens, J. L., Herrero-Beaumont, G., Rovati, L., Hiligsmann, M., & Reginster, J.-Y. (2010). Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamol. International Journal of Clinical Practice, 64 (6), 756-62. doi:10.1111/j.1742-1241.2010.02362.x

Bruyère, O. (December 2009). Both weight-bearing and non–weightbearing exercise improved function in patients with knee osteoarthritis. Evidence-Based Medicine, 14 (6), 178. doi:10.1136/ebm.14.6.178

Neuprez, A., Johansson, H., Kanis, J., McCloskey, E. V., Oden, A., Bruyère, O., Hiligsmann, M., Devogelaer, J.-P., Kaufmann, J.-M., & Reginster, J.-Y. (December 2009). Rationalisation du remboursement des médicaments de l'ostéoporose : de la mesure isolée de la densité osseuse à l’intégration des facteurs cliniques de risque fracturaire. Validation de l’algorithme FRAX®. Revue Médicale de Liège, 64 (12), 612-619.

Bruyère, O. (18 November 2009). Données récentes sur les traitements symptomatiques à action lente dans l'arthrose. Paper presented at Réunion "Groupe Local d'Evaluation Médicale" (GLEM), Etterbeek, Belgium.

Bruyère, O. (14 November 2009). Quoi de neuf dans la prise en charge de l'ostéoporose. Paper presented at 19ième congrès national de la Société Marocaine de Rhumatologie, Marrakech, Morocco.

Bruyère, O., COLLETTE, J., DEROISY, R., Rabenda, V., Neuprez, A., Hiligsmann, M., & Reginster, J.-Y. (October 2009). Biochemical markers of bone and cartilage remodelling: interest in the prediction of lumbar disc degeneration progression and effects of strontium ranelate over a 3-year period. Arthritis and Rheumatism, 60 (number 10 (suppl.)), 313.

Hiligsmann, M., Rabenda, V., Bruyère, O., & Reginster, J.-Y. (October 2009). The clinical and economic burden of nonadherence with osteoporosis medications. Value in Health, 12 (7), 444. doi:10.1016/S1098-3015(10)75197-4

Hiligsmann, M., Rabenda, V., Bruyère, O., & Reginster, J.-Y. (October 2009). The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients. Arthritis and Rheumatism, 60 (number 10 (suppl.)), 328.

Bruyère, O. (01 April 2009). Le traitement de l'arthrose en dehors des traitements physiques. Où en est-on en 2009? Paper presented at Réunion du "Dodécagroupe", Tavier, Belgium.

Bruyère, O. (28 March 2009). Non-pharmacological strategy to decrease risk of fall in the elderly. Paper presented at Consensus meeting on Treatment of osteoporosis in the elderly, Paris, France.

Bruyère, O. (27 March 2009). Vitamin D : epidemiologic aspect of the deficiency. Paper presented at 5th Euregio conference of Clinical chemistry and laboratory medicine, Liège, Belgium.

Bruyère, O. (19 March 2009). New data for the management of osteoarthritis. Paper presented at Ninth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, Athens, Greece.

Bruyère, O. (12 March 2009). Utilisation des glucosamines dans l'arthrose. Paper presented at Réunion "Groupe Local d'Evaluation Médicale" (GLEM), Charleroi, Belgium.

Bruyère, O. (08 March 2009). Relation entre changement de Densité Minérale Osseuse et évolution du risque fracturaire. Paper presented at Congrès International de Médecine Interne, Bruxelles, Belgium.

Bruyère, O., Collette, J., Deroisy, R., Rabenda, V., Hiligsmann, M., & Reginster, J.-Y. (March 2009). Prediction of spinal osteoarthritis progression by assessment of biochemical markers of bone and cartilage remodelling: a 3-year study. Osteoporosis International, 20 (Suppl.1), 8.

Bruyère, O., Decock, C., Collette, J., Ortolani, S., Cormier, C., Detilleux, J., Frankinet, P., & Reginster, J.-Y. (March 2009). Relationship between 3-month changes in biochemical markers of bone remodelling and 3-year changes in bone mineral density in patients treated with strontium ranelate. Osteoporosis International, 20 (Suppl.1), 86-87.

Bruyère, O., Detilleux, J., Decock, C., & Reginster, J.-Y. (March 2009). Relationship between changes in bone mineral density and vertebral fracture incidence: an analysis of the last 3 years of an 8-year treatment with strontium ranelate. Osteoporosis International, 20 (Suppl.1), 11.

Bruyère, O., Hiligsmann, M., Frankinet, P., Detilleux, J., & Reginster, J.-Y. (March 2009). Association between changes in bone mineral density and fracture incidence in postmenopausal women receiving calcium and vitamin D : A 3-year study. Osteoporosis International, 20 (Suppl.1), 87-88.

Bruyère, O., & Reginster, J.-Y. (March 2009). Treatment of osteoarthritis with glucosamine sulftate: from clinical to economic data. Osteoporosis International, 20 (Suppl.1), 182.

Hiligsmann, M., Bruyère, O., & Reginster, J.-Y. (March 2009). Cost-utility of strontium ranelate for the prevention and treatment of postmenopausal osteoporotic women. Osteoporosis International, 20 (S1), 129.

Rabenda, V., Bruyère, O., & Reginster, J.-Y. (March 2009). Relationship between changes in bone mineral density and compliance to strontium ranelate. Osteoporosis International, 20 (Suppl.1), 152-153.

Scholtissen, S., Bruyère, O., Hiligsmann, M., Neuprez, A., Herrero-Beaumont, G., Rovati, L., & Reginster, J.-Y. (March 2009). Glucosamine sulfate in the treatment of knee osteoarthritis: impact on health utility. Osteoporosis International, 20 (Suppl.1), 149.

Scholtissen, S., Bruyère, O., Hiligsmann, M., Neuprez, A., Pavelka, K., Rovati, L., & Reginster, J.-Y. (March 2009). Effect of glucosamine sulfate on health utility data in patients with knee osteoarthritis : reanalysis of two 3-year prospective studies. Osteoporosis International, 20 (Suppl.1), 18.

Bruyère, O., Brandi, M. L., Burlet, N., Harvey, N., Lyritis, G., Minne, H., Boonen, S., REGINSTER, J.-Y., Rizzoli, R., & Akesson, K. (2009). La gestione post-frattura del paziente con frattura di femore: Una visione prospettica. Clinical Cases in Mineral and Bone Metabolism, 6 (3), 270-279.

Bruyère, O., De Cock, C., Deroisy, R., & Reginster, J.-Y. (2009). Bone mineral density and health related quality of life: a 3-year follow-up study of osteoportic postmenopaul women. The Open Geritric Medicine Journal, 2, 44-52.

Bruyère, O., Decock, C., Delhez, M., Collette, J., & Reginster, J.-Y. (2009). Highest prevalence of vitamin D inadequacy in institutionalized women compared with noninstitutionalized women: a case-control study. Women's Health, 5 (1), 49-54. doi:10.2217/17455057.5.1.49

Bruyère, O., DeCock, C., Mottet, C., Neuprez, A., MALAISE, O., & Reginster, J.-Y. (2009). Low dietary calcium in European postmenopausal osteoporotic women. Public Health Nutrition, 12 (1), 111-114. doi:10.1017/S1368980008002024

Bruyère, O., Detilleux, J., Decock, C., & Reginster, J.-Y. (2009). Relations entre les variations de densité minérale osseuse et l'incidence des fractures vertébrales: analyse des 3 dernières années d'un traitement de 8 ans sous ranélate de strontium. Revue du Rhumatisme, 76, 1070.

Bruyère, O., & Reginster, J.-Y. (2009). The need for economic evaluation in osteoarthritis. Aging Health, 5 (5), 591-594. doi:10.2217/ahe.09.57

Bruyère, O., & Reginster, J.-Y. (2009). Place de la densitométrie osseuse dans le diagnostic et le suivi des patients ostéoporotiques. Ortho-Rhumato, 7, 3-5.

Bruyère, O., Scholtissen, S., Neuprez, A., Hiligsmann, M., & Reginster, J.-Y. (2009). Effets du sulfate de chondroitine sur les indices d'utilité de santé chez des sujets gonarthrosiques et analyses économiques préliminaires. Revue du Rhumatisme, 76, 1051.

Bruyère, O., SCHOLTISSEN, S., NEUPREZ, A., Hiligsmann, M., Toukouki, A., & Reginster, J.-Y. (2009). Impact of chondroitin sulphate on health utility in patients with knee osteoarthritis: towards economic analysis. Journal of Medical Economics, 12 (4), 356-360. doi:10.3111/13696990903438617

Bruyère, O., Scholtissen, S., Neuprez, A., Severens, H., Herrero-Beaumont, G., Rovati, L., Hiligsmann, M., & Reginster, J.-Y. (2009). Analyses coût-efficacité du sulfate de glucosamine chez des patients gonarthrosiques : comparaison avec le paracétamol. Revue du Rhumatisme, 76, 1097.

Bruyère, O., Varela, A. R., Adami, S., Detilleux, J., Rabenda, V., Hiligsmann, M., & Reginster, J.-Y. (2009). Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women. European Journal of Epidemiology, 24, 707-712. doi:10.1007/s10654-009-9381-4

Hiligsmann, M., Ethgen, O., Bruyère, O., Richy, F., Gathon, H.-J., & Reginster, J.-Y. (2009). Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Treatments in Osteoporosis. Value in Health, 12 (5), 687-696. doi:10.1111/j.1524-4733.2008.00497.x

NEUPREZ, A., Hiligsmann, M., Bruyère, O., & Reginster, J.-Y. (2009). Efficacite anti-fracturaire de l'ibandronate administre par voie intraveineuse: de la complexite des etudes epidemiologiques interventionnelles a la pratique quotidienne. Revue Médicale de Liège, 64 (10), 525-9.

Neuprez, A., Johansson, H., Kanis, J., Mc Closkey, E., Oden, A., Bruyère, O., Hiligsmann, M., Devogelaer, J.-P., Kaufman, J.-M., & Reginster, J.-Y. (2009). Rationalisation du remboursement des médicaments de l'ostéoporose : de la mesure isolée de la densité osseuse à l'intégration des facteurs cliniques de risque fracturaire. Validation de l'algorithme FRAX(r). Revue du Rhumatisme, 76, 1070-1.

Reginster, J.-Y., Bruyère, O., Sawicki, A., Roces-Varela, A., Fardellone, P., Roberts, A., & Devogelaer, J.-P. (2009). Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years. BONE, 45, 1059-64. doi:10.1016/j.bone.2009.08.004

Reginster, J.-Y., Deroisy, R., NEUPREZ, A., Hiligsmann, M., Zegels, B., & Bruyère, O. (2009). Strontium ranelate: new data on fracture prevention and mechanisms of action. Current Osteoporosis Reports, 7 (3), 96-102. doi:10.1007/s11914-009-0016-1

Reginster, J.-Y., Hiligsmann, M., Rabenda, V., Zegels, B., Neuprez, A., & Bruyère, O. (2009). Ibandronate in the management of postmenopausal osteoporosis. Clinical Medicine. Therapeutics, 1, 1409-1421.

Rizzoli, R., Bruyère, O., Cannata-Andia, J. B., Devogelaer, J.-P., Lyritis, G., Ringe, J. D., Vellas, B., & Reginster, J.-Y. (2009). Management of osteoporosis in the elderly. Current Medical Research and Opinion, 25 (10), 2373-2387. doi:10.1185/03007990903169262

Scholtissen, S., Guillemin, F., Bruyère, O., Collette, J., Dousset, B., Kemmer, C., Culot, S., Cremer, D., Dejardin, H., Hubermont, G., Lefebvre, D., Pascal-Vigneron, V., Weryha, G., & Reginster, J.-Y. (2009). Assessment of determinants for osteoporosis in elderly men. Osteoporosis International, 20 (7), 1157-66. doi:10.1007/s00198-008-0789-6

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (December 2008). Cost-utility of calcium and vitamin D supplementation in the treatment of postmenopausal osteoporotic women. Osteoporosis International, 19 (S2), 363.

Hiligsmann, M., Bruyère, O., & Reginster, J.-Y. (December 2008). Cost-utility of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women. Osteoporosis International, 19 (S2), 450.

Hiligsmann, M., Rabenda, V., Gathon, H.-J., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (December 2008). Impact of medication non-compliance and non-persistence on pharmacoeconomic evaluations in osteoporosis. Osteoporosis International, 19 (S2), 282. doi:10.1016/S1098-3015(10)66788-5

Bruyère, O. (18 October 2008). Debates on osteoporosis management. Paper presented at Congress of The Belgian Menopause Society, Bruxelles, Belgium.

Bruyère, O., Decock, C., COLLETTE, J., Ortolani, S., Cormier, C., Detilleux, J., FRANKINET, P., & Reginster, J.-Y. (October 2008). Relationship between 3-month changes in biochemical markers of bone remodelling and 3-year changes in bone mineral density in patients treated with strontium ranelate. Arthritis and Rheumatism, 58 (Suppl.1), 743.

Bruyère, O., Hiligsmann, M., FRANKINET, P., Detilleux, J., & Reginster, J.-Y. (October 2008). Association between changes in bone mineral density and fracture incidence in postmenopausal osteoporotic women receiving calcium and vitamin D: a 3-year follow-up study. Arthritis and Rheumatism, 58 (Suppl.1), 743.

DeCock, C., Bruyère, O., Collette, J., & Reginster, J.-Y. (July 2008). Déficit en vitamine D chez les femmes françaises ostéoporotiques et ostéopéniques. Revue du Rhumatisme, 75, 839-844. doi:10.1016/j.rhum.2007.10.623

Hiligsmann, M., Bruyère, O., Ethgen, O., Pire, G., Gathon, H.-J., & Reginster, J.-Y. (July 2008). Efficiency and recommendations for osteoporosis screening strategy. Paper presented at 7th European Conference on Health Economics, Rome, Italy.

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (July 2008). Efficiency of calcium and vitamin D in the management of osteoporosis. Paper presented at 7th European Conference on Health Economics, Rome, Italy.

Bruyère, O. (2008). Femoral BMD, Not Spinal, Best Predicts Risk of Future Vertebral Fractures. Eprint/Working paper retrieved from https://orbi.uliege.be/2268/94012.

Bruyère, O., Brandi, M., Vellas, B., Hiligsmann, M., & Reginster, J.-Y. (June 2008). Relationship between long-term changes in femoral neck bone mineral density and hip fracture incidence in untreated postmenopausal osteoporotic women. Annals of the Rheumatic Diseases, 67 (Suppl.II), 403.

Bruyère, O., Collette, J., Christiansen, F., Fardellone, F., Detroz, A., Deroisy, R., & Reginster, J.-Y. (June 2008). Association between lumbar disc degeneration and biochemical markers of bone and cartilage remodelling. Annals of the Rheumatic Diseases, 67 (Suppl.II), 231.

Bruyère, O., Delhez, M., Collette, J., & Reginster, J.-Y. (June 2008). Prevalence of vitamin D inadequacy in institutionalized osteoporotic postmenopausal women. Annals of the Rheumatic Diseases, 67 (Suppl.II), 403.

Bruyère, O., Pieck, C., Hiligsmann, M., Zegels, B., Delhez, M., Mottet, C., & Reginster, J.-Y. (June 2008). Place of residence as a risk factor for hip fracture? A case-control 3-year study. Annals of the Rheumatic Diseases, 67 (Suppl.II), 428.

Bruyère, O., Roces-Varela, A., Adami, S., & Reginster, J.-Y. (June 2008). Association between changes in bone mineral density and vertebral fracture incidence in untreated postmenopausal women : a 3-year prospective study. Annals of the Rheumatic Diseases, 67 (Suppl.II), 89.

Bruyère, O. (2008). Osteoporosis patients demonstrate high levels of vitamin D depletion. Eprint/Working paper retrieved from https://orbi.uliege.be/2268/94016.

Bruyère, O., Brandi, M. L., Vellas, B., Hiligsmann, M., & Reginster, J.-Y. (April 2008). Changes in femoral neck bone mineral density are associated with hip fracture incidence in untreated postmenopausal women. Osteoporosis International, 19 (Suppl.1), 18-19.

Bruyère, O., Collette, J., Christiansen, C., Padrino, J. M., Fardellone, J. P., Detroz, A., Deroisy, R., & Reginster, J.-Y. (April 2008). Association between spinal osteoarthritis and biochemical markers of bone and cartilage remodelling. Osteoporosis International, 19 (Suppl.1), 200.

Bruyère, O., Pieck, C., Hiligsmann, M., Zegels, B., Delhez, M., Mottet, C., & Reginster, J.-Y. (April 2008). Place of residence as a risk factor for hip fracture? A case-control 3-year study. Osteoporosis International, 19 (Suppl.1), 200.

Bruyère, O., Roces-Varela, A., Adami, S., & Reginster, J.-Y. (April 2008). Association between changes in bone mineral density and vertebral fracture incidence in untreated postmenopausal women. Osteoporosis International, 19 (Suppl.1), 199.

DeCock, C., Bruyère, O., & Reginster, J.-Y. (April 2008). Bone Mineral Density and health-related quality of life: a 3-year follow-up in osteoporotic postmenopausal women. Osteoporosis International, 19 (Suppl.1), 54.

Hiligsmann, M., Bruyère, O., Ethgen, O., Pire, G., & Reginster, J.-Y. (April 2008). Efficiency and recommendations for osteoporosis screening strategy. Osteoporosis International, 19 (S1), 116.

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (April 2008). Efficiency of calcium and vitamin D supplementation in the management of osteoporosis. Osteoporosis International, 19 (S1), 113.

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (April 2008). Cost-utility of strontium ranelate in the treatment of postmenopausal women. Osteoporosis International, 19 (S1), 6.

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (April 2008). Cost-effectiveness of mass screening and targeted biphosphonates treatment in osteoporosis. Osteoporosis International, 19 (S1), 117.

Scholtissen, S., Guillemin, F., Kemmer, C., Culot, S., Bruyère, O., & Reginster, J.-Y. (April 2008). Assessement of risk factors for osteoporotic fractures in elderly men. Osteoporosis International, 19 (Suppl.1), 200-201.

Bruyère, O., Delferriere, D., Roux, C., Wark, J. D., Spector, T., Devogelaer, J.-P., Brixen, K., Adami, S., Fechtenbaum, J., Kolta, S., & Reginster, J.-Y. (March 2008). Effects of Strontium Ranelate on Spinal Osteoarthritis Progression. Annals of the Rheumatic Diseases, 67 (3), 335-9. doi:10.1136/ard.2007.075572

Reginster, J.-Y., Collette, J., NEUPREZ, A., Zegels, B., Deroisy, R., & Bruyère, O. (10 February 2008). Role of Biochemical Markers of Bone Turnover as Prognostic Indicator of Successful Osteoporosis Therapy. BONE, 42, 832-836. doi:10.1016/j.bone.2008.01.021

Bruyère, O., Pavelka, K., Rovati, L. C., Gatterova, J., Giacovelli, G., Olejarova, M., Deroisy, R., & Reginster, J.-Y. (February 2008). Total Joint Replacement after Glucosamine Sulphate Treatment in Knee Osteoarthritis: Results of a Mean 8-Year Observation of Patients from Two Previous 3-Year, Randomised, Placebo-Controlled Trials. Osteoarthritis and Cartilage, 16 (2), 254-60. doi:10.1016/j.joca.2007.06.011

Reginster, J.-Y., Collette, J., Neuprez, A., & Bruyère, O. (2008). Strontium ranelate in the management of spinal and peripheral osteoporosis. Review of Endocrinology, 26-33.

Bruyère, O. (26 January 2008). Le traitement de l'ostéoporose de la femme jeune. Paper presented at Congrès International de Rhumatologie et de Médecine Interne (IFDA), Budapest, Hungary.

Bruyère, O., Brandi, M.-L., Burlet, N., Harvey, N., Lyritis, G., Minne, H., Boonen, S., Reginster, J.-Y., Rizzoli, R., & Akesson, K. (2008). Post-fracture management of patients with hip fracture: a perspective. Current Medical Research and Opinion, 24 (10), 2841-51. doi:10.1185/03007990802381430

Bruyère, O., Burlet, N., Delmas, P. D., Rizzoli, R., Cooper, C., & Reginster, J.-Y. (2008). Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system. BMC Musculoskeletal Disorders, 9, 165. doi:10.1186/1471-2474-9-165

Bruyère, O., Decock, C., Collette, J., Ortolani, S., Cormier, C., Detilleux, J., Franquinet, P., & Reginster, J.-Y. (2008). Relationship between 3-month changes in biochemical markers of bone remodelling and 3-year changes in bone mineral density in patients treated with strontium ranelate. Osteoporosis International, 19 (S2), 244.

Bruyère, O., Detilleux, J., Decock, C., & Reginster, J.-Y. (2008). Relationships between changes in bone mineral density and vertebral fracture incidence : an analysis of the last 3 years of an 8-year treatment with strontium ranelate. Osteoporosis International, 19 (S2), 459.

Bruyère, O., Hiligsmann, M., FRANKINET, P., Detilleux, J., & Reginster, J.-Y. (2008). Association between changes in bone mineral density and fracture incidence in postmenopausal osteoporotic women receiving calcium and vitamin D : a 3-year follow-up study. Osteoporosis International, 19 (S2), 274.

Bruyère, O., & Reginster, J.-Y. (2008). Vitamin D status and response to antiosteoporotic therapy. Women's Health, 4 (5), 445-7. doi:10.2217/17455057.4.5.445

Bruyère, O., & Reginster, J.-Y. (2008). Correlation between increased bone mineral density and decreased fracture risk - Bone mineral density as a tool to monitor postmenopausal osteoporosis treatment. Medicographia, 30 (4), 355-359.

De Cock, C., Bruyère, O., Collette, J., & Reginster, J.-Y. (2008). Vitamin D inadequacy in French osteoporotic and osteopenic women. Joint Bone Spine, 75 (5), 567-72. doi:10.1016/j.jbspin.2007.10.012

Hiligsmann, M., Bruyère, O., Ethgen, O., Gathon, H.-J., & Reginster, J.-Y. (2008). Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women. BONE, 43 (6), 991-4. doi:10.1016/j.bone.2008.08.119

Hiligsmann, M., Bruyère, O., Pire, G., & Reginster, J.-Y. (2008). Evaluation économique de la campagne de dépistage de l'ostéoporose menée en Province de Liège avec le concours de Liège Province Santé. Revue Médicale de Liège, 63 (10), 588-94.

Hiligsmann, M., Bruyère, O., & Reginster, J.-Y. (2008). Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. Revue Médicale de Liège, 63 (7-8), 480-487.

Hiligsmann, M., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (2008). An Economic Evaluation of Quantitative Ultrasonometry as Pre-Screening Test for the Identification of Patients with Osteoporosis. Disease Management and Health Outcomes, 16 (6), 429-438. doi:10.2165/0115677-200816060-00008

NEUPREZ, A., Hiligsmann, M., Scholtissen, S., Bruyère, O., & Reginster, J.-Y. (2008). Strontium ranelate: The first agent of a new therapeutic class in osteoporosis. Advances in Therapy, 25 (12), 1235-56. doi:10.1007/s12325-008-0125-8

Reginster, J.-Y., NEUPREZ, A., & Bruyère, O. (2008). Ibandronate in profile: drug characteristics and clinical efficacy. Expert Opinion on Drug Metabolism and Toxicology, 4 (7), 941-51. doi:10.1517/17425255.4.7.941

Bruyère, O., Roux, C., Badurski, J., Isaia, G., de Vernejoul, M. C., Cannata, J., Ortolani, S., Slosman, D., Detilleux, J., & Reginster, J.-Y. (December 2007). Relationship between Change in Femoral Neck Bone Mineral Density and Hip Fracture Incidence During Treatment with Strontium Ranelate. Current Medical Research and Opinion, 23 (12), 3041-5. doi:10.1185/030079907X242818

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (December 2007). Efficience d'un dépistage de masse de l'ostéoporose par ultrasons: approche économique par microsimulation. Revue du Rhumatisme, 74 (10-11), 1072-3.

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (December 2007). Analyse coût-efficacité d'un dépistage de masse de l'ostéoporose par DEXA combiné à un traitement par alendronate chez la femme ostéoporotique. Revue du Rhumatisme, 74 (10-11), 1072-3.

Bruyère, O. (13 October 2007). Densité Minérale Osseuse et risque fracturaire : une relation prédictive? Paper presented at Congrés International de Rhumatologie et de Médecine Interne (IFDA), St-Petersburg, Russia.

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (October 2007). Cost-effectiveness of osteoporosis screening campaign for Belgian women. Value in Health, 10 (6), 395. doi:10.1016/S1098-3015(10)65384-3

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (October 2007). Cost-effectiveness of bone densitometry screening combined with alendronate therapy for those who have osteoporosis. Value in Health, 10 (6), 236. doi:10.1016/S1098-3015(10)64899-1

Reginster, J.-Y., Heraud, F., Zegels, B., & Bruyère, O. (October 2007). Symptom and structure modifying properties of chondroitin sulfate in osteoarthritis. Mini Reviews in Medicinal Chemistry, 7 (10), 1051-1061. doi:10.2174/138955707782110088

Bruyère, O. (2007). Exercise intervention prevents falls in frail older patients. Eprint/Working paper retrieved from https://orbi.uliege.be/2268/92837.

Bruyère, O., Delferriere, D., Roux, C., Wark, J. D., Spector, T., Devogelaer, J.-P., Brixen, K., Adami, S., Fechtenbaum, J., Kolta, S., & Reginster, J.-Y. (September 2007). Effects of strontium ranelate on radiographic spinal osteoarthritis progression. Arthritis and Rheumatism, 56 (number 9 (suppl.)), 315.

Bruyère, O., Malaise, O., NEUPREZ, A., Collette, J., & Reginster, J.-Y. (August 2007). Prevalence of vitamin D inadequacy in European postmenopausal women. Current Medical Research and Opinion, 23 (8), 1939-1944. doi:10.1185/030079907X219562

Bruyère, O., & Reginster, J.-Y. (August 2007). Highlights from the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis. Expert Opinion on Pharmacotherapy, 8 (11), 1779-1784. doi:10.1517/14656566.8.11.1779

Bruyère, O., Roux, C., Detilleux, J., Slosman, D. O., Spector, T. D., Fardellone, P., Brixen, K., Devogelaer, J. P., Diaz-Curiel, M., Albanese, C., Kaufman, J. M., Pors-Nielsen, S., & Reginster, J.-Y. (August 2007). Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. Journal of Clinical Endocrinology and Metabolism, 92 (8), 3076-3081. doi:10.1210/jc.2006-2758

Malaise, O., Bruyère, O., & Reginster, J.-Y. (August 2007). Strontium ranelate normalizes bone mineral density in osteopenic patients. Aging Clinical and Experimental Research, 19 (4), 330-333. doi:10.1007/BF03324710

Bruyère, O., Delferriere, D., Roux, C., Fechtenbaum, J., Kolta, S., & Reginster, J.-Y. (July 2007). Positive effects of strontium ranelate on spine osteoarthritis progression. Annals of the Rheumatic Diseases, 66 (Suppl.II), 58.

Bruyère, O., Roux, C., Detilleux, J., & Reginster, J.-Y. (June 2007). Increase in femoral neck bone mineral density is associated with decrease in vertebral and hip fracture incidence during a 3-year treatment with strontium ranelate. Annals of the Rheumatic Diseases, 66 (Suppl.II), 521.

COLLETTE, J., Reginster, J.-Y., Bruyère, O., DEROISY, R., Jupsin, I., Devogelaer, J.-P., Adami, S., & Marcelli, C. (May 2007). Dissociation between bone formation and bone resorption evidenced by changes in biochemical markers of bone turnover in patients treated with strontium ranelate. Calcified Tissue International, 80 (Suppl.1), 120.

COLLETTE, J., Reginster, J.-Y., Bruyère, O., Roux, C., Lorenc, R., Felsenberg, D., & Spector, T. D. (May 2007). Strontium ranelate decreases vertebral fracture risk whatever the level of pretreatment bone turnover markers. Calcified Tissue International, 80 (Suppl.1), 29-30.

Reginster, J.-Y., Bruyère, O., & NEUPREZ, A. (May 2007). Current role of glucosamine in the treatment of osteoarthritis. Rheumatology, 46 (5), 731-735. doi:10.1093/rheumatology/kem026

Neuprez, A., Bruyère, O., Collette, J., & Reginster, J.-Y. (26 April 2007). Vitamin D inadequacy in Belgian postmenopausal osteoporotic women. BMC Public Health, 7 (147), 64. doi:10.1186/1471-2458-7-64

Bruyère, O. (2007). Pinning down pain: acupuncture offers pain relief for osteoarthritis patients. Eprint/Working paper retrieved from https://orbi.uliege.be/2268/94017.

Bruyère, O., De Cock, C., Neuprez, A., MALAISE, O., & Reginster, J.-Y. (March 2007). Calcium daily food intake is very low in European postmenopausal women. Osteoporosis International, 18 (Suppl.1), 125.

Bruyère, O., Delferriere, D., Roux, C., Fechtenbaum, J., Kolta, S., & Reginster, J.-Y. (March 2007). Strontium ranelate prevents spine osteoarthritis progression in patients with prevalent spinal osteoarthritis. Osteoporosis International, 18 (Suppl1), 16-S17.

Bruyère, O., MALAISE, O., Neuprez, A., Collette, J., & Reginster, J.-Y. (March 2007). Prevalence of vitamin D inadequacy is high in European postmenopausal women. Osteoporosis International, 18 (Suppl.1), 124.

Bruyère, O., Pavelka, K., Rovati, L. C., Gatterova, J., Giacovelli, G., Olejarova, M., Deroisy, R., & Reginster, J.-Y. (March 2007). Total joint replacement after glucosamine sulfate treatment of knee osteoarthritis: results from a 8-year prospective cohort. Osteoporosis International, 18 (Suppl.1), 81.

Collette, J., Reginster, J.-Y., Bruyère, O., Deroisy, R., Jupsin, I., Devogelaer, J.-P., Adami, S., & Marcelli, C. (March 2007). Dissociation between bone formation and bone resorption evidenced by changes in biochemical markers of bone turnover in patients treated with strontium ranelate. Osteoporosis International, 18 (Suppl.1), 125.

Collette, J., Reginster, J.-Y., Bruyère, O., Roux, C., Lorenc, R., Felsenberg, D., & Spector, T. D. (March 2007). Strontium ranelate decreases vertebral fracture risk whatever the level of pretreatment bone turnover markers. Osteoporosis International, 18 (Suppl.1), 127-128.

Hiligsmann, M., Richy, F., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (March 2007). Rationale and development of an individual patient-based model to accurately assess the efficacy of osteoporosis management. Osteoporosis International, 18 (S1), 169.

Neuprez, A., Bruyère, O., & Reginster, J.-Y. (March 2007). Vitamin D inadequacy in Belgian postmenopausal women. Osteoporosis International, 18 (Suppl.1), 123.

Reginster, J.-Y., Malaise, O., NEUPREZ, A., & Bruyère, O. (February 2007). Strontium ranelate in the prevention of osteoporotic fractures. International Journal of Clinical Practice, 61 (2), 324-328. doi:10.1111/j.1742-1241.2006.01249.x

Bruyère, O. (2007). Epidémiologie de l'environnement. (ULiège - Université de Liège, Epidémiologie de l'environnement).

Bruyère, O., Genant, H., Kothari, M., Zaim, S., White, D., Peterfy, C., Burlet, N., Richy, F., Ethgen, D., Montague, T., Dabrowski, C., & Reginster, J.-Y. (January 2007). Longitudinal study of magnetic resonance imaging and standard X-rays to assess disease progression in osteoarthritis. Osteoarthritis and Cartilage, 15 (1), 98-103. doi:10.1016/j.joca.2006.06.018

Bruyère, O., & Reginster, J.-Y. (2007). Structure modification in osteoarthritis. European Musculoskeletal Review, 27-30.

Bruyère, O., & Reginster, J.-Y. (2007). Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip Osteoarthritis. Drugs and Aging, 24 (7), 573-580. doi:10.2165/00002512-200724070-00005

Malaise, O., Bruyère, O., & Reginster, J.-Y. (2007). Intraveinous paracetamol: a review of efficacy and safety in therapeutic use. Future Neurology, 2 (6), 673-688. doi:10.2217/14796708.2.6.673

Neuprez, A., Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (2007). Prevention of hip fractures in osteoporosis. Minerva Ortopedica e Traumatologica, 58 (5), 423-437.

Reginster, J.-Y., Burlet, N., Close, P., & Bruyère, O. (2007). Injectable bisphosphonates for the treatment of osteoporosis. Women's Health, 3 (6), 719-23. doi:10.2217/17455057.3.6.719

Bruyère, O., Cormier, C., Fardellone, P., Kahan, A., Kolta, S., Kuntz, J. L., Javier, R. M., Meunier, P., & Reginster, J.-Y. (December 2006). Corrélation entre l'augmentation de la densité minérale osseuse et la réduction du risque fracturaire lors d'un traitement par ranélate de strontium. Revue du Rhumatisme, 73, 1060.

Bruyère, O., MALAISE, O., Neuprez, A., Collette, J., & Reginster, J.-Y. (December 2006). Prévalence élevée de la carence en vitamine D chez la femme ménopausée en Europe et principalement en France : analyse d'une cohorte de 8532 sujets. Revue du Rhumatisme, 73, 1052.

Richy, F., Bruyère, O., & Reginster, J.-Y. (December 2006). Tendance dans l'utilisation de biphosphonates, de vitamine D et de calcium dans l'ostéoporose postménopausique : une analyse à 10 ans. Revue du Rhumatisme, 73, 1174.

Bruyère, O., Delmas, P. D., Devogelaer, J.-P., Slosman, D. O., Albanese, C., & Reginster, J.-Y. (November 2006). Increase in femoral neck bone mineral density is associated with decrease in hip fracture incidence during treatment with strontium ranelate. Arthritis and Rheumatism, 54 (Suppl), 586.

Bruyère, O., Detilleux, J., & Reginster, J.-Y. (November 2006). Bone mineral density assessment is an appropriate monitoring tool for the management of strontium ranelate-treated osteoporotic patients. Arthritis and Rheumatism, 54 (Suppl), 586.

Bruyère, O., MALAISE, O., Neuprez, A., COLLETTE, J., & Reginster, J.-Y. (November 2006). European postmenopausal osteoporotic women have high prevalence of vitamin D inadequacy. Arthritis and Rheumatism, 54 (Suppl), 585.

Reginster, J.-Y., COLLETTE, J., Bruyère, O., DEROISY, R., & Jupsin, I. (November 2006). Biochemical markers of bone turnover confirm the dual mode of action of strontium ranelate: increase in bone formation and decrease in bone resorption. Arthritis and Rheumatism, 54 (Suppl), 590.

Altman, R. D., Abramson, S., Bruyère, O., Clegg, D., Herrero-Beaumont, G., Maheu, E., Moskowitz, R., Pavelka, K., & Reginster, J.-Y. (October 2006). Commentary: osteoarthritis of the knee and glucosamine. Osteoarthritis and Cartilage, 14 (10), 963-966. doi:10.1016/j.joca.2006.06.010

Bruyère, O. (31 August 2006). Relations entre augmentation de la densité minérale osseuse et la diminution du risque fracturaire. Paper presented at Quatrième PROTELOS International Advisory Board, Paris, France.

Bruyère, O., Collette, J., Kothari, M., Zaim, S., White, D., Genant, H., Peterfy, C., Burlet, N., Ethgen, D., Montague, T., Dabrowski, C., & Reginster, J.-Y. (August 2006). Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Annals of the Rheumatic Diseases, 65 (8), 1050-1054. doi:10.1136/ard.2005.045914

Bruyère, O., Reginster, J.-Y., Giacovelli, G., Barbetta, B., Rovati, L. C., & Pavelka, K. (July 2006). Clinical significance of the long-term symptom-modifying effects of glucosamine sulfate: comment on the article by Brandt and Mazzuca. Arthritis and Rheumatism, 54 (7), 2339-2341. doi:10.1002/art.21867

Bruyère, O., MALAISE, O., Neuprez, A., & Reginster, J.-Y. (June 2006). Young postmenopausal women have high prevalence of inadequate serum vitamin D levels: results of a European study. Osteoporosis International, 17 (Suppl.2), 56.

Bruyère, O., MALAISE, O., Neuprez, A., & Reginster, J.-Y. (June 2006). High prevalence of inadequate serum vitamind D levels in osteoporotic European postmenopausal women. Osteoporosis International, 17 (Suppl.2), 33-34.

MALAISE, O., Bruyère, O., Deroisy, R., Jupsin, I., & Reginster, J.-Y. (June 2006). Strontium Ranelate normalizes bone mineral density in osteopenic patients. Osteoporosis International, 17 (Suppl.2), 103.

Richy, F., Bruyère, O., Maassen, P., Pire, G., & Reginster, J.-Y. (June 2006). Self-reported versus measured prevalence of osteoporosis. An age-stratified analysis of its diagnostic coverage. Osteoporosis International, 17 (Suppl.2), 45-46.

Richy, F., Bruyère, O., Mawet, A., & Reginster, J.-Y. (June 2006). Prescription and coprescription patterns of bone-active substances among postmenopausal women. Osteoporosis International, 17 (Suppl.2), 60.

Bruyère, O., & Reginster, J.-Y. (April 2006). Assessment of structure-modifying drugs in osteoarthritis: surrogate or hard clinical end points? Future Rheumatology, 1 (2), 199-206. doi:10.2217/17460816.1.2.199

Bruyère, O., Delmas, P. D., Devogelaer, J.-P., Slosman, D. O., Albanese, C., & Reginster, J.-Y. (March 2006). Relations between increase in femoral neck bone mineral density and decrease in hip fracture incidence during treatment with strontium ranelate. Osteoporosis International, 17 (Suppl.1), 96.

Bruyère, O., Fardellone, P., Kaufman, J.-M., Adami, S., Torrijos, A., & Reginster, J.-Y. (March 2006). One-year increase in hip (hip or femoral neck) bone mineral density pridicts long-term (3 years) decrease in vertebral fracture incidence in patients treated with strontium ranelate. Osteoporosis International, 17 (Suppl.1), 96.

Bruyère, O., Giacovelli, G., Pavelka, K., Rovati, L., & Reginster, J.-Y. (March 2006). Effect of glucosamine sulfate on newly proposed/recommended clinical trial end-points in patients with knee osteoarthritis. Osteoporosis International, 17 (Suppl.1), 13.

Bruyère, O., Kothari, M., Peterfy, C., Zaim, S., White, D., Burlet, N., Richy, F., Ethgen, D., Montague, T., Dabrowski, C., Genant, H., & Reginster, J.-Y. (March 2006). Longitudinal study of magnetic resonance imaging and fixed-flexion radiography to assess progression of osteoarthritis of the knee. Osteoporosis International, 17 (Suppl.1), 85.

Bruyère, O., MALAISE, O., Neuprez, A., & Reginster, J.-Y. (March 2006). High prevalence of inadequate serum vitamind D levels in osteoporotic European postmenopausal women. Osteoporosis International, 17 (Suppl.1), 86.

Bruyère, O., MALAISE, O., Neuprez, A., & Reginster, J.-Y. (March 2006). Early postmenopausal women have high prevalence of inadequate serum vitamin D levels. Results of a European study. Osteoporosis International, 17 (Suppl.1), 85-86.

Bruyère, O., MALAISE, O., Neuprez, A., & Reginster, J.-Y. (March 2006). Calcium daily food intake in European post-menopausal women. Osteoporosis International, 17 (Suppl.1), 101.

Bruyère, O., Roux, C., Cannata, J. B., Rizzoli, R., Brixen, K., Brandi, M. L., & Reginster, J.-Y. (March 2006). Associations between increase in bone mineral density and decrease in clinical vertebral fracture incidence during a treatment with strontium ranelate. Osteoporosis International, 17 (Suppl.1), 8.

MALAISE, O., Bruyère, O., Deroisy, R., Jupsin, I., & Reginster, J.-Y. (March 2006). Strontium Ranelate normalizes bone mineral density in osteopenic patients. Osteoporosis International, 17 (Suppl.1), 63.

Reginster, J.-Y., Richy, F., & Bruyère, O. (March 2006). Activite antalgique de la glucosamine dans l'arthrose: quoi de neuf en 2006? Revue Médicale de Liège, 61 (3), 169-72.

Richy, F., Bruyère, O., Maassen, P., Pire, G., & Reginster, J.-Y. (March 2006). Self-reported versus measured prevalence of osteoporosis. An age-stratified analysis of its diagnostic coverage. Osteoporosis International, 17 (Suppl.1), 93-94.

Richy, F., Bruyère, O., Mawet, A., & Reginster, J.-Y. (March 2006). Prescription and coprescription patterns of bone-active substances among postmenopausal women. Osteoporosis International, 17 (Suppl.1), 93.

Bruyère, O. (2006). Adose a day keeps the fractures away...but a dose a month is just as good. Eprint/Working paper retrieved from https://orbi.uliege.be/2268/94013.

Reginster, J.-Y., & Bruyère, O. (2006). Symptomatische effecten van de glucosamine bij artrose. Wat onthouden we uit de nieuwe Europese (GUIDE) en Noord-Amerikaanse (GAIT) studies ? Medi-Sfeer, 271, 15-17.

Reginster, J.-Y., & Bruyère, O. (2006). Symptomatische effecten van de glucosamine bij artrose. Wat onthouden we uit de nieuwe Europese (GUIDE) en Noord-Amerikaanse (GAIT) studies? Ortho-Rhumato, 4, 56-58.

Reginster, J.-Y., & Bruyère, O. (2006). Effets symptomatiques de la glucosamine dans l’arthrose. Que retenir des nouvelles études européenne (GUIDE) et nord-américaine (GAIT) ? Medi-Sphere, 271, 15-17.

Reginster, J.-Y., & Bruyère, O. (2006). Effets symptomatiques de la glucosamine dans l’arthrose. Que dire des nouvelles études européenne (GUIDE) et américaine (GAIT) ? Ortho-Rhumato, 4, 56-58.

Reginster, J.-Y., & Bruyère, O. (2006). Effets symptomatiques de la glucosamine dans l’arthrose. Pharma-Sphère, 110, 26-28.

Bruyère, O. (06 December 2005). Qualité des travaux de fin d'études. Paper presented at Réunion pédagogique de la Haute Ecole André Vésale, Liège, Belgium.

Bruyère, O., Richy, F., & Reginster, J.-Y. (December 2005). Three year joint space narrowing predicts long term incidence of knee surgery in patients with osteoarthritis: an eight year prospective follow up study. Annals of the Rheumatic Diseases, 64 (12), 1727-1730. doi:10.1136/ard.2005.037309

Kothari, M., Bruyère, O., COLLETTE, J., Peterfy, C., Zaim, S., White, D., Burlet, N., Ethgen, D. J., Montague, T., Dabrowski, C., Reginster, J.-Y., & Genant, H. K. (September 2005). Magnetic Resonance Imaging and biochemical markers of osteoarthritis of the knee. Arthritis and Rheumatism, 52 (number 9 (suppl.)), 71.

Kothari, M., Peterfy, C., Bruyère, O., Zaim, S., White, D., Burlet, N., Ethgen, D. J., Montague, T., Dabrowski, C., Reginster, J.-Y., & Genant, H. K. (September 2005). Longitudinal study of magnetic resonance imaging and fixed-flexion radiography to assess progression of osteoarthritis of the knee. Arthritis and Rheumatism, 52 (number 9 (suppl.)), 65.

Richy, F., Bruyère, O., Maassen, P., Pire, G., & Reginster, J.-Y. (September 2005). Self-reported versus measured prevalence of osteoporosis. An age-stratified analysis of its diagnostic coverage. Arthritis and Rheumatism, 52 (number 9 (suppl.)), 228-229.

Jupsin, I., Collette, J., Henrotin, Y., Bruyère, O., Sarlet, N., & Reginster, J.-Y. (April 2005). Strontium Ranelate (Fujisawa/Servier). Current Opinion in Investigational Drugs, 6 (4), 435-44.

Altman, R. D., Abadie, E., Avouac, B., Bouvenot, G., Branco, J., Bruyère, O., Calvo, G., Devogelaer, J.-P., Dreiser, R. L., Herrero-Beaumont, G., Kahan, A., Kreutz, G., Laslop, A., Lemmel, E. M., Menkes, C., Pavelka, K., Van De Putte, L., Vanhaelst, L., & Reginster, J.-Y. (March 2005). Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis. Osteoporosis International, 16 (Suppl.3), 10. doi:10.1016/j.joca.2004.10.012

Bruyère, O., COLLETTE, J., Kothari, M., Zaim, S., White, D., Peterfy, C., Burlet, N., Ethgen, D., Montague, T., & Reginster, J.-Y. (March 2005). Baseline hyaluronic acid measurement predicts one-year changes in knee magnetic resonance imaging global score (WORMS) in patients with knee osteoarthritis. Osteoporosis International, 16 (Suppl.3), 47.

Bruyère, O., Kothari, M., Zaim, S., White, D., Peterfy, C., Burlet, N., Ethgen, D., Montague, T., & Reginster, J.-Y. (March 2005). Knee whole-organ MRI score (WORMS) as a surrogate marker for X-ray joint space narrowing. Osteoporosis International, 16 (Suppl.3), 6.

Bruyère, O., Kothari, M., Zaim, S., White, D., Peterfy, C., Genant, H. K., Ethgen, D., Montague, T., Burlet, N., LEONORI, L., & Reginster, J.-Y. (March 2005). One-year progression of knee osteoarthritis: correlations between X-Rays and magnetic resonance imaging changes. Osteoporosis International, 16 (Suppl.3), 46-47.

Bruyère, O., Kothari, M., Zaim, S., White, D., Peterfy, C., Genant, H. K., Ethgen, D., Montague, T., Burlet, N., Richy, F., & Reginster, J.-Y. (March 2005). Femoro-tibial joint space width, assessed by standard X-Ray, is associated with tibial cartilage volume and thickness, assessed by magnetic resonance imaging. Osteoporosis International, 16 (Suppl.3), 46.

Bruyère, O., Pavelka, K., Richy, F., Giacovelli, G., Rovati, L. C., & Reginster, J.-Y. (March 2005). Responders to glucosamine sulfate in knee osteoarthritis. Osteoporosis International, 16 (Suppl.3), 77.

Bruyère, O., Richy, F., & Reginster, J.-Y. (March 2005). Three-year joint space narrowing predicts long-term incidence of knee surgery in patients with osteoarthritis: an 8-year prospective follow-up study. Osteoporosis International, 16 (Suppl.3), 77. doi:10.1136/ard.2005.037309

Reginster, J.-Y., Richy, F., & Bruyère, O. (March 2005). A critical analysis of the efficacy of estrogens on spinal and non-spinal fracture reduction. Osteoporosis International, 16 (Suppl.3), 47.

Richy, F., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (March 2005). Screening for osteoporosis: systematic DXA or pre-screening with questionnaires? An economic point of view. Osteoporosis International, 16 (Suppl.3), 101.

Richy, F., Schacht, E., Bruyère, O., Ethgen, O., Gourlay, M., & Reginster, J.-Y. (March 2005). Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: A comparative meta-analysis. Calcified Tissue International, 76 (3), 176-186. doi:10.1007/s00223-004-0005-4

Richy, F., Schacht, E., Bruyère, O., Ethgen, O., Gourlay, M., & Reginster, J.-Y. (March 2005). An indirect comparison of the efficacies of vitamin D and its hydroxylated analogs in postmenopausal and corticosteroid-induced osteoporosis. Osteoporosis International, 16 (Suppl.3), 29.

Bruyère, O., Wuidart, M. A., Di Palma, E., Gourlay, M., Ethgen, O., Richy, F., & Reginster, J.-Y. (February 2005). Controlled whole body vibration to decrease fall risk and improve health-related quality of life of nursing home residents. Archives of Physical Medicine and Rehabilitation, 86 (2), 303-307. doi:10.1016/j.apmr.2004.05.019

Altman, R. D., Abadie, E., Avouac, B., Bouvenot, G., Branco, J., Bruyère, O., Calvo, G., Devogelaer, J. P., Dreiser, R. L., Herrero-Beaumont, G., Kahan, A., Kreutz, G., Laslop, A., Lemmel, E. M., Menkes, C. J., Pavelka, K., Van De Putte, L., Vanhaelst, L., & Reginster, J.-Y. (January 2005). Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis. Osteoarthritis and Cartilage, 13 (1), 13-19. doi:10.1016/j.joca.2004.10.012

Bruyère, O. (2005). Complément d'épidémiologie, PartimI: techniques approfondies d'épidémiologie interventionnelle; PartimII: techniques économétriques appliquées à l'épidémiologie; PartimIII: techniques quantitatives en médecine factuelles. (ULiège - Université de Liège).

Bruyère, O., Edwards, J., & Reginster, J.-Y. (2005). what are the effects of treatments to prevent fractures in postmenopausal osteoporosis. BMJ Clinical evidence, 13, 325-327.

Bruyère, O., Edwards, J., & Reginster, J.-Y. (2005). Fracture prevention in postmenopausal women. Clinical Evidence, 13, 1419-1434.

Giacovelli, G., Bruyère, O., Barbetta, B., Pavelka, K., Reginster, J.-Y., & Rovati, L. C. (2005). Clinical relevance of pain and function outcomes in glucosamine sulfate long-term trials. Osteoarthritis and Cartilage, 13 (A), 69.

Reginster, J.-Y., Bruyère, O., Fraikin, G., & Henrotin, Y. (2005). Current Concepts in the Therapeutic Management of Osteoarthritis with Glucosamine. Bulletin. Hospital for Joint Diseases, 63 (1-2), 31-36.

Reginster, J.-Y., LECART, M.-P., Bruyère, O., & Burlet, N. (2005). Glucosamine sulphate in osteoarthritis: from symptoms to structure modification. Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry, 4, 217-220. doi:10.2174/1568014054065212

Lecart, M.-P., Bruyère, O., & Reginster, J.-Y. (December 2004). Combination/Sequential Therapy in Osteoporosis. Current Osteoporosis Reports, 2 (4), 123-30. doi:10.1007/s11914-996-0011-8

Richy, F., Ethgen, O., Bruyère, O., Mawet, A., & Reginster, J.-Y. (December 2004). Primary prevention of osteoporosis: Mass screening scenario or prescreening with questionnaires? An economic perspective. Journal of Bone and Mineral Research, 19 (12), 1955-1960. doi:10.1359/JBMR.040903

Richy, F., Deceulaer, F., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (November 2004). Development and validation of the ORACLE score to predict risk of osteoporosis. Mayo Clinic Proceedings, 79 (11), 1402-1408. doi:10.4065/79.11.1402

Bruyère, O. (2004). Approche épidémiologique de l'identification des déterminants de la progression structurelle et clinique de l'arthrose. Contribution à son approche thérapeutique. Unpublished doctoral thesis, ULiège - Université de Liège.
Jury: .

Richy, F., Bruyère, O., Ethgen, O., Rabenda, V., Bouvenot, G., Audran, M., Herrero-Beaumont, G., Moore, A., Eliakim, R., Haim, M., & Reginster, J.-Y. (July 2004). Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach [letter to the editor]. Annals of the Rheumatic Diseases, 63 (7), 759-766. doi:10.1136/ard.2003.015925

Bruyère, O. (15 May 2004). Effects of Whole body Vibration in the elderly.

DeCeulaer, F., Hanssens, L., Tancredi, A., Bruyère, O., Richy, F., Pire, G., Maassen, P., & Reginster, J.-Y. (May 2004). Evaluation of the osteoporosis self-assessment tool (OST) as a screening test for osteoporosis and osteopenia in men. Osteoporosis International, 15 (Suppl.1), 54.

Ethgen, O., Bruyère, O., Richy, F., Dardennes, C., & Reginster, J.-Y. (May 2004). Health-related quality of life in total hip and total knee arthroplasty - A qualitative and systematic review of the literature. Journal of Bone and Joint Surgery. American Volume, 86 (5), 963-974. doi:10.2106/00004623-200405000-00012

Ethgen, O., Tancredi, A., Jacques, J., Bruyère, O., Richy, F., & Reginster, J.-Y. (May 2004). Do patients with osteoporotic hip fracture recover their initial health-related quality of life? Osteoporosis International, 15 (Suppl.1), 50.

Hanssens, L. C., De Ceulaer, F., Tancredi, A., Bruyère, O., Richy, F., Halkin, V., Pire, G., Maassen, P., & Reginster, J.-Y. (May 2004). Evaluation of prevalence of osteoporosis and osteopenia in men presenting at multiple risk detection campaign. Osteoporosis International, 15 (Suppl.1), 54.

Hanssens, L., Tancredi, A., DeCeulaer, F., Bruyère, O., Zegels, B., Halkin, V., Pire, G., Maassen, P., & Reginster, J.-Y. (May 2004). Evaluation of the relationship between IGF-1, IGF-BP3, BMD and age in men presenting at a multiple risk detection campaign. Osteoporosis International, 15 (Suppl.1), 48-49.

Richy, F., Gourlay, M., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (May 2004). BMD in men: which normative data? Osteoporosis International, 15 (Suppl.1), 54.

Abadie, E., Ethgen, D., Avouac, B., Bouvenot, G., Branco, J., Bruyère, O., Calvo, G., Devogelaer, J.-P., Dreiser, R. L., Herrero-Beaumont, G., Kahan, A., Kreutz, G., Laslop, A., Lemmel, E. M., Nuki, G., Van de Putte, L., Vanhaelst, L., & Reginster, J.-Y. (April 2004). Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis. Osteoarthritis and Cartilage, 12 (4), 263-268. doi:10.1016/j.joca.2004.01.006

Richy, F., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (April 2004). Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporosis International, 15 (4), 301-310. doi:10.1007/s00198-003-1570-5

Ethgen, O., Vanparijs, P., Delhalle, S., Rosant, S., Bruyère, O., & Reginster, J.-Y. (March 2004). Social support and health-related quality of life in hip and knee osteoarthritis. Quality of Life Research, 13 (2), 321-330. doi:10.1023/B:QURE.0000018492.40262.d1

Reginster, J.-Y., Sarkar, S., Zegels, B., Henrotin, Y., Bruyère, O., Agnusdei, D., & Collette, J. (February 2004). Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk. BONE, 34 (2), 344-351. doi:10.1016/j.bone.2003.10.004

Bruyère, O. (2004). Techniques Spéciales de la Personne Agée. (Haute Ecole de la Province de Liège André Vésale, Techniques Spéciales de la Personne Agée).

Bruyère, O., Pavelka, K., Richy, F., Giacovelli, G., Rovati, L. C., & Reginster, J.-Y. (2004). Responders to glucosamine sulfate in knee osteoarthritis. Arthritis and Rheumatism, 50 (suppl.1), 29.

Bruyère, O., Pavelka, K., Richy, F., Giacovelli, G., Rovati, L. C., & Reginster, J.-Y. (2004). Responders to glucosamine sulfate in knee osteoarthritis. Osteoporosis International, 12 (SB), 76.

Bruyère, O., Pavelka, K., Rovati, L. C., Deroisy, R., Olejarova, M., Gatterova, J., Giacovelli, G., & Reginster, J.-Y. (2004). Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies. Menopause, 11 (2), 138-143. doi:10.1097/01.GME.0000087983.28957.5D

Bruyère, O., Richy, F., & Reginster, J.-Y. (2004). Minimal joint space narrowing is a better predictor of the need for surgery than mean joint space narrowing : an 8-year prospective followup study in knee osteoarthritis. Osteoarthritis and Cartilage, 12 (SB), 54.

Christgau, S., Henrotin, Y., Tanko, L. B., Rovati, L. C., Collette, J., Bruyère, O., Deroisy, R., & Reginster, J.-Y. (2004). Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate. Clinical and Experimental Rheumatology, 22 (1, JAN-FEB), 36-42.

REGINSTER, J.-Y., Richy, F., & Bruyère, O. (2004). A critical analysis of the efficacy of estrogens on spinal and non-spinal fracture reduction. Reproduction Humaine et Hormones, XVII (5), 419-423.

Richy, F., Ethgen, O., Bruyère, O., deceulaer, F., & Reginster, J.-Y. (2004). From sample size to effect-size : small study effect investigation (SSEi). Internet Journal of Epidemiology, 1 (2).

Richy, F., Gourlay, M., Ross, P. D., Sen, S. S., Radican, L., De Ceulaer, F., Ben Sedrine, W., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (January 2004). Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium. QJM: Monthly Journal of the Association of Physicians, 97 (1), 39-46. doi:10.1093/qjmed/hch002

Abadie, E., Avouac, B., Bouvenot, G., Branco, J., Bruyère, O., Calvo, G., Devogelaer, J.-P., Dieppe, P., Dreiser, R. L., Herrero-Beaumont, G., Kreutz, G., Laslop, A., Lemmel, E. M., Nuki, G., Van de Putte, L., & Reginster, J.-Y. (November 2003). Do new methods of investigation allow faster assessment of drugs efficacy in osteoarthritis? Osteoporosis International, 14 (Suppl. 7), 2.

Bruyère, O., Compère, S., Gathy, C., Rovati, L. C., Giacovelli, G., Deroisy, R., & Reginster, J.-Y. (November 2003). Five-year follow-up patients issued from a previous 3-year randomised, controlled trial of glucosamine sulfate in knee osteoarthritis. Osteoporosis International, 14 (Suppl 7), 9.

Bruyère, O., Pavelka, K., Rovati, L. C., Deroisy, R., Olejarova, M., Gatterova, J., Giacovelli, G., & Reginster, J.-Y. (November 2003). Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two large, randomised, placebo-controlled, double-blind, 3-year studies. Osteoporosis International, 14 (Suppl. 7), 62.

Bruyère, O., Wuidart, M. A., di Palma, E., Gourlay, M., Ethgen, O., Richy, F., & Reginster, J.-Y. (November 2003). Controlled whole body vibration to decrease fall risk and improve health related quality of life in elderly patients. Osteoporosis International, 14 (Suppl. 7), 63.

De Ceulaer, F., Hanssens, L., Tancredi, A., Bruyère, O., Richy, F., Pire, G., Maassen, P., & Reginster, J.-Y. (November 2003). Evaluation of the osteoporosis self-assessment tool (OST) as a screening test for osteoporosis and osteopenia in men. Osteoporosis International, 14 (Suppl. 7), 93.

Ethgen, O., Rabenda, V., Bruyère, O., & Reginster, J.-Y. (November 2003). Projecting the prevalence of osteoarthritis and osteoporosis over the five forthcoming decades: their increasing impact on public health. Osteoporosis International, 14 (Suppl. 7), 65-66.

Ethgen, O., Tancredi, A., Brugneaux, C., Richy, F., Bruyère, O., & Reginster, J.-Y. (November 2003). Prospective evaluation of health-related quality of life in total hip and knee arthroplasties. Osteoporosis International, 14 (Suppl. 7), 66.

Ethgen, O., Tancredi, A., Jacques, J., Bruyère, O., Richy, F., & Reginster, J.-Y. (November 2003). Do patient with osteoporotic hip fracture recover their initial health-related quality of life? Osteoporosis International, 14 (Suppl. 7), 66.

Hanssens, L., De Ceulaer, F., Tancredi, A., Bruyère, O., Richy, F., Halkin, V., Pire, G., Maassen, P., & Reginster, J.-Y. (November 2003). Evaluation of prevalence of osteoporosis and osteopenia in men presenting at multiple risk detection campaign. Osteoporosis International, 14 (Suppl. 7), 90.

Hanssens, L., Tancredi, A., De Ceulaer, F., Bruyère, O., Zegels, B., Halkin, V., Pire, G., Maassen, P., & Reginster, J.-Y. (November 2003). Evaluation of the relationship between IGF-I, IGF-BP3, BMD and age in men presenting at a multiple risk detection campaign. Osteoporosis International, 14 (Suppl. 7), 90-S91.

Pavelka, K., Bruyère, O., Rovati, L. C., Olejarova, M., Giacovelli, G., & Reginster, J.-Y. (November 2003). Relief in mild-to-moderate pain is not a confounder in joint space narrowing assessment of full extension knee radiographs in recent osteoarthritis structure modifying drug trials. Osteoporosis International, 14 (Suppl. 7), 62-63. doi:10.1016/S1063-4584(03)00166-3

Richy, F., Bruyère, O., Ethgen, O., Rabenda, V., Bouvenot, G., Audran, M., Herrero Beaumont Cuenca, G., Moore, A., Eliakim, R., Van De Putte, L., Haim, M., & Reginster, J.-Y. (November 2003). Time-dependent risk of gastrointestinal complications induced by NSAIDS use: a consensus statement using meta-analytic approach. Osteoporosis International, 14 (Suppl. 7), 9.

Richy, F., Bruyère, O., Ethgen, O., Rabenda, V., Deceulaer, F., Bonvenot, G., Audran, M., Herrero-Beaumont Cuenca, G., Moore, A., Eliakim, R., Van De Putte, L., Haim, M., & Reginster, J.-Y. (November 2003). Time-dependent assessment of the gastrointestinal risk induced by low-dose aspirin intake: a meta-analysis. Osteoporosis International, 14 (Suppl. 7), 95.

Richy, F., Gourlay, M., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (November 2003). Rational to use OSIRIS® (osteoporosis index of risk) to prescreen for osteoporosis in the general population. Osteoporosis International, 14 (Suppl. 7), 67-68.

Richy, F., Gourlay, M., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (November 2003). BMD in men: which normative data? Osteoporosis International, 14 (Suppl. 7), 66-67.

Richy, F., Gourlay, M., Neuprez, A., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (November 2003). Bone mineral density and vertebral fractures in women who have discontinued hormone replacement therapy: a retrospective population-based study. Osteoporosis International, 14 (Suppl. 7), 67.

Richy, F., Pire, G., Maassen, P., Ethgen, O., Gourlay, M., Bruyère, O., & Reginster, J.-Y. (November 2003). Evaluation of an osteoporosis screening campaign in the general population: does misclassification by screening test impact on the perception of the campaign? Osteoporosis International, 14 (Suppl. 7), 68.

Richy, F., Pire, G., Maassen, P., Gourlay, M., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (November 2003). Evaluation of a campaign for osteoporosis screening in the general population: what is the follow-up given by general practitioners to a positive screening result? Osteoporosis International, 14 (Suppl. 7), 67.

Bruyère, O. (18 October 2003). Long term clinical experience with glucosamine sulfate long-term clinical trials. Paper presented at 59th National Congress of Orthopaedic Surgery and Traumatology, Athens, Greece.

Bruyère, O., Compere, S., Rovati, L. C., Giacovelli, G., DEROISY, R., & Reginster, J.-Y. (October 2003). Five-year follow-up of patients from a previous 3-year randomised, controlled trial of glucosamine sulfate in knee osteoarthritis. Osteoarthritis and Cartilage, 11 (Suppl.1), 10-11.

Pavelka, K., Bruyère, O., Rovati, L. C., Olejarova, M., Giacovelli, G., & Reginster, J.-Y. (October 2003). Relief in mild-to-moderate pain is not a confounder in joint space narrowing assessment of full extension knee radiographs in recent osteoarthritis structure-modifying drug trials. Osteoarthritis and Cartilage, 11 (10), 730-737. doi:10.1016/S1063-4584(03)00166-3

Bruyère, O. (11 September 2003). Les pathologies osteo-articulaires : approche pluridisciplinaire. Paper presented at Colloque de l'Association des Licenciés en Sciences de la Santé Publique, Liège, Belgium.

Bruyère, O., Compere, S., Rovati, L. C., Giacovelli, G., DEROISY, R., & Reginster, J.-Y. (September 2003). Five-year follow-up of patients from a previous 3-year randomised, controlled trial of glucosamine sulfate in knee osteoarthritis. Arthritis and Rheumatism, 48 (number 9 (suppl.)), 80.

Bruyère, O., Wuidart, M.-A., Di Palma, E., & Reginster, J.-Y. (September 2003). Controlled whole body vibrations improve health related quality of life in elderly patients. Arthritis and Rheumatism, 48 (9, Suppl. S), 502.

Reginster, J.-Y., Bruyère, O., Lecart, M.-P., & Henrotin, Y. (September 2003). Naturocetic (glucosamine and chondroitin sulfate) compounds as structure-modifying drugs in the treatment of osteoarthritis. Current Opinion in Rheumatology, 15, 651-655. doi:10.1097/00002281-200309000-00022

Richy, F. Y., Bruyère, O., Ethgen, O., Cucherat, M., & Reginster, J.-Y. (September 2003). Structural and symptomatic efficacy of glucosamine and chondroitine sulfate in osteoarthritis: a comprehensive meta-analysis. Arthritis and Rheumatism, 48 (number 9 (suppl.)), 214.

Reginster, J.-Y., Bruyère, O., & Henrotin, Y. (August 2003). New perspectives in the management of osteoarthritis. Structure modification: Facts or fantasy? Journal of Rheumatology. Supplement, 67 (Suppl. 67), 14-20.

Richy, F., Bruyère, O., Ethgen, O., Cucherat, M., Henrotin, Y., & Reginster, J.-Y. (14 July 2003). Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis - A comprehensive meta-analysis. Archives of Internal Medicine, 163 (13), 1514-1522. doi:10.1001/archinte.163.13.1514

Bruyère, O., COLLETTE, J., Ethgen, O., Rovati, L. C., Giacovelli, G., Henrotin, Y., Seidel, L., & Reginster, J.-Y. (May 2003). Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. Journal of Rheumatology, 30 (5), 1043-50.

Bruyère, O., Dardenne, C.-B., Lejeune, E., Zegels, B., Pahaut, A., Richy, F., Seidel, L., Ethgen, O., Henrotin, Y., & Reginster, J.-Y. (May 2003). Subchondral tibial bone mineral density predicts future joint space narrowing at the medial femoro-tibial compartment in patients with knee osteoarthritis. BONE, 32 (5), 541-545. doi:10.1016/S8756-3282(03)00059-0

Bruyère, O., Collette, J., Delmas, P., Rouillon, A., Roux, C., Seidel, L., Richy, F., & Reginster, J.-Y. (25 April 2003). Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women. Maturitas, 44 (4), 259-265. doi:10.1016/S0378-5122(03)00042-2

Bruyère, O., Henrotin, Y., Honore, A., Rovati, L. C., Seidel, L., Dardenne, C.-B., & Reginster, J.-Y. (April 2003). Impact of the joint space width measurement method on the design of knee osteoarthritis studies. Aging Clinical and Experimental Research, 15 (2), 136-41. doi:10.1007/BF03324491

Richy, F., Bousquet, J., Ehrlich, G. E., Meunier, P. J., Israel, E., Morii, H., Devogelaer, J.-P., Peel, N., Haim, M., Bruyère, O., & Reginster, J.-Y. (March 2003). Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporosis International, 14 (3), 179-190. doi:10.1007/s00198-003-1398-z

Reginster, J.-Y., Kvasz, A., Bruyère, O., & Henrotin, Y. (February 2003). is there any rationale for prescribing hormone replacement therapy (HTR) to prevent or to treat osteoarthritis? Osteoarthritis and Cartilage, 11 (2), 87-91. doi:10.1053/joca.2002.0872

Bruyère, O. (2003). Techniques approfondies d'épidémiologie interventionnelle. (ULiège - Université de Liège, Compléments d'épidémiologie).

Bruyère, O., Edwards, J., & Reginster, J.-Y. (2003). Fracture prevention in postmenopausal women. Clinical Evidence, 9, 1186-202.

Bruyère, O., Honore, A., Ethgen, O., Rovati, L. C., Giacovelli, G., Henrotin, Y., Seidel, L., & Reginster, J.-Y. (January 2003). Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthritis and Cartilage, 11 (1), 1-5. doi:10.1053/joca.2002.0848

Bruyère, O., Collette, J., Lejeune, E., Ethgen, O., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (November 2002). Correlation between biochemical markers of bone and cartilage metabolism and structural progression of hand osteoarthritis. A three-year prospective study. Osteoporosis International, 13 (Suppl.3), 51.

Bruyère, O., Collette, J., Lejeune, E., Ethgen, O., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (November 2002). Baseline measurement of urine pyridinoline and deoxypyridinoline is correlated with 3-year hip osteoarthritis progression. Osteoporosis International, 13 (Suppl.3), 51.

Bruyère, O., Ethgen, O., Lejeune, E., Giacovelli, G., Richy, F., Seidel, L., Henrotin, Y., Rovati, L. C., & Reginster, J.-Y. (November 2002). Clinical severity of knee osteoarthritis poorly predicts long-term radiographic outcomes. Osteoporosis International, 13 (Suppl.3), 51.

Bruyère, O., Lambert, V., Dardenne, C., Lejeune, E., Zegels, B., Pahaut, A., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (November 2002). Subchondral tibial bone mineral density predicts joint space narrowing at the medial femoro-tibial compartment in patients with knee osteoarthritis. Osteoporosis International, 13 (Suppl.3), 51-52.

Ethgen, O., Bruyère, O., Richy, F., Paul, I., Gosset, C., & Reginster, J.-Y. (November 2002). Burden of chronic osteoarticular disorders compared to others commonly reported chronic conditions. Results from a large health interview survey of Belgian individuals aged over 45 years. Osteoporosis International, 13 (Suppl.3), 49-50.

Ethgen, O., Bruyère, O., Tancredi, A., Richy, F., De Ceulaer, F., & Reginster, J.-Y. (November 2002). Patient health profiles in osteoarthritis: is there a difference according to follow-up pattern? Results from the Belgian National Health Interview Survey. Osteoporosis International, 13 (Suppl.3), 49.

Ethgen, O., Richy, F., De Ceulaer, F., Bruyère, O., & Reginster, J.-Y. (November 2002). Musculoskeletal disorders in a time demographic changes: a real challenge for the future in Europe and Northern America. Osteoporosis International, 13 (Suppl.3), 48-49.

Kvasz, A., Bruyère, O., Neuprez, A., & Reginster, J.-Y. (November 2002). Is there any rationale for prescribing hormone replacement therapy (HRT) to prevent or to treat osteoarthritis? Osteoporosis International, 13 (Suppl.3), 59.

Pavelka, K., Rovati, L. C., Gatterova, J., Bruyère, O., Deroisy, R., Machacek, S., Giacovelli, G., & Reginster, J.-Y. (November 2002). Pain relief is not a confounder in joint space narrowing assessment of full extension knee radiographs in osteoarthritis structure-modifying drug trials. Osteoporosis International, 13 (Suppl.3), 19-20.

Richy, F., Bousquet, J., Devogelaer, J.-P., Ehrlich, G., Meunier, P. J., Peel, N., Morii, H., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (November 2002). Inhaled corticosteroids effects on bone in asthmatic and COPD patients: what is the evidence? Osteoporosis International, 13 (Suppl.3), 22.

Richy, F., Bruyère, O., Ethgen, O., Cucherat, M., Henrotin, Y., & Reginster, J.-Y. (November 2002). Structural and symptomatic efficacy of glucosamine and chondroitine sulfate in osteoarthrits: a comprehensive meta-analysis. Osteoporosis International, 13 (Suppl.3), 55-56.

Bruyère, O., COLLETTE, J., Lejeune, E., Ethgen, O., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (September 2002). Correlation between biochemical markers of bone and cartilage metabolism and structural progression of hand osteoarthritis. A three year prospective study. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 152-3.

Bruyère, O., COLLETTE, J., Lejeune, E., Richy, F., Ethgen, O., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (September 2002). Baseline measurement of urine pyridinoline and deoxypyridinoline is correlated with 3-year hip osteoarthritis progression. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 149.

Bruyère, O., Ethgen, O., Lejeune, E., Giacovelli, G., Richy, F., Seidel, L., Henrotin, Y., Rovati, L., & Reginster, J.-Y. (September 2002). Clinical severity of knee osteoarthritis poorly predicts long-term radiographic outcomes. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 153.

Bruyère, O., LAMBERT, V., Dardenne, C., Lejeune, E., Zegels, B., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (September 2002). Subchondral tibial bone mineral density predicts joint space narrowing at the medial femoro-tibial compartment in patients with knee osteoarthritis. Arthritis and Rheumatism, 16 (number 9 (suppl.)), 154.

Ethgen, O., Bruyère, O., Richy, F., Paul, I., Gosset, C., & Reginster, J.-Y. (September 2002). Health and economic burden of chronic osteoarticular disorders in the population aged over 45 years: a comparative analysis with other commonly reported chronic health dysfunctions. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 469.

Richy, F., Bousquet, J., Devogelaer, J.-P., Ehrlich, G., Meunier, P., Peel, N., Morii, H., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (September 2002). Meta-analysis of the effects of inhaled corticosteroids on bone in asthmatic and COPD patients. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 464.

Bruyère, O. (2002). Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Unpublished DEA/DES thesis, ULiège - Université de Liège.
Jury: .

Pavelka, K., Rovati, L. C., Gatterova, J., Bruyère, O., Deroisy, R., Machacek, S., Giacovelli, G., Gonzalez, C., & Reginster, J.-Y. (June 2002). Pain relief is not a confounder in joint space narrowing assessment of full extension knee radiographs. Annals of the Rheumatic Diseases, 61 (Suppl.1), 118.

Reginster, J.-Y., Henrotin, Y., Bruyère, O., Gonzalez, C., Giacovelli, G., & Rovati, L. C. (June 2002). Radiographic severity of knee osteoarthritis is highly correlated with future progression of the disease. Annals of the Rheumatic Diseases, 61 (Suppl.1), 124.

Reginster, J.-Y., Henrotin, Y., Bruyère, O., Gonzalez, C., Giacovelli, G., & Rovati, L. C. (June 2002). Joint space narrowing is poorly correlated with symptoms worsening in knee-osteoarthritis: results from the prospective follow-up of 106, placebo-treated patients for three years. Annals of the Rheumatic Diseases, 61 (Suppl.1), 121.

Bruyère, O. (2002). Techniques approfondies d'épidémiologie interventionnelle. (ULiège - Université de Liège).

Bruyère, O. (2002). Evaluation de la qualité. (Haute Ecole de la Province de Liège André Vésale, Evaluation de la qualité).

Bruyère, O., Edwards, J., & Reginster, J.-Y. (2002). Fracture prevention in postmenopausal women. Clinical Evidence, 8, 1089-102.

Bruyère, O., Honore, A., Rovati, L. C., Giacovelli, G., Henrotin, Y., Seidel, L., & Reginster, J.-Y. (2002). Radiologic features poorly predict clinical outcomes in knee osteoarthritis. Scandinavian Journal of Rheumatology, 31 (1), 13-6. doi:10.1080/030097402317255309

Bruyère, O., Stephaniak, N., & Reginster, J.-Y. (2002). Biochemical markers in glucocorticoid-induced osteoporosis. In A. Giustina, A. Angeli, E. Canalis, & F. Manelli (Eds.), Glucocorticoid-induced osteoporosis (pp. 30) 49-59). Basel, Switzerland: Karger. doi:10.1159/000061072

Halkin, V., Bruyère, O., & Reginster, J.-Y. (2002). Osteoporosis in the very elderly. Medicographia, 24 (4), 316-321.

Pavelka, K., Rovati, L. C., Gatterova, J., Bruyère, O., DEROISY, R., Machacek, S., Giacovelli, G., Gonzalez, C., & Reginster, J.-Y. (2002). Pain relief is not a confounder in joint space narrowing assessment of full extension knee radiographs. Osteoarthritis and Cartilage, 10 (SA), 16-17.

Reginster, J.-Y., Kvasz, A., Bruyère, O., & Henrotin, Y. (2002). Glucosamine and chondroitine sulfate. In Anti Aging Medizin 2001 : Konferenz der German Society of Anti-Aging Medicine (pp. 97-104). Berlin, Germany: Congres Compact Publ.

Bruyère, O. (2001). Méthodologie de l'essai thérapeutique. (ULiège - Université de Liège).

Bruyère, O., COLLETTE, J., Delmas, P., Rouillon, A., Roux, C., Seidel, L., & Reginster, J.-Y. (2001). Early (3-month) changes in serum osteocalcin and urinary C-telopeptide of type I collagen could be of interest to identify postmenopausal osteoporotic women with the highest risk to present new vertevral deformities. Clinical Rheumatology, 5 (Suppl.1), 426.

Bruyère, O., COLLETTE, J., Delmas, P., Rouillon, A., Roux, C., Seidel, L., & Reginster, J.-Y. (2001). Early (3-month) changes in serum osteocalcin and urinary C-telopeptide of type I collagen could be of interest to identify postmenopausal osteoporotic women with the highest risk to present new vertebral deformities. Arthritis and Rheumatism, 44 (Suppl.1), 257.

Bruyère, O., COLLETTE, J., Delmas, P., Rouillon, A., Seidel, L., & Reginster, J.-Y. (2001). Interest of four biochemical markers of bone turnover in prediction of baseline and long-term (changes) of bone mineral density in postmenopausal osteoporotic women. Clinical Rheumatology, 5 (Suppl.1), 426.

Bruyère, O., Ethgen, O., Rovati, L. C., Giacovelli, G., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (2001). Radiographic severity of knee osteoarthrits is highly correlated with future progression of the disease. Osteoarthritis and Cartilage, 9 (Suppl.B), 44-45.

Bruyère, O., Ethgen, O., Rovati, L. C., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (2001). Radiographic severity of knee osteoarthrits is highly correlated with future progression of the disease. Clinical Rheumatology, 5 (Suppl.1), 412.

Bruyère, O., Henrotin, Y., Honoré, A., Rovati, L. C., Giacovelli, G., Seidel, L., & Reginster, J.-Y. (2001). Tibial subchondral sclerosis is significantly correlated with long-term (3-year) radiological progression of knee osteoarthritis. Osteoarthritis and Cartilage, 9 (Suppl.B), 23.

Bruyère, O., Henrotin, Y., Honoré, A., Rovati, L. C., Giacovelli, G., Seidel, L., & Reginster, J.-Y. (2001). Tibial subchondral sclerosis and femoral osteophytes are linked to symptomatic and structural severity of knee osteoarthritis. Osteoarthritis and Cartilage, 9 (Suppl.B), 22.

Bruyère, O., Henrotin, Y., Honoré, A., Rovati, L. C., Seidel, L., Dardenne, C.-B., & Reginster, J.-Y. (2001). Impact of joint space width measurement method on sample size calculation in knee osteoarthritis studies. Clinical Rheumatology, 5 (Suppl.1), 413.

Bruyère, O., Henrotin, Y., Honoré, A., Rovati, L. C., Seidel, L., & Reginster, J.-Y. (2001). Tibial subchondral sclerosis is significantly correlated with long-term (3-year) radiological progression of knee osteoarthritis. Arthritis and Rheumatism, 44 (Suppl.1), 139.

Bruyère, O., Henrotin, Y., Honoré, A., Rovati, L. C., Seidel, L., & Reginster, J.-Y. (2001). Tibial subchondral sclerosis is significantly correlated with long-term (3-year) radiological progression of knee osteoarthritis. Clinical Rheumatology, 5 (Suppl.1), 412.

Bruyère, O., Henrotin, Y., Honoré, A., Rovati, L. C., Seidel, L., & Reginster, J.-Y. (2001). Tibial subchondral sclerosis and femoral osteophytes are linked to symptomatic and structural severity of knee osteoarthritis. Clinical Rheumatology, 5 (Suppl.1), 411.

Bruyère, O., Lejeune, E., Dardenne, C.-B., Henrotin, Y., & Reginster, J.-Y. (2001). Relationship between subchondral tibial bone mineral density and joint space width at the medial femoro-tibial compartment in patients with knee osteoarthritis. Osteoarthritis and Cartilage, 9 (Suppl.B), 23.

Bruyère, O., Lejeune, E., Dardenne, C.-B., Henrotin, Y., & Reginster, J.-Y. (2001). Relationship between subchondral tibial bone mineral density and joint space width at the medial femoro-tibial compartment in patients with knee osteoarthritis. Clinical Rheumatology, 5 (Suppl.1), 411.

Bruyère, O., Lejeune, E., Dardenne, C.-B., Henrotin, Y., & Reginster, J.-Y. (2001). Relationship between subchondral tibial bone mineral density and joint space width at the medial femoro-tibial compartment in patients with knee osteoarthritis. Arthritis and Rheumatism, 44 (Suppl.1), 138.

Bruyère, O., & Reginster, J.-Y. (2001). Fracture prevention in postmenopausal women. Clinical Evidence, 6, 831-843.

Bruyère, O., & Reginster, J.-Y. (2001). Fracture prevention. Clinical Evidence, 5, 738-741.

Bruyère, O., Zegels, B., Dardenne, C.-B., Lejeune, E., Henrotin, Y., & Reginster, J.-Y. (2001). Measurement of the tibial subchondral bone mineral density: a potential tool for diagnosis and monitoring of knee osteoarthrits. Clinical Rheumatology, 5 (Suppl.1), 411.

Bruyère, O., Zegels, B., Dardenne, C.-B., Lejeune, E., Henrotin, Y., & Reginster, J.-Y. (2001). Measurement of the tibial subchondral bone mineral density: a potential tool for diagnosis and monitoring of knee osteoarthrits. Osteoarthritis and Cartilage, 9 (Suppl.B), 61.

Ethgen, O., Van Parijs, P., Delhalle, S., Rosant, S., Bruyère, O., & Reginster, J.-Y. (2001). Importance of social companionship in the determination of health-related quality of life in hip and knee osteoarthrits. Clinical Rheumatology, 5 (Suppl.1), 413.

Ethgen, O., Van Parijs, P., Delhalle, S., Rosant, S., Bruyère, O., & Reginster, J.-Y. (2001). Importance of social companionship in the determination of health-related quality of life in hip and knee osteoarthrits. Osteoarthritis and Cartilage, 9 (Suppl.B), 19-20.

Ethgen, O., Van Parijs, P., Delhalle, S., Rosant, S., Bruyère, O., & Reginster, J.-Y. (2001). Importance of social companionship in the determination of health-related quality of life in hip and knee osteoarthrits. Arthritis and Rheumatism, 44 (Suppl.1), 183.

Reginster, J.-Y., & Bruyère, O. (2001). HRT in the prevention and treatment of osteoporosis. In Jaarbook 2000 (pp. 157-166). Vlaamse Vereniging voor Obstetrie en Gynaecologie Publ.

Reginster, J.-Y., Bruyère, O., Rovati, L. C., Honoré, A., Giacovelli, G., Seidel, L., & Henrotin, Y. (2001). Radiologic features poorly predict clinical outcomes in knee osteoarthritis. Osteoarthritis and Cartilage, 9 (Suppl.B), 49.

Reginster, J.-Y., Bruyère, O., Rovati, L. C., Honoré, A., Seidel, L., & Henrotin, Y. (2001). Radiologic features poorly predict clinical outcomes in knee osteoarthritis. Clinical Rheumatology, 5 (Suppl.1), 412.

Reginster, J.-Y., COLLETTE, J., Bruyère, O., Rovati, L. C., Giacovelli, G., DEROISY, R., Seidel, L., & Henrotin, Y. (2001). Short term (1-year) changes in keratan sulfate levels predict long-term (3-year) radiological evolution of knee osteoarthritis in patients treated with glucosamine sulfate. Osteoarthritis and Cartilage, 9 (Suppl.B), 35.

Reginster, J.-Y., COLLETTE, J., Bruyère, O., Rovati, L. C., Giacovelli, G., DEROISY, R., Seidel, L., & Henrotin, Y. (2001). Short term (1-year) changes in keratan sulfate levels predict long-term (3-year) radiological evolution of knee osteoarthritis in patients treated with glucosamine sulfate. Arthritis and Rheumatism, 44 (Suppl.1), 139.

Reginster, J.-Y., COLLETTE, J., Zegels, B., Henrotin, Y., Bruyère, O., & Durez, P. (2001). Relationship between 1-year change in bone turnover marker PINP and 3-year vertebral fracture risk reduction with raloxifene therapy in postmenopausal women with osteoporosis: result from the MORE trial. Clinical Rheumatology, 5 (Suppl.1), 425.

Reginster, J.-Y., Deroisy, R., Rovati, L. C., Lee, R. L., Lejeune, E., Bruyère, O., Giacovelli, G., Henrotin, Y., Dacre, J. E., & Gosset, C. (January 2001). Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet, 357, 251-256. doi:10.1016/S0140-6736(00)03610-2

Reginster, J.-Y., Henrotin, Y., Christiansen, C., Gamwell-Henriksen, E., Bruyère, O., Collette, J., & Christgau, S. (2001). Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. Calcified Tissue International, 69 (3), 130-137. doi:10.1007/s002230020042

Reginster, J.-Y., Sakar, S., COLLETTE, J., Zegels, B., Henrotin, Y., Bruyère, O., Wrong, M., Harper, K., & Agnusdei, D. (2001). Relationship between 1-year change in bone turnover marker PINP and 3-year vertebral fracture risk reduction with raloxifene therapy in postmenopausal women with osteoporosis: result from the MORE trial. BONE, 28 (Suppl.1), 239.

Reginster, J.-Y., Taquet, A., Christiansen, C., Gamwell-Henriksen, E., Bruyère, O., Collette, J., & Christgau, S. (2001). Bone resorption in postmenopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. BONE, S28, 177. doi:10.1007/s002230020042

Reginster, J.-Y., Taquet, A. N., Christiansen, C., Gamwell-Henriksen, E., Bruyère, O., COLLETTE, J., & Christgau, S. (2001). Bone resorption in postmenopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. Clinical Rheumatology, 5 (Suppl.1), 427. doi:10.1007/s002230020042

Reginster, J.-Y., Taquet, A. N., Christiansen, C., Gamwell-Henriksen, E., Christgau, S., Bruyère, O., & COLLETTE, J. (2001). Respective value of four biochemical markers of bone resorption for the diagnosis of postmenopausal osteoporosis and the monitoring of anti-resorptive therapies. Clinical Rheumatology, 5 (Suppl.1), 421.

Bruyère, O. (18 March 2000). L'ostéoporose: une maladie qui s'évite. Paper presented at Salon "Accord'Age", Liège, Belgium.

Ben Sedrine, W., Devogelaer, J.-P., Kaufman, J.-M., Goemaere, S., Depresseux, G., Bruyère, O., & Reginster, J.-Y. (March 2000). The simple calculated osteoporosis risk estimation (SCORE) does not allow identification of Belgian women with a high risk of osteoporosis. Value in Health, 3, 94-95.

Ben Sedrine, W., Devogelaer, J., Kaufman, J., Goemaere, S., Depresseux, G., Bruyère, O., & Reginster, J.-Y. (March 2000). Interest of the simple calculated osteoporosis risk estimation (SCORE) tool for a more rational use of bone densitometry. Value in Health, 3, 94.

Ben Sedrine, W., Devogelaer, J., Kaufman, J., Goemaere, S., Depresseux, G., Bruyère, O., & Reginster, J.-Y. (2000). The simple calculated ostoporosis risk estimation (SCORE) does not allow to identify Belgian women with a high risk of osteoporosis. Osteoporosis International, 11 (S2), 3.

Ben Sedrine, W., Devogelaer, J.-P., Kaufman, J.-M., Goemaere, S., Depresseux, G., Bruyère, O., & Reginster, J.-Y. (2000). The simple calculated osteoporosis risk estimation (SCORE) does not allow identification of Belgian women with a high risk of osteoporosis. Annals of the Rheumatic Diseases, 59 (Suppl.1), 80.

Ben Sedrine, W., Devogelaer, J., Kaufman, J., Goemaere, S., Depresseux, G., Bruyère, O., & Reginster, J.-Y. (2000). Interest of the simple calculated osteoporosis risk estimation (SCORE) tool for a more rational use of bone densitometry. Osteoporosis International, SS (S5), 13.

Ben Sedrine, W., Devogelaer, J.-P., Kaufman, J.-M., Goemaere, S., Depresseux, G., Bruyère, O., & Reginster, J.-Y. (2000). Interest of the simple calculated osteoporosis risk estimation (SCORE) tool for a more rational use of bone densitometry. Annals of the Rheumatic Diseases, 59 (Suppl.1), 80-81.

Bruyère, O. (2000). Prévention et Promotion de la Santé. (Haute Ecole de la Province de Liège André Vésale, Prévention et Promotion de la Santé).

Bruyère, O., COLLETTE, J., Zegels, B., Rovati, L. C., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (2000). Baseline values and early (6-month) changes in total and bone specific alkaline phosphatase do not predict long-term (4-year) bone mineral density changes in postmenopausal osteoporotic women treated with fluoride. Arthritis and Rheumatism, 43 (S1), 199.

Bruyère, O., & Reginster, J.-Y. (2000). Fracture prevention. New topic. Clinical Evidence, 4, 587-590.

Reginster, J.-Y., & Bruyère, O. (January 2000). Alternatives à l'hormonothérapie substitutive comme prévention de l'ostéoporose postménopausique. Lettre du Gynécologue, 248, 15-17.

Reginster, J.-Y., Bruyère, O., Audan, M., Avouac, B., Body, J.-J., Bouvenot, G., Brandi, M.-L., Gennari, C., Kaufman, J.-M., Lemmel, E.-M., Vanhaelst, L., Weryha, G., & Devogelaer, J.-P. (2000). Do estrogens effectively prevent osteoporosis-related fractures? Calcified Tissue International, 67, 191-194. doi:10.1007/s002230001135

Reginster, J.-Y., COLLETTE, J., Rovati, L. C., DEROISY, R., Bruyère, O., & Henrotin, Y. (2000). Changes in serum osteocalcin but not other serum and urinary markers of bone and cartilage metabolism, measured after 12 months, are significantly correlated to long-term (36 monts) structural changes in knee osteoarthritis. Arthritis and Rheumatism, 43 (Suppl.1), 398.

Reginster, J.-Y., COLLETTE, J., Rovati, L. C., DEROISY, R., Honore, A., Bruyère, O., Seidel, L., & Henrotin, Y. (2000). Biochemical markers of bone and cartilage remodeling are poorly correlated with clinical and radiological severity of knee osteoarthritis. Arthritis and Rheumatism, 43 (Suppl.1), 339.

Reginster, J.-Y., Gillot, V., Bruyère, O., & Henrotin, Y. (2000). Evidence of nutriceutical effectiveness in the treatment of osteoarthritis. Current Rheumatology Reports, 2 (6), 472-477. doi:10.1007/s11926-000-0023-9

Reginster, J.-Y., Paul, I., Fraikin, G., & Bruyère, O. (2000). Bisphosphonates. In The management of the menopause : the Millenium Review (pp. 297-304). London, United Kingdom: Parthenon Publ.

Reginster, J.-Y., Taquet, A.-N., & Bruyère, O. (2000). Skeletal effect of selective oestrogen receptor modulators (SERMs). In SERMs, a novel option to maintain health in the menopause (pp. 49-61). London, United Kingdom: Martin Dunitz Publ.

Bruyère, O. (1997). Répercussion d'une scoliose sur le contenu minéral osseux des cols fémoraux du sujet adulte. Unpublished master thesis, ULiège - Université de Liège.
Jury: .